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ABSTRACT 
RNA polymerase II (RNAPII) is a multiprotein complex responsible for transcription of 
messenger RNAs and some small non-coding RNAs. The largest subunit of RNAPII Rbp1 
harbors an extended C-terminal domain (CTD) that is reversibly phosphorylated in 
transcription cycle-dependent manner. Phosphorylation of the CTD is a dynamic process 
that regulates transcription and coordinates it with pre-mRNA processing. It has been 
shown previously that multidomain peptidyl-prolyl isomerase Rct1 from 
Schizosaccharomyces pombe is associated with transcriptionally active chromatin and 
that it regulates transcriptional activity of RNAPII. Here I investigated a potential role of 
Rct1 in coupling RNAPII transcription and pre-mRNA splicing.  
I demonstrate that Rct1 interacts with the fission yeast SR proteins, Srp1 and Srp2, SR 
protein-like splicing factor Prp2 (U2AFLG) and SR protein-specific kinase Dsk1 in vitro. I 
show that Rct1 employs the RS domain for all of the interactions, but also the PPIase 
domain for the interactions with Srp2 and Prp2. Similarly, Srp2 and Prp2 employ the RS 
domain for the interactions, whereas the RS domain of Srp1 is not required. By 
chromatin immunoprecipitation I show that Rct1 and Srp2 associate with transcritionally 
active chromatin at dis2, osm1 and rho1 genes with a distribution pattern similar to 
RNAPII and that Rct1 RS domain promotes release of RNAPII from the intron-dependent 
stalling/slow down at dis2 gene. I also demonstrate that Rct1 RS domain modulates the 
activity of Rct1 in an heterologous system of the yeast two hybrid assay. As the RS 
domain of Rct1 interacts with splicing factors Prp2 and Srp2, which also create a complex 
with RNAPII in vitro, I propose a working model where Rct1 negatively regulates RNAPII 
processivity in an intron-dependent manner and promotes release of RNAPII from the 
intron-dependent stalling/slow down in Prp2 and/or Srp2-dependent manner. For the 
first time I also show that endogenous Srp1 and Srp2 proteins are entirely nuclear and 
prevalently phosphorylated proteins. In accordance with proposed function of Srp1 in 
sequestration of Srp2, I did neither observe Srp1 to be associated with the 
transcriptionally active chromatin, nor to create the complex with RNAPII. Finally, in the 
yeast two hybrid screen I identified a novel Rct1 interacting protein named translin 
(Tsn1). Although the function of Tsn1 in fission yeasts remain elusive, I show that Tsn1, 
like Rct1, associates with transcriptionally active chromatin and interacts with splicing 
factor Prp2 and splicing related kinase Prp4, suggesting that it might be also involved in 
the regulation of co-transcriptional splicing. 
      
  
ZUSAMMENFASSUNG 
Die RNA Polymerase II (RNAPII) ist ein Multiprotein-Komplex der für die Transkription der 
messenger RNAs (mRNA) und einiger kleiner, nicht kodierender RNAs verantwortlich ist. 
Die größte Untereinheit der RNAPII, Rbp1, enthält eine verlängerte C-terminale Domäne 
(CTD), die abhängig vom Transkriptions-Zyklus reversibel phosphoryliert ist. Die 
Phosphorylierung der CTD ist ein dynamischer Prozess, der die Transkription reguliert 
und diese durch pre-mRNA Prozessierung koordiniert. Es wurde bereits gezeigt, dass die 
Multidomänen Peptidyl-Prolyl Isomerase Rct1 aus Schizosaccharomyces pombe mit 
transkriptionell aktivem Chromatin assoziiert ist und die transkriptionelle Aktivität von 
RNAPII reguliert. In dieser Arbeit habe ich die potentielle Rolle von Rct1 in Verbindung 
von RNAPII vermittelter Transkription und pre-mRNA splicing untersucht.  
Ich demonstriere dass Rct1 mit den SR Proteinen Srp1 und Srp2, dem SR Protein-
ähnlichen splicing Faktor Prp2 (U2AFLG) und der SR Protein-spezifischen Kinase Dsk1 sich 
teilender Hefezellen in vitro interagiert. Ich zeige dass Rct1 die RS Domäne für alle diese 
Interaktionen nutzt, aber ebenso die PPIase Domäne für die Wechselwirkung mit Srp2 
und Prp2. Ebenso nutzen Srp2 und Prp2 die RS Domäne für die Interaktionen, 
wohingegen die RS Domäne von Srp1 nicht benötigt wird. Mit Hilfe von Chromatin-
Immunopräzipitation zeige ich dass Rct1 und Srp2 mit transkriptionell aktivem Chromatin 
an dis2, osm1 und rho1 Genen assoziiert ist. Das Verteilungsmuster ähnelt dem von 
RNAPII. Des Weiteren zeige ich dass die RS Domäne von Rct1 die Freisetzung von RNAPII 
bei der Intron-abhängigen Verzögerung der Transkription am dis2 Gen fördert. Ich stelle 
auch dar dass die RS Domäne von Rct1 dessen Aktivität in einem Heterologen System des 
yeast two hybrid assay moduliert. Da die RS Domäne von Rct1 mit den splicing Faktoren 
Prp2 und Srp2 interagiert, welche auch in vitro einen Komplex mit RNAPII bilden, erstelle 
ich ein Modell in welchem Rct1 die RNAPII Prozessivität in Abhängigkeit von Introns 
negativ reguliert und die Freisetzung von RNAPII an Introns mit verlangsamter 
Transkription in Abhängigkeit von Prp2 und/oder Srp2 begünstigt. Außerdem zeige ich 
zum ersten Mal, dass endogene Srp1- und Srp2-Proteine vollständig im Zellkern 
lokalisiert und häufig phosphoryliert sind. In Übereinstimmung mit der angenommenen 
Funktion von Srp1 zur Sequestrierung von Srp2 habe ich Srp1 weder in Assoziation mit 
aktiviertem Chromatin, noch im Komplex mit RNAPII beobachtet. Darüber hinaus habe 
ich im yeast two hybrid screen ein neues mit Rct1 interagierendes Protein, genannt 
translin (Tsn1), identifiziert. Obwohl die Funktion von Tsn1 in sich teilender Hefe unklar 
bleibt, zeige ich dass Tsn1, wie Rct1, mit transkriptionell aktivem Chromatin assoziiert ist. 
Ebenso interagiert Tsn1 mit dem splicing Faktor Prp2 und der splicing-verwandten Kinase 
Prp4, was nahe legt dass Tsn1 ebenfalls an der Regulierung von co-transkriptionellem 
splicing beteiligt ist. 
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ABBREVIATIONS 
::  genomic fusion 
3-AT  3-amino-1,2,4-triazole 
AD  activation domain 
Ala  alanine 
Asn  asparagine 
ATP   adenosine tri-phosphate 
BD  DNA-binding domain 
BSA  bovine serum albumin 
cDNA  coding DNA 
ChIP chromatin 
immunoprecipitation 
CIP  calf intestine phosphatase 
CLIP cross-linking and immuno-
precipitation 
CPF cleavage/polyadenylation 
factor 
CsA  cyclosporin A 
CTD  C-terminal domain of RNAPII 
DMSO  dimethylsulphoxide 
dNTPs  deoxynucleotide triphosphates 
DRB 5,6-dichloro-1-b-D-
ribofuranosylbenzimidazole 
EDA  spliceosomal exon definition 
complex A 
EDE spliceosomal exon definition 
complex E 
EDTA ethylenediaminetetraacetic 
acid 
EGTA  ethylene glycol tetraacetic acid 
ESE  exonic splicing enhancer 
ESS  exonic splicing silencer 
FKBP  FK506 binding proteins 
GE  geneticin 
GFP  green fluorescent protein 
Gly  glycine 
GST  glutathione S-transferase 
GTP  guanosine tri-phosphate 
H  hygromycin 
H3K36me3  histon H3 lysine 36 
trimethylation  
H3K4me3 histon H3 lysine 4 
trimethylation 
HA  hemagglutinine 
His  histidine 
HIV  human immunodeficiency virus 
hnRNP heterogenous nuclear 
ribonucleoproteins 
hs  Homo sapiens 
Ile  isoleucine 
IPTG  isopropyl-β-D-thio-galactoside 
mRNA  messenger RNA 
Abbreviation 
 
 
2 
NaOAc  sodium acetate 
NELF  negative elongation factor 
NLS  nuclear localization signal 
nmt no message in thiamine, here 
the name of repressible 
promoter 
OD600  optical density at λ 600 nm  
ORF  open reading frame 
PCR  polymerase chain reaction 
PEG  polyethylene glycol 
Phe  phenylalanine 
PPIase  peptidyl prolyl isomerase 
pre-mRNA precursor of messenger RNA  
Pro  proline 
P-TEFb positive transcription 
elongation factor b 
PTPA protein phosphatase 2A 
phosphatase activator 
PVDF  polyvinylidene fluoride 
Py  polypyrimidine tract 
qRT-PCR  quantitative real-time PCR 
RBD  RNA-binding domain  
rDNA  ribosomal DNA 
RNAPII  RNA polymerase II 
RRM  RNA recognition motif 
RS domain domain rich in arginines and 
serines 
RT-PCR  reverse transcription PCR 
sc  Sacharomyces cerevisiae 
SCP  small CTD phosphatase 
SDS  sodium dodecyl sulfate 
SELEX systematic evolution of ligands 
by exponential enrichment 
Ser  serine 
snRNA  small nuclear RNA 
snRNP small nuclear 
ribonucleoprotein 
sp  Schizosaccharomyces pombe 
TCA  trichloro acetic acid 
TFIIH  transcription factor IIH 
Thr  threonine 
Tyr  tyrosine 
U2AF  U2 snRNP auxiliary factor 
UTR  untranslated region 
Val  valine 
wt  wild type 
XXX name of gene XXX in S. 
cerevisiae 
xxx  name of gene xxx in S. pombe  
Xxx protein, product of gene XXX in 
S. cerevisiae or in xxx S. pombe 
xxx
+
 wild type allele of gene xxx in 
S. pombe 
Abbreviation 
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xxx-T protein Xxx tagged with tag T 
in S. pombe 
xxx-Y gene xxx mutated by Y 
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Δxxx deletion of gene xxx in S. 
pombe 
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1. INTRODUCTION  
1.1. RNA POLYMERASE II 
The RNA polymerase II (RNAPII catalyzes synthesis of mRNA molecules and some small 
non-coding RNAs using one strand of DNA as a template. The core RNAPII is composed of 
12 subunits (Rpb1-Rpb12) that are structurally and functionally conserved from yeast to 
human (Mitsuzawa and Ishihama, 2004). The largest subunit of RNAPII Rpb1 has globular 
N-terminal catalytic domain and unique C-terminal domain (CTD) that protrudes out of 
the catalytic core just below the RNA exit point (Meinhart et al., 2005; Cramer et al., 
2004). The CTD of RNAPII is largely unstructured and composed of a number of Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 heptad peptide repeats. The exact number of repeats 
varies among different organisms (reviewed in Chapman et al., 2008). For instance there 
are 26 repeats in fission yeasts and 52 repeats in humans, but in humans only 26 repeats 
harbor the consensus sequence, whereas the C-terminal repeats are highly degenerated. 
The Ser2, Ser5 and Ser7 of CTD are phosphorylated in transcription cycle-dependent 
manner and the phosphorylated CTD then serves as a binding platform for many 
regulatory proteins.  
1.1.1. RNAPII transcription cycle 
The RNAPII mediated transcription cycle has three different stages: initiation, elongation 
and termination controlled by different regulatory factors (reviewed in Palancade and 
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Bensaude, 2003; Phatnani and Greenleaf, 2006; Cho EJ, 2007; Egloff and Murphy, 2008; 
Margaritis and Holstege, 2008; Buratowski S, 2009). The current working model of 
RNAPII mediated transcription (see Fig. 1.1., Egloff and Murphy, 2008; Buratowski S, 
2009) is as follows: Prior to the transcription, the nonphosphorylated RNAPII associates 
with DNA and the Mediator (reviewed in Margaritis and Holstege, 2008) in the 
transcription pre-initiation complex. The Mediator is a multiprotein complex that  
interacts with DNA regulatory elements and guides the RNAPII to the promoter. Once at 
the promoter the RNAPII awaits for appropriate signals to start transcription. Upon 
receiving the initiation signal the Ser5 of CTD becomes phosphorylated, the RNAPII 
interactions with the Mediator are disrupted and the RNAPII starts initial phase of 
transcription, so called promoter escape. At this stage RNAPII transcribes only a short 
sequence and then it pauses. The release from this promoter-proximal paused state 
requires the phosphorylation of Ser2, the key determinant of productive elongation 
phase. The major part of productive elongation is characterized by both Ser5 and Ser2 
phosphorylations, whereas towards the end of gene the Ser2 phosphorylation becomes 
the prevalent CTD modification (Kim et al., 2010). The Ser2 phosphorylation is also 
required for efficient termination and togethr with the Ser5 phosphorylation must be 
removed prior to another round of transcription. 
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Figure 1.1.  Schematic representation of RNAPII transcription cycle according to Egloff and 
Murphy (2008). 
Prior to the initiation of transcription the dephosphorylated RNAPII is recruited to gene’s 
promoter by help of pre-initiation Mediator complex (a). Upon intitiation the TFIIH transcription 
factor phosphorylates Ser5 of RNAPII CTD and 5’ end of nascent pre-mRNA is capped (b). After 
completion of this first step of transcription Ser2 of CTD is phosphorylated by P-TEFb 
transcription factor and RNAPII enters the productive elongation phase of transcription (c). Ser7 
of CTD also becomes phosphorylated at the beginning of the elongation phase, however, the 
function of this modification in transcription of protein coding genes is unknown. After 
completion of the elongation phase the Ser5 and Ser2 are dephosphorylated and RNAPII is 
released for another round of transcription (d). As indicated in the scheme, different steps of 
transcription are coupled to different RNA processing activities. 
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This working model is well consistent with the observation that RNAPII is pre-associated 
with gene’s promoters in the majority of transcription events and waits for appropriate 
signals to begin the transcription (reviewed in Fujita and Schlegel, 2010). This often leads 
to cryptic transcription of first bases producing transcripts that are immediately 
degraded. Controlled switch from the cryptic transcription to the productive elongation 
enables cell to respond promptly to environmental stimuli and metabolic demands 
(reviewed in Margaritis and Holstege, 2008). Transcription is usually provided by more 
than one RNAPII complex on a gene at the same time, further increasing the amount of 
RNA product generated per time. During the transcription the phosphorylated RNAPII 
CTD domain is recognized by a number of RNA processing factors that couple the mRNA 
synthesis with downstream RNA processing pathways, e.g. capping, splicing, 
polyadenylation, in a well organized sequential order (reviewed in Cramer et al., 2001; 
Millevoi and Vagner, 2010; Pirngruber et al., 2009a; Cowling VH, 2009; Lenasi and 
Barboric, 2010; Lunde et al., 2010). The associated factors also modify the chromatin 
structure along the transcribed gene to facilitate the progression of next RNAPII enzyme 
(Kundu et al, 2007). It is also plausible that the looping of the template DNA enables the 
recruitment of terminating RNAPII complex back to the promoter further increasing the 
overall rate of transcription (reviewed in Brickner JH, 2009; Moore and Proudfood, 
2009).   
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1.1.2. Regulation of RNAPII transcription by CTD domain modifications – the 
”CTD code”   
The main modification of RNAPII CTD is the transcription cycle-dependent Ser2 and Ser5 
phosphorylation. It is regulated by several factors, positive and negative transcriptional 
regulators. While the positive regulators act mainly to enhance the Ser5 and Ser2 
phosphorylation, the negative regulators inhibit it. There are several kinases implicated 
in the phosphorylation of RNAPII CTD. The main kinase responsible for Ser5 
phosphorylation and transcription initiation is hsCDK7/scKin28/spMcs6 cyclin-dependent 
kinase, the component of general transcription factor TFIIH (Hengartner et al., 1998; 
Rickert et al., 1999; Watanabe et al., 2000). The CDK7 creates complex with hscyclin 
H/scCcl1/spMcs2 and requires hsMAT1/scTfb3/spPmh1 co-factor to phosphorylate the 
RNAPII CTD (Watanabe et al., 2000). The Ser5 can be also phosphorylated by 
hsCDK8/scSrb10/spSrb10 kinase that is associated with the Mediator in the transcription 
pre-initiation complex (Rickert et al., 1999; Blazek et al., 2005). The mammalian CDK8 
can either induce transcription by CTD phosphorylation (Hengartner et al., 1998) or 
repress the transcription by phosphorylation of cyclin H in TFIIH transcription factor 
(Akoulitchev et al., 2000; Knuesel et al., 2009). On the contrary, in yeasts the Srb10 
kinase, an homologue of CDK9, represses transcription of RNAPII by CTD phosphorylation 
(Hengartner et al., 1998). Although the mechanisms of CDK8 and Srb10 mediated 
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initiation seems to be different, it is obvious that CDK8/Srb10 kinase is important for 
transcription  initiation.  
The phosphoryaltion of Ser2 is catalyzed by positive elongation factor P-TEFb (Marshall 
et al., 1996; Lee and Greenleaf, 1997). Up to date there has been only one P-TEFb 
complex known in metazoans, composed of CDK9 kinase and cyclin T1. By contrast in 
yeasts two kinases homologous to CDK9 were identified and implicated in Ser2 
phosphorylation (Wood and Shilatifard, 2006). The budding yeast kinase Bur1 in complex 
with cyclin Bur2 was determined to phosphorylate the promoter-proximal Ser2 residues 
in Kin28-dependent manner and this initial Ser2 phosphorylation was shown to stimulate 
Ctk1/Ctk2 kinase/cyclin complex to phosphorylate promoter-distal Ser2 residues (Keogh 
et al., 2003; Qiu et al., 2009). Both Bur1/Bur2 and Ctk1/Ctk2 complexes have 
homologues in fission yeasts, the Cdk9/Pch1 and Lsk1/Lsc1, respectively (Pei and 
Shuman, 2003; Karagiannis and Balasubramanian, 2007). Very recently, kinases 
homologous to Ctk1/Lsk1 were identified in Drosophila (dCDK12) and humans (hCDK12 
and hCDK13) and were shown to harbour the same promotor-distal Ser2 specificity 
(Bartkowiak et al., 2010). The main negative regulators of Ser2 phosphorylation are DRB 
sensitivity-inducing factor (hsDSIF/scSpt5/spSpt5) and negative elongation factor (NEL). 
They are both associated with paused RNAPII and released upon the phosphorylation by 
CDK9 (reviewed in (Pirngruber et al., 2009a; Fujita and Schlegel, 2010). The CTD of 
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template-free RNAPII can be also phosphorylated on Ser5 and Ser2 by 
hsCDC2/scCdc28/spCdc2 cyclin-dependent kinase and on Ser5 by hsERK-1/2 kinase, 
resulting in inactive hyperphosphorylated form of RNAPII (Egloff and Murphy, 2008).  
Also Ser7 of CTD can be reversibly phosphorylated by hsCDK7/scKin28/spMcs6 kinase at 
the promoter-proximal regions (Akhtar et al., 2009; Glover-Cutter et al., 2009) and Bur1 
kinase at the promoter-distal regions (Tietjen et al., 2010). The Ser7 phosphorylation was 
detected along the whole transcriptional units, but it was enriched at the 5’ ends of 
genes and on introns suggesting that it might be involved in the splicing regulation (Kim 
et al., 2010). Moreover, the Ser7 phosphorylation, as well as the Ser2 phosphorylation, 
are necessary for recruitment of snRNA gene-specific Integrator complex to the CTD 
(Egloff et al., 2010) and the Ser7 phosphorylation signal co-localizes with the early 
termination factor Nrd1 on the snRNA genes (Kim et al., 2010). These results suggest that 
Ser7 phosphorylation is mainly required for the transcription of non-coding snRNAs, but 
still might have an yet not defined function in the transcription of mRNA genes. 
Beside of serines Tyr1 and Thr4 of CTD can be also phosphorylated. First, it was shown 
that Thr4 of CTD is phosphorylated by p34 kinase in vitro (Zhang and Corden, 1991). 
Later Baskaran et al. (1993, 1997) showed that the tyrosine kinase encoded by c-abl 
protooncogene phosphorylates Tyr1 on recombinant CTD in vitro, while the 
overexpression of c-abl increases Tyr1 phosphorylation and gene transcription in vivo. 
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However, up to date no function has been attributed to the Tyr1 and Thr4 
phosphorylations. The mammalian CTD was also found to be glycosilated by the addition 
of N-acetylglucoseamine to the hydroxyl groups of serine and threonine residues (Kelly 
et al., 1993). The glycosilation, however, takes place only on the non-phosphorylated 
CTD, suggesting that it somehow regulates RNAPII recruitment to the promoter. 
Furthermore, the Ser2-Pro3 or Ser5-Pro6 bonds of CTD can be specifically targeted by 
peptidyl prolyl cis/trans isomerases (PPIases) (Shaw PE, 2007). These enzymes change 
the conformation of peptidyl-prolyl bonds in a well controlled substrate-specific manner 
and can fine tune the existing “CTD code” in a very specific way (see part 1.5 for details). 
Upon completion of transcription the pSer2 and pSer5 are dephosphorylated by CTD-
specific phosphatases and the dephosphorylated RNAPII is then released for another 
round of transcription (reviewed in Meinhart et al., 2005). The main phosphatase 
responsible for dephosphorylation of CTD seems to be hsFcp1/scFcp1/spFcp1, the 
component of the transcription factor TFIIH. The human Fcp1 was reported to 
dephosphorylate both pSer2 and pSer5 with equal efficiency (Lin et al., 2002) or with the 
preference for pSer5 (Kong et al., 2005), whereas the fission yeast Fcp1 seems to have a 
preference for pSer2 (Hausmann and Shuman, 2002). The activity of Fcp1 on CTD 
substrate is further modulated by other CTD-binding proteins (Palancade et al., 2003). 
For example, it was reported that the PPIase Pin1 (see also part 1.5.) can modulate Fcp1 
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specificity for pSer2 or pSer5 (Kops et al., 2002). Yeo et al. (2003, 2005) described a 
family of small CTD phosphatases (SCPs) with catalytic domain structure similar to that of  
Fcp1, which are involved in the dephosphorylation of pSer5 in humans. Krishnamurthy et 
al. (2004) identified pSer5 specific phosphatase Ssu72 associated with the 
cleavage/polyadenylation factor (CPF) complex in budding yeasts. Later an homologue of 
Ssu72 in humans was described (St-Pierre et al., 2005) and Zheng et al. (2005) discovered 
ubiquitin-like domain UBLCP1 CTD phosphatase with preference for pSer5. Most recently 
Mosley et al. (2009) described a novel CTD phosphatase Rtr1 required for pSer5 
dephosphorylation during the early elongation phase of transcription in budding yeasts.  
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1.2. Pre-mRNA SPLICING  
1.2.1. Splicing mechanism and regulation of spliceosome assembly 
Many pre-mRNA transcripts harbor sequence regions – introns that are not translated 
into peptide, but are excised of the pre-mRNA transcript in two subsequent 
transesterification reactions – the splicing reactions. The splicing reactions are catalyzed 
by the spliceosome, a dynamic ribonucleoprotein (RNP) complex composed of small 
nuclear RNAs (snRNAs: U1, U2, U3, U4, U5) and many proteins (reviewed in Staley and 
Guthrie, 1998; Jurica and Moore, 2003; Ritchie et al., 2009; Newman and Nagai, 2010). 
The snRNAs associate with diverse protein splicing factors and commit the major 
catalytic activities of the spliceosome. The step-by-step spliceosomal assembly model 
(Fig.1.2.) is generally accepted (Wahl et al., 2009). In this model the U1 snRNP first 
recognizes the GU sequence at the 5’ splice site of an intron and the U2AF auxiliary 
factor together with the SF1/BBP protein recognize the branch point, polypyrimidine 
tract (Py) and the AG dinucleotide at the 3’ splice site of the intron creating the 
prespliceosomal E complex. Then the SF1/BBP is released and U2 snRNP binds to the 
branch point sequence just upstream of the Py tract resulting in the prespliceosomal A 
complex. Finally, the U4/U6.U5 tri-snRNP complex is added to the A complex to form the 
inactive spliceosomal B complex. Prior to the catalysis individual components of the 
spliceosomal B complex are rearranged and the U1 and U4 snRNPs are released. The 
remaining snRNPs then form the active spliceosomal complex B* that catalyzes the first 
transesterification reaction. Again, some re-arrangements occur to form the 
spliceosomal C complex that catalyses the second transesterification reaction. After the 
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second transesterification reaction the spliceosome disassembles and the spliced mRNA 
is released, but still tightly packed with numerous proteins.  
 
Figure 1.2.  Schematic representation of spliceosome assembly according to Wahl et al. (2009).  
In the first step of spliceosomal assembly the U1 and U2 snRNPs recognize the 5’ and 3’ splice 
sites of target intron in prespliceosomal A complex. Then U4/U6.U5 tri-snRNP complex is added 
to create precatalytic spliceosomal B complex. After some rearrangements the U1 and U4 
snRNPs are released and the spliceosomal B* complex then catalyzes the 1st transesterification 
reaction. After some additional remodeling the spliceosomal C complex catalyses the 2nd 
transesterification reaction. Finally, the U2.U4.U6 complex dissociates and spliced mRNA is 
released in a complex with associated proteins ready for export out of the nucleus. The extensive 
remodeling of spliceosomal complexes is catalyzed by eight different DExD/H-type RNA 
dependent ATPases/helicases and one GTPase as indicated in the picture. 
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The individual spliceosomal complexes can be isolated and the associated RNA splicing 
intermediates can be visualized. Indeed the majority of spliceosomal subcomplexes were 
purified and the corresponding protein components were identified. First the core 
spliceosomal proteins were identified (Neubauer et al., 1998; Rappsilber et al., 2002; 
Stevens et al.; 2002; Zhou et al., 2002) and later the individual spliceosomal complexes 
were defined more thoroughly: the pre-spliceosomal A complex (Behzadnia et al., 2007), 
the spliceosomal B* complex (Makarova et al., 2004; Deckert et al., 2006; Bessonov et 
al., 2008) and the spliceosomal C complex (Bessonov et al., 2008). In these studies 
synthetic RNAs with a single intron were used as a matrix for the in vitro assembly of the 
spliceosomal components. This approach likely resulted in the reduced complexity of 
isolated complexes. Therefore, Chen et al. (2007) purified native mRNA-associated 
protein complex named supraspliceosome. This complex isolated either form human or 
mouse cells contained more then 300 proteins. Many of them were well known 5’ and 3’ 
end processing factors, RNA export factors and chromatin modifying factors, as well as 
some proteins with unknown function.     
The spliceosomal assembly model described above suggests that the spliceosomal 
components are rearranged thoroughly during the splicing process. The major driving 
force for the spliceosomal rearrangements are the DExD/H-type RNA dependent 
ATPases/helicases that associate with spliceosome at different stages of assembly and 
facilitate the reorganization of the RNA-RNA and RNA-protein interactions (Staley and 
Guthrie, 1998; Wahl et al., 2009). Eight helicases (scSub2/hsUAP56, scPrp5, 
scPrp28/hsU5-100K, scBrr2/hsU5-200K, scPrp2, scPrp16/hsPRP16, scPrp22/hsHRH1, 
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scPrp43/hsmDEAH9) are well conserved from yeasts to man and are essential for the 
function of spliceosome (Staley and Guthrie, 1998; Wahl et al., 2009). Up to date only 
one GTPase Snu114/U5-116 has been identified within the spliceosomal complex 
(Fabrizio et al., 1997). The other distinct regulatory proteins associated with the 
spliceosome are peptidyl prolyl cis/trans isomerases (PPIases) of cyclophilin family, i.e. 
the enzymes that catalyze isomerization of peptidyl bonds proceeding proline (reviewed 
in Mesa et al., 2008). The change of peptidyl prolyl bond from cis to trans conformation, 
or vice versa, might change the structure and function of the target protein significantly 
and the PPIases therefore likely contribute to the major spliceosomal rearrangements 
(see part 1.5. for details). Nevertheless, the precise model of PPIase-dependent 
spliceosomal remodeling is still missing.  
Many spliceosomal components are posttranslationally modified. In humans at least four 
different kinases, hsSRPK1/scSky1/spDsk1, hsSRPK2, hsPRP4/spPrp4 and 
hsClk/Sty/scKns1/spLkh1 act together to phosphorylate different spliceosomal 
components (Wahl at al., 2009). The SRPK1, SRPK2 and Clk/Sty are characterized as the 
RS domain-specific kinases (see part 1.3.2. for details). The SRPK1 and SRPK2 are both 
able to phosphorylate the RS domain of prototypical SR protein ASF/SF2, in accordance 
with the preference of both kinases for the RS domain (Kuroyanagi et al., 1998; Wang et 
al., 1998). However, in vivo they are components of two distinct spliceosomal complexes. 
Whereas the SRPK1 associates preferentially with U1 snRNP complex, the SRPK2 creates 
complex with the U4/U6.U5 tri-snRNP (Mathew et al., 2008). As a part of tri-snRNP 
complex the SRPK2 phosphorylates the RS domain of PRP28 helicase in vivo and as a 
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consequence regulates the spliceosomal B complex assembly. The spPrp4 was the first 
kinase identified to phosphorylate a non-SR protein splicing factor, the spPrp1 
(Schwelnus et al., 2001). Later Dellaire et al. (2002) showed that the human PRP4 kinase 
is a component of the U4/U6.U5 tri-snRNP complex and the experiments of Schneider et 
al. (2010a) revealed that the phosphorylation of hsPRP6, spPrp1 and hsPRP31 proteins of 
this complex by PRP4 is necessary for the spliceosome B complex formation. The mouse 
and fission yeast Prp4 homologues were reported to phosphorylate also the RS domain 
of ASF/SF2 SR protein (Gross et al., 1997). Interestingly, the human PRP4 protein has RS 
rich N-terminal domain typical of SR proteins (see also part 1.3.), but the S. pombe 
homologue miss this region. There are few more spliceosomal phosphoproteins reported 
up to date, however, the information regarding the mechanism of spliceosomal 
phosphoregulation is only sparse (Mermoud et al., 1992, 1994; Misteli T, 1999). The 
other protein modifications recognized among splicing factors are ubiquitination and 
acetylation, but there likely also exist other, yet not detected, modifications (Wahl et al., 
2009). 
1.2.2. Constitutive and alternative splicing 
In protozoa and lower eukaryotes (e.g. yeasts) the majority of introns are constitutively 
spliced. On the contrary, in the higher eukaryotes splicing results in alternative splicing 
pattern of many genes (reviewed in Graveley BR, 2000; Pozzoli and Sironi, 2005; Keren et 
al., 2010). As a consequence different splice variants with different information regarding 
the function and faith of the mRNA, i.e. information that leads to the mRNA translation, 
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deposition or decay, are generated (reviewed in Giorgi and Moore, 2007; Houseley and 
Tollervey, 2009; Moore and Proudfoot, 2009).  
Several types of alternative splicing have been described (reviewed in Hertel KJ, 2008; 
Long and Caceres, 2009; Keren et al., 2010). The most common type of alternative 
splicing in fungi, protozoa, lower metazoans and plants is the intron retention, whereas 
the prevalent type in higher eukaryotes is the exon skipping and alternative 3’ and 5’ 
splice site selection. Two models have been proposed to describe the intron retention 
and exon skipping mechanisms (Berget SM, 1995). For the intron retention an intron 
definition model have been proposed (Fig. 1.3.A). In this model the splicing of an intron is 
guided by the intron bridging interactions that occur among different splicing factors. 
The alternative intron is then spliced out employing the mechanism described in the 
section 1.2.1. The small intron size and some experimental evidence argument for the 
intron recognition model to be the prevalent mode of splice site recognition in the fission 
yeasts (Romfo et al., 2000; Haraguchi et al., 2007). For the exon skipping mechanism an 
exon definition model have been proposed (Fig 1.3.B.). In this case the exon skipping is 
defined by the interaction network that assembles across an exon. Here, U2AF and U1 
snRNP bound to the exon adjacent 3’ and 5’ splice sites pair together and interact with 
the U4/U6.U5 tri-snRNP to create the exon definition complex (Schneider et al., 2010b). 
As a result the splicing machinery recognize only the 5’ splice site upstream and 3’ splice 
site downstream of exon and cuts the exon out together with the adjacent introns. If the 
alternative exon inclusion is appropiate, the exon definition complex is changed to the 
intron definition complex, i.e. the U2AF of exon definition complex pairs with the 
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upstream 5’ splice site and U1 snRNP with the downstream 3’ splice site to excise only 
the intronic sequences and not the exon (Schneider et al., 2010b).  
 
Figure 1.3. Intron and exon definition models according to Schellenberg et al. (2008). 
In the intron definition model (a) the 5’ splice site is recognized by U1 snRNP complex and 3’ 
splice site by SF1/BBP.U2AF65 complex in the pre-spliceosomal E complex. Later the U2 snRNA 
complex is bound at the 3’ splice site and the U1 and U2 snRNPs interact with each other in 
spliceosomal A complex. Finally the intron is spliced out by catalytically active spliceosomal C 
complex and the two constitutive exons (red and blue) are joined together. In the exon definition 
model (b,c) the alternative exon (green) can be either spliced out (c) or retained (b) in the mature 
mRNA. If retained (b), the SF1/BBP.U2AF65 complex binds at the exon’s 3’ splice site and the U1 
snRNP at the exon’s 5’ splice site in the exon definition E complex (EDE). Upon U2 snRNP binding 
the upstream U2 snRNP interacts with the downstream U1 snRNP complex in the exon definition 
A complex (EDA). After exon definition complex has been created it is converted to intron 
definition A complexes over the exon’s adjacent introns and the adjacent introns are spliced out. 
If the alternative exon is spliced out (c), the exon definition complex is not created and the 
pairing occurs between the U1 snRNP upstream of alternative exon and U2 snRNP downstream 
of alternative exon. As a result the alternative exon with the adjacent introns is spliced out. The 
exon definition complex formation is inhibited by the action of different hnRNP protein like PTB, 
that interfere with U2AF65 binding and U1 and U2 snRNP pairing. 
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In some genes the transition between exon definition and intron definition complex is 
controlled by PTB factor that inhibits binding of U2AF to the 3’ splice site and U1 and U2 
snRNP pairing and therefore interfere with the formation of the exon definition complex 
(Sharma et al., 2005, 2008; for review see Schellenberg et al., 2008, see also Fig. 1.3.C). 
Although PTB is the best understood factor required for the exon to intron definition 
transition, it is likely not the only factor required for the regulation of this process. 
From the above is clear that the first steps of splicing reaction must be under the tight 
control of splicing factors to ensure the proper splicing pattern of target genes. It seems 
plausible that the definitive splice site selection occurs during the spliceosomal A 
complex formation and it was proposed that the hydrolysis of ATP at this stage of 
assembly locks the paired 5’ and 3’ splice sites for the final splicing pattern (Kotlajich et 
al., 2009). Prior to the final pairing between the U1 and U2 snRNPs a dynamic network of 
interactions defines the splice sites. There are several strategies employed by different 
splicing factors and heterogeneous nuclear RNPs (hnRNPs) to select the optimal splice 
site. In general, these factors recognize the signal RNA sequences adjacent to the 
putative splice site and communicate the information to the core splicing machinery 
(reviewed in Pozzoli and Sironi, 2005; Hertel KJ, 2008; Shellenberg et al., 2008; Long and 
Caceres, 2009; Shepard and Hertel, 2009). The sequences are termed enhancers, if their 
recognition leads to preferential inclusion of the splice site, or silencers, if they result in 
skipping of the splice site. The major group of proteins that positively regulate 
spliceosomal assembly are the SR proteins (see part 1.3. for details), whereas the 
negative regulation is mainly mediated by the structurally diverse hnRNP proteins 
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(Pozzoli and Sironi, 2005). Different positive regulators can act in synergy to enhance 
splicing of a particular intron, but the combined action of the positive and negative 
regulators is antagonistic (Fig. 1.4.). A final splicing pattern is therefore the result of 
summed interactions that occur at the particular splice site.  
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1.3. SR PROTEINS, SR-LIKE PROTEINS AND REGULATION OF SPLICING 
The SR proteins  are group of splicing factors with the key function in regulation of 
constitutive and alternative splicing (reviewed in Long and Caceres, 2009; Shepard and 
Hertel, 2009). Although they were originally identified as splicing factors (Fig. 1.4.), 
nowadays the functions assigned to them cover many different stages of gene 
expression, ranging from transcription to translation (reviewed in Moore and Proudfoot, 
2009; Zhong et al., 2009).  
 
Figure 1.4. Schematic representation of interactions leading to alternative splice site choice 
according to Long and Caceres (2009). 
The interaction of U2AF splicing factor with 3’ splice site and U1-70K splicing factor with 5’ splice 
site is regulated by exonic splicing enhancer-bound (ESE-bound) SR proteins that positively 
regulate the splice site selection (A). Alternatively, the upstream 3’ splice site can be attenuated 
by the interactions with exonic splicing silencer-bound (ESS-bound) hnRNP proteins (B). The 
splice site selection can be also modulated by free SR proteins that are not, bund to RNA (C).  
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According to the current definition (Long and Caceres, 2009), all members of this group 
are characterized by one or two RRM domains and an RS domain and must act as splicing 
regulators. Proteins with similar structural features, but not involved in the splicing 
regulation, or proteins with the RS domain, but lacking the RRM domain, are collectively 
termed SR-like or SR-related proteins and are not considered bona fide SR proteins. Both, 
SR proteins and SR-like proteins might harbor additional domains with diverse functions 
(Long and Caceres, 2009). 
1.3.1. The RNA recognition motif (RRM domain) and its function 
The RNA recognition motif (RRM) domain, also known as RNA binding domain (RBD), is a 
protein fold consisting of at least four β-strands and two α-helices organized in 
β1α1β2β3α2β4 topology (reviewed in Maris et al., 2005; Clery et al., 2008). Based on 
numerous crystal structures the β-strands create an antiparallel β-sheet spatially 
arranged in β4β1β3β2 order with two α-helices positioned above or below it.  There are 
two highly conserved segments named RNP1 (Lys/Arg-Gly-Phe/Tyr-Gly/Ala-Phe/Tyr-
Val/Ile/Leu-X-Phe/Tyr) and RNP2 (Ile/Val/Leu-Phe/Tyr-Ile/Val/Leu-X-Asn-Leu) on β3 and 
β1 strands, respectively, that are essential for RRM-RNA binding. The RNA binding is 
mediated by aromatic residues of Phe or Tyr side chains (marked in bold) that stack with 
the RNA bases. The resulting RRM-RNA binding affinity and specificity is usually high, but 
can be modulated by protein – protein interactions employing the β2 and β4 strands, the 
intervening loops and C-terminal and N-terminal parts of the protein. A single RRM 
domain can recognize two to eight nucleotides of RNA (Clery et al., 2008); however, 
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multiple RRM domains often cooperate in RNA binding and recognize longer stretches of 
RNA (Ding et al., 1999; Handa et al., 1999).  
The SR proteins usually employ the RRM domains for recognition of the enhancer or 
silencer sequences. Many SR protein target sequences were identified employing either 
SELEX/functional SELEX or CLIP procedures (Liu et al., 1998; 2000; Sanford et al., 2008). 
Many splicing factors recognize their target sequences individually; however, sometimes 
two SR proteins can cooperate to enhance the splicing of an alternative exon as was 
reported for ASF/SF2 and 9G8 on FP/ESE of bovine growth hormone pre-mRNA (Li et al., 
2000). Also the phosphorylation status of an SR protein influences the ESE binding. For 
example Srp40 binds to the enhancer only if it is phosphorylated on the RS domain 
(Tacke et al., 1997). Furthermore, the RRMs can cooperate with the other domains, for 
example zinc knuckle domain, in the recognition of the target sequence (Cavaloc et al., 
1999). Some SR proteins, including ASF/SF2, have two RRM domains, but only the RRM1 
has conserved RNP1 and RNP2 motifs. The RRM2 does not harbor the RNP1 and RNP2, 
but instead has conserved SWQDLKD motif that contributes to RNA binding (Tacke RMJ, 
1995; Tintaru et al., 2007). The RRM1 of ASF/SF2 was implicated in binding to enhancer, 
whereas the RRM2 seems to be required for alternative 5’ splice site selection of 
adenovirus E1A gene (Dauksaite and Akusjarvi, 2004). Importantly, although the RRM 
domain is considered to be mainly an RNA binding domain, in some proteins it also 
participates, or is fully endowed, in the protein-protein interactions as exemplified by 
RRM3 of U2AF65 protein (Kielkopf et al., 2001; Selenko et al., 2003; reviewed in Maris et 
al., 2005). Therefore, although the RRM domains of SR proteins are mainly responsible 
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for binding to RNA regulatory elements they can be also involved in the transient protein 
- protein interactions that occur during the spliceosomal assembly. 
1.3.2. The RS domain and its function  
The RS domain is usually C-terminal domain of SR proteins characterized by a number of 
stretches consisting of arginine-serine dipeptides and hence prevalently positively 
charged. The serines of this domain are targeted by RS domain-specific kinases of SRPK 
and Clk/Sty families (Stamm S, 2008; Long and Caceres, 2009; Shepard and Hertel, 2009). 
The phosphorylated RS domain usually harbors nuclear localization signal (NLS) that 
interacts with the SR protein nuclear import receptor. On the contrary, the 
dephosphorylation of RS domain is usually required for the efficient nuclear export of 
shuttling SR proteins (Lin et al., 2005; Tenenbaum and Aguirre-Ghiso, 2005). The 
phosphorylation is also considered to prevent the spontaneous aggregation of 
unphosphorylated RS domain proteins (Nikolakaki et al., 2008). It is plausible that the RS 
domain phosphorylation is a highly ordered process. This is well documented for ASF/SF2 
protein (Aubol et al., 2003; Ngo et al., 2005; Velazquez-Dones et al., 2005; Ma et al., 
2009). The RS domain of ASF/SF2 can be subdivided into two regions, N-terminal RS1 and 
C-terminal RS2. The RS1 is phosphorylated by SRPK1 kinase in the cytoplasm and 
subsequently the protein is transported into the nucleus where it is deposited in the 
nuclear speckles. The RS2 is phosphorylated by Clk/Sty in the nucleus and as a result the 
ASF/SF2 is released from the nuclear speckles and associates with the spliceosome. I n 
the order to become fully active, the RS domain must be transiently dephosphorylated 
during the splicing process (Mermoud et al., 1992, 1994). 
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The RS domain is both, protein and RNA interacting domain. The RS-RS domain 
interactions were detected among several splicing factors (Wu and Maniatis, 1993) and 
are believed to direct, at least partially, the early steps of spliceosomal assembly 
(reviewed in Graveley BR, 2000). Three of the key spliceosomal components, U1-70K, 
U2AF65 and U2AF35 harbor an RS domain. In the early models of splice site recognition 
and complex A assembly the enhancer bound SR proteins were suggested to interact 
through their RS domains with U1-70K, U2AF65 and U2AF35 splicing factors (Graveley BR, 
2000). First Wu and Maniatis (1993) showed that these interactions are RS domain-
dependent. Their results were well consistent with later experiments (Zuo and Maniatis, 
1996; Graveley et al., 2001) that investigated enhancer-dependent complex E formation 
at the weak 3’ splice site of doublesex (dsx) gene in Drosophila. They showed that the 
enhancer bound SR proteins (Tra and Tra2) interact with U2AF35 that in turn recruits 
U2AF65 to the Py tract. However, some other experimental evidence does not support 
this model. For example Rudner et al. (1998) showed that the RS domains of either 
U2AF35 or U2AF65 subunits in Drosophila are dispensable in vivo and do not affect the dsx 
pre-mRNA splicing, although the double deletion is synthetically lethal. Similarly, the 
results of Li and Blencowe (1999) suggest that the U2AF65 binding to weak 3’ splice site of 
dsx is not enhancer-dependent.  
The RS domains of SR proteins were also implicated in the direct interactions with the 
pre-mRNA/snRNA duplexes (reviewed in Graveley BR, 2004; Hertel and Graveley, 2005) 
and it was proposed that they promote pairing of the RNA strands and facilitate the 
spliceosomal rearrangements (Fig. 1.5., Shen and Green, 2006).  
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Figure 1.5. Molecular interactions at the branch site and the 3’ splice site in the spliceosomal E 
and A complexes according to Wahl et al. (2009). 
In the pre-spliceosomal E complex (top) the SF1/BBP protein (green) occupy the branch site, the 
U2AF35 protein binds to 3’ splice site (light pink) and U2AF65 (dark pink) binds the Py tract. The 
U2AF65 also interacts with SF1/BBP via the RRM3 domain and U2AF35 via the linker region 
between the RRM1 and RS domain. Upon the binding of U2 snRNP (bottom) the SF1/BBP 
dissociates and the branch site is recognized by a complementary sequence of U2 snRNA. This 
RNA-RNA interaction is further stabilized by the RS domain of U2AF65 protein. The U2AF65 also 
interacts with the protein components of U2 snRNP via the RRM3 domain.  
 
Valcarcel et al. (1996) showed that the RS domain of U2AF65 can bind to the branch point 
sequence of an intron in the spliceosomal E complex. Later experiments of Shen et al. 
(2004b) revealed that this interaction is replaced by another RS-RNA interaction in the 
spliceosomal A complex. At this stage the pre-mRNA/U2 RNA duplex is recognized by the 
RS domain of an enhancer-bound SR protein, for example ASF/SF2. Another SR protein, 
this time not bound to the enhancer, associates with the 5’ splice site in the spliceosomal 
C complex together with the U6 snRNA (Shen et al., 2004a). This together with RS-RS 
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domain protein interactions discussed above increase the complexity of not yet fully 
understood SR protein-dependent splicing regulation. However, it is plausible that both 
RS-RS and RS-RNA interactions are important for the spliceosome assembly and splicing 
regulation. (Shen and Green, 2006; Hertel and Graveley, 2005). 
1.3.3. Fission yeast SR proteins and SR-like proteins 
Up to date there are two SR proteins, Srp1 and Srp2, characterized in fission yeasts and 
one predicted SR protein Rsd1. Like in higher eukaryotes the large subunit of U2AF factor 
Prp2 has structure reminiscent of SR proteins. On the contrary, the small subunit of U2AF 
factor (spU2AFSM) and the U1-70K protein (spUsp101) do not harbor the RS domains. 
Furthermore, the RS domains of fission yeast proteins are phosphorylated by at least 
three different kinases, Dsk1, Lkh1 and Prp4. The structure and activity of Dsk1 and Lkh1 
is similar to that of SRPK1 and Clk/Sty1 in the higher eukaryotes (reviewed in Kaufer and 
Potashkin, 2000; Kuhn and Kaufer, 2003). 
Srp1 
The nonessential protein Srp1 has one N-terminal RRM domain (designated RBD1 in 
Gross et al., 1998) with conserved RNP1 and RNP2 motives and one C-terminal RS 
domain. It was identified as a suppressor of prp4-73 splicing defective phenotype when 
overexpressed Gross et al. (1998).  
The RS domain of Srp1 can be subdivided into three regions, designated RS1, RS2 and 
RS3. Tang et al. (1998) showed that the overexpression of truncated Srp1 ΔRS protein, 
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but not the overexpression of the full length protein in the wild type cells, resulted in the 
accumulation of unspliced pre-mRNAs and growth defects. Similarly, the mutation of any 
of the RS regions and subsequent overexpression of the mutated proteins resulted in the 
same phenotype. These experiments show that every subdomain of Srp1 RS domain is 
essential for pre-mRNA splicing in vivo. Importantly, the deletion of RS domain does not 
interfere with the correct nuclear localization of Srp1 protein, as might have been 
expected (Lutzelberger et al., 1999). The RS domain of Srp1 is both, in vivo and in vitro, 
phosphorylated by Dsk1 kinase (Tang et al., 2002, 2007), an homologue of human SRPK1 
(Tang et al., 1998, 2000) and Lkh1 kinase, a member of Clk/Sty family of kinases (Kim et 
al., 2001; Tang et al., 2003). Furthermore, the deletion of dsk1 gene resulted in the 
partial retention of Srp1 protein in the cytoplasm (Tang et al., 2007) arguing that the 
Dsk1 mediated phosphorylation is important for Srp1 localization. The genetic 
interaction between srp1 and prp4 (Gross et al., 1998) and the fact that both human and 
fission yeast Prp4 kinases phosphorylate the RS domain of ASF/SF2  in vitro (Alahari et al., 
1993; Gross et al., 1997) opens the possibility that the Prp4 kinase is also required for the 
phosphorylation of Srp1. However, the direct experimental evidence to support this 
assumption is missing.  
From the experiments described above is clear that the overexpression of Srp1 RRM 
domain in the wild type cells has a dominant negative effect on the cell viability and pre-
mRNA splicing. By mutational analysis Gross et al. (1998) showed that the mutation of 
the highly conserved motif RDAEDA, that is located just upstream of RRM, rescues the 
deleterious effect of Srp1 RRM domain overexpression. This experiment therefore argues 
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that the RDAEDA-dependent RRM binding to its substrate has a negative effect on the 
splicing of the tested RNA. 
The only interacting protein found in the yeast two hybrid screen with Srp1 protein as a 
bait was Srp2 protein (Tang et al., 2002). This interaction was further verified in vitro and 
turned out to be inhibited by Dsk1-dependent Srp1 phosphorylation. Srp1 was also 
assayed for the interactions with Prp2 in vitro (U2AFLG, Tang et al., 2002) and U2AFSM in 
the yeast two hybrid assay (Webb and Wise, 2004), but was not found to interact with 
any of the two proteins. There is also no experimental evidence for the interaction of 
Srp1 with any ESE elements (Webb et al., 2005b). Therefore, it was postulated that Srp1 
is not directly involved in the splice site selection, but that it likely serves to modulate the 
activity and localization of Srp2 protein (Tang et al., 2007). 
Srp2 
The Srp2 is an essential protein with two N-terminal RRM domains, RRM1 and RRM2 
(marked as RBD1 and RBD2 in Lutzelberger et al., 1999), and an atypical C-terminal RS 
domain.  
The RRM1 has conserved RNP1 and RNP2 motives, whereas the RRM2 does not. Instead 
it has a highly conserved SWQDLKD motif also typical for the human SR proteins ASF/SF2, 
SRp55, SRp75, SRp40 and SRp30 (Dauksaite and Akusjarvi, 2004). The RRM2 domain, in 
particular the SWQDLKD motif, seems to be the most important for the function of Srp2 
protein, because only the RRM2 mutants were not able to rescue the conditional lethal 
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phenotype of nmt1-8::srp2+ strain, although the RRM1 and RS mutants did rescue this 
phenotype (Lutzelberger et al., 1999). Furthermore, the overexpression of proteins with 
deleted RRM2 domain or with mutated SWQDLKD motif in the wild type strain resulted 
in the significant growth defects, whereas the overexpression of full length, Srp2 ΔRRM1 
or Srp2 ΔRS proteins did not. Interestingly, the overexpression of Srp2 ΔRRM1ΔRRM2 
protein did not have any effect on cell growth, suggesting that the RRM2 domain buffers 
otherwise deleterious effect of RRM1 domain overexpression. This is also the case if 
RRM1 of Srp2 is replaced with RRM1 of Srp1, suggesting that the RRM2 of Srp2 indeed 
modulates the activity of adjacent RRM1 domain. Interestingly, the interaction of Srp2 
with the non-phosphorylated Srp1 does not depend on the Srp2 phosphorylation status 
(Tang et al., 2002).  
The RS domain has only two short RS dipeptide-rich segments, but if they are mutated 
the overexpressed proteins are not able to rescue the conditional lethal phenotype of 
nmt1-8::srp2
+ strain (Lutzelberger et al., 1999). The protein localization studies showed 
that these segments are important for the nuclear localization of Srp2 protein, explaining 
the mentioned phenotype. The RS domain of Srp2 is phosphorylated by Dsk1 and Lkh1 
kinases (Tang et al., 1998, 2000, 2002, 2007) and the Dsk1-dependent Srp2 
phosphorylation seems to be, at least partially, responsible for the nuclear localization of 
Srp2 protein (Tang et al., 2007).  
As already mentioned the Srp2 protein interacts with Srp1 protein  in vivo and in vitro 
(Tang et al., 2002). Furthermore, Srp2 was found to interact with U2AFSM in the yeast 
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two hybrid assay (Webb and Wise, 2004) and with purine-rich ESEs in the yeast three 
hybrid assay (Webb et al., 2005b). The binding of Srp2 to either native S. pombe ESEs or 
the well characterized ESEs of higher eukaryotes well correlated with the enhanced 
splicing rate of the assayed introns, directly linking the Srp2 protein function with the 
splicing regulation. In fact one of the Srp2-dependent ESEs in S. pombe lies within the 
exon 6 of srp2+ gene opening the possibility that Srp2 autoregulates splicing of its own 
pre-mRNA in vivo; however, an evidence for this scenario from in vivo experiments is still 
missing (Webb et al., 2005b).  
Prp2 
The essential protein Prp2 (U2AFLG) is a component of the core spliceosomal machinery. 
The prp2+ gene was originally identified in the genetic screen aimed to identify the 
factors required for pre-mRNA splicing in S. pombe (Potashkin et al., 1989). Later it was 
determined to be the homologue of the large subunit of U2AF splicing factor (Potashkin 
et al., 1993). Despite the structural similarity, Romfo et al. (1999) showed that the 
human U2AF65 and Prp2 are not functionally interchangeable. Prp2 has N-terminal RS 
domain followed by a short linker region, two canonical RRM domains, RRM1 and RRM2, 
an C-terminal pseudo-RRM domain ψRRM (or RRM3) and all four of them are essential 
for viability (Webb et al., 2005a).  
Similar to other SR proteins the RS domain of Prp2 is phosphorylated by Dsk1 protein 
kinase (Tang et al., 1998, 2000) and is required for the efficient nuclear localization of the 
Prp2 protein (Tang et al., 2007). The deletion of RS domain has dominant negative effect 
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on the cell viability, but does not interfere with spliceosomal E complex formation (Webb 
et al., 2005b). It is therefore possible that the Prp2 RS domain is required for the later 
steps of spliceosomal assembly (Webb et al., 2005).   
The linker region between the RS domain and RRM1 domain is responsible for the 
interaction with the U2AFSM, the small subunit of U2AF factor (Wentz-Hunter KPJ, 1996; 
Webb et al., 2005b). The mammalian homologue U2AF35 employs the pseudo-RRM for 
the interactions with the linker region of U2AF65 subunit in reciprocal tong-in-groove 
tryptophan interaction (Kielkopf at al., 2001).  The Prp2 also creates a stable complex 
with Bpb1, a fission yeast homologue of hsSF1/BBP/scMsl5 (Huang et al., 2002) and 
interacts in the yeast two hybrid assay, with Uap2p transcription factor, the homologue 
of human Tat-SF1 protein (McKinney et al., 1997) and Prp10 splicing factor (Gozani et al., 
1998), the homologue of human SAP 155 (Habara et al., 1998).  
Deletion of either RRM1 or RRM2 domain independently of each other renders cell 
lethality, implying the essential function of these domains (Webb et al., 2005a). Based on 
homology with human U2AF65 the RRM1 and RRM2 domains were implicated in binding 
to Py tract of target introns (Zamore and Green, 1989). However in S. pombe, the 
presence of pyrimidine rich sequence is not a prerequisite for Prp2-dependent splicing, 
because even the splicing of introns without the Py tract or introns with deleted Py tract 
required the fully active Prp2 (Romfo et al., 1999, Sridharan and Singh, 2007). 
Furthermore, Sridharan and Singh (2007) performed experiments with conditional 
mutant of RRM2 (C387Y) showing that splicing of certain introns does not require the 
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same activity of Prp2 as the splicing of the others. They showed that the introns with 
conventional Py tract positioned between the branch site and 3’ splice site, as well as the 
introns lacking the Py sequence, were fully dependent upon the Prp2 activity, whereas 
the introns with long Py tract upstream of the branch site were not. Interestingly, Prp2-
independent introns became Prp2-dependend when the upstream Py tract was deleted, 
pointing to the possible existence of two independent mechanism for splice site 
recognition. Furthermore, the mutations D307N and A383Q in RRM2, as well as some 
point mutations in U2AFSM and Bpb1 proteins caused exon skiping of an artificial, 
otherwise included exon in S. pombe (Haraguchi et al., 2007). This happens in the 
transcription-dependent manner, showing that Prp2 and the U2AF/Bpb1 complex are 
important for correct co-transcriptional splice site selection.  
The deletion of Prp2 ψRRM has the same effect on the cell viability as the deletion of 
either RRM1 or RRM2, implying possibility that the fission yeast ψRRM is also involved in 
RNA binding (Banerjee et al., 2004; Webb et al., 2005a), although no effect on RNA 
binding and splicing of model introns was observed in vitro after the deletion of U2AF65 
ψRRM domain (Banerjee et al., 2004). The role of ψRRM in the pre-mRNA splicing was 
for a long time discussed. By using the ψRRM conditional point mutants Sridharan and 
Singh (2007) showed that fully active ψRRM is important for the efficient splicing of 
many genes. However, at the same time it was fully or partially dispensable for the 
splicing of certain introns, usually harboring a long Py tract. Furthermore, Banerjee et al. 
(2004) pointed at the important role of ψRRM in the protein-protein interactions as the 
deletion of Prp2 ψRRM abolished the interactions with Bpb1 and Prp10. 
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1.4. COUPLING SPLICING WITH TRANSCRIPTION  
There is a longstanding evidence that transcription and splicing are interconnected in 
vivo (reviewed in Kaufer and Potashkin, 2000; Cramer et al., 2001; Ram and Ast, 2007; 
Das et al. 2007; Allemand et al., 2008; Pirngruber et al., 2009; Lenasi and Barboric, 2010). 
The first evidence that splicing affects transcription came from the experiments of 
Brinster et al. (1988) who showed that the presence of promoter proximal intron(s) 
enhances transcription of assyed gene (see also Furger et al., 2002). Additional 
experiments revealed that truncation of RNAPII CTD causes defects in splicing, as well as 
in capping and polyadenylation (McCracken et al., 1997), and that the purified 
phosphorylated RNAPII is able to activate the splicing reaction in vitro (Hirose et al., 
1999). Different transcription factors that affect the rate of transcription were reported 
to regulate splicing. The direct evidence that the rate of transcription regulates 
alternative splice site choice came from the experiments of De la Mata et al. (2003), who 
showed that C4 mutation of human RNAPII reduces the RNAPII transcriptional rate and 
consequently affects the alternative splicing of selected genes. Later Dye et al. (2006) 
designed an interesting experiment in which the transcribed intron was co-
transcriptionally cleaved. They showed that the intron cleavage does not interfere with 
the efficient splicing, as would be expected, if it have not been coupled to the 
transcription. Furthermore, there is also extensive evidence that the phosphorylated CTD 
acts as a scaffold recruiting the splicing factors to the elongating RNAPII (see part 1.4.1. 
for details). 
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1.4.1. Recruitment of splicing factors to RNAPII CTD 
Different splicing factors are co-transcriptionally recruited to CTD of RNAPII in 
phosphorylation-dependent manner. The first splicing factor found to interact with CTD 
was Prp40, the yeast homologue of FPB11 (Morris and Greenleaf, 2000). Then Fong and 
Zhou (2001) showed that transcription of reporter HIV-1 template is stimulated by co-
transcriptional recruitment of different U snRNPs. This recruitment is mediated by TAT-
SF1 transcription elongation factor that in turn interacts with key elongation factor P-
TEFb, the heterodimer of CDK9 kinase and cyclin T1. The similar interconnection 
between splicing factors and P-TEFb was revealed by Bres et al. (2005), who showed that 
splicing associated protein SKIP directly binds and activates P-TEFb factor in vivo. 
Because SKIP was reported to interact with U5 snRNP and U4/U6.U5 tri-snRNP 
complexes, these experiments provide an evidence for coupling of the later steps of 
spliceosomal assembly with the regulation of transcriptional elongation. The key role of 
CDK9 in coupling transcription with splicing is further underlined by the fact the 
depletion of 7SK snRNP complex results in induced transcription and enhanced exon 
inclusion (Barboric et al., 2009; Lenasi and Barboric, 2010). This is important because 7SK 
snRNP is a complex of 7SK snRNA with several proteins that interact with Cdk9 and 
inhibit its binding to cyclin T1 and as a consequence inhibit the transcriptional elongation 
(Nguyen et al., 2001; Yang et al., 2001). Later Kameoka et al. (2004) found the CTD 
associated transcription factors p54nrb and TLS to cross-link with the 5’ splice site of the 
nascent RNA. The cross-linked proteins were part of a large protein complex composed 
of hyperphosphorylated RNAPII, a number of transcription elongation factors, U1 snRNP 
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and U2 snRNP proteins, arguing that p54nrb and TLS directly couple 5’ splice site selection 
with the transcription. Also the proteomic analyses of spliceosomal complexes revealed a 
number of associated transcription factors with known or unknown function in RNAPII 
transcription (Zhou et al., 2002; Makarova et al., 2004; Deckert et al., 2006; Behzadnia et 
al., 2007; Bessonov et al., 2008). The expanded list of factors with possible role in 
coupling transcription and splicing is reviewed in Allemand et al. (2008).  
There exists extensive evidence that spliceosome assemble on CTD of RNAPII in a 
stepwise manner.  Gornemann et al. (2005) showed that the cap binding complex (CBC) 
is necessary for the co-transcriptional spliceosome assembly pointing at the necessity of 
co-transcriptional capping for spliceosome assembly. Also the individual spliceosomal 
spliceosomal complexes are added one after the other. The stepwise assembly of 
spliceosome was studied in vivo by chromatin immunopreciptiation of U1 snRNP, U2 
snRNP and U5 snRNP complexes (Lacadie and Rosbash, 2005; Gornemann et al., 2005). 
With this approach Lacadie and Rosbash (2005) showed that in yeasts the recruitment of 
U2 snRNP and U5 snRNP is dependent upon the U1 snRNP. They also showed that the U1 
snRNP is recruited to transcripts lacking the 5’ SS as well, suggesting that the pairing of 
U1 with 5‘ SS occurs following the U1 snRNP recruitment to the nascent transcript and 
not vice versa. It is plausible that the U2AF subunit of the pre-spliceosomal complex also 
associates with RNAPII co-transcriptionally. The U2AF65 protein was found to 
immunoprecipitate in a complex with RNAPII, elongation factor SII (TFIIS) and U1, U2 and 
U4 snRNPs (Robert et al., 2002; Ujvari et al., 2004). Second, Davies et al. (1998) showed 
that WT1, a human transcription factor, interacts with U2AF65 protein in vitro and co-
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localize with the splicing factors in vivo. Interestingly, the association of WT1 with the 
splicing factors was enhanced in certain isoforms of WT1 compared to the others, 
revealing additional level of regulation. Das et al. (2007) analyzed proteins that associate 
with immunopurified human RNAPII. They found more than 100 proteins associated with 
RNAPII. Beside the transcription factors a number of SR proteins and U1 snRNP proteins 
were enriched at RNAPII isolate.  
 
 
Figure 1.6.  A working model for SR protein functions in coupling splicing to RNAPII 
transcription according to Zhong et al. (2009). 
The SR proteins are likely recruited to paused Ser5 phosphorylated RNAPII together with 
P-TEFb transcription elongation factor concomitant with the Ser2 phosphorylation. When 
splicing signal emerges out of the RNAPII RNA exit pore the RNAPII associated SR-
proteins recognize and bind their target sequences on nascent pre-mRNA (1). As a result 
H3K36 methylation is increased and RNAPII is transiently paused (2). The RNAPII pausing 
might help to recruit additional splicing factors to RNAPII and nascent pre-mRNA (3). 
After successful splicing accomplishment, the RNAPII is released from its paused state to 
finish pre-MRNA synthesis.  
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The SR proteins, and also U1 snRNP proteins, were found to interact with RNAPII in RNA-
dependent manner, possibly, via U1 snRNP complex. They also used sophisticated in vitro 
transcription assay to show that the SR proteins associated with CTD are required for co-
transcriptional splicing of reporter genes, but do not  promote their post-transcriptional 
splicing (Fig. 1.6.). Furthermore, Lin et al. (2008) showed that the depletion of SC35, a 
well characterized human SR protein, results in reduced Ser2 CTD phosphorylation, 
defective P-TEFb recruitment and attenuated RNAPII elongation. 
1.4.2. Chromatin modifications and co-transcriptional splicing 
The CDK9, a kinase component of P-TEFb elongation factor, is responsible for the 
phosphorylation of Ser2 of RNAPII CTD (see part 1.1.2. for details), but it also 
phosphorylates some other transcription regulators (Pirngruber et al., 2009). The 
downstream evens guided by CDK9-dependent phosphorylations result in a complex 
network of chromatin modifications, including the histon methylations. One possible link 
between splicing and chromatin modifications is the SWI/SNF chromatin remodeling 
complex. The catalytic subunit of SWI/SNF complex Brm was reported to interact with 
splicing factor Sam68 and U1 and U5 snRNAs and regulate the intron incusion/exculsion 
of several genes in transcription rate-dependent manner (Batsche et al., 2006). 
Furthermore, the PRP4 kinase, a component of U4/U6.U5 tri-snRNP complex, co-purifies 
in one complex with BRG1, a catalytic component of SWI/SNF complex and 
phosphorylates the BRG1 protein in vitro (Dellaire et al., 2002). Later Sims et al. (2007) 
identified a stable complex between CHD1 H3K4me3 methyltransferase and the 
components of the spliceosome. The physiological relevance of this interaction was 
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further supported by the fact that the knockdown of CHD1 resulted in reduced levels of 
H3K4me3 methylation, reduced association of U2 snRNP with chromatin and altered 
splicing of pre-mRNAs in vivo. Another possible link coupling splicing and histon H3 
H3K36me3 methylation is the Spt6 transcription elongation factor. It binds to the Ser2 
phosphorylated CTD and recruits HYPB/Setd2 histone methyltransferase responsible for 
H3K36me3 methylation to elongating RNAPII complex (Yoh et al., 2007). The relevance of 
this finding to the co-transcriptional splicing regulation was also revealed by genome 
wide comparisons of epigenetic marks relative to various regulatory elements. In this 
respect it was shown that the 5’ ends of exons in humans, flies and C. elegans are 
enriched in the nucleosomes and that this enrichment positively correlate with increased 
distribution of histon H3 H3K36me3 methylation (Andersson et al., 2009; Schwartz et al., 
2009; Hon et al., 2009). The H3K36me3 methylation is also higher on exons relative to 
introns, and lower on alternatively spliced exons (Andersson et al., 2009; Kolasinska-
Zwierz et al., 2009; Schwartz et al., 2009; Hon et al., 2009). The H3K36me3 methylation 
levels were also positively correlated with gene expression levels. Also some other histon 
H3 methylations were found to be either enriched or depleted from the exons and also 
correlated with the exon expression levels (Andersson et al., 2009; Hon et al., 2009).  
1.4.3. Transcription regulates alternative splicing in fission yeasts 
The majority of S. pombe introns are constitutively spliced. However, few reports refer 
about the existence of several splice variants of a gene (prp10, zas1 and cds1) in fission 
yeasts under the normal growth conditions, i.e. mitotic cell cycle (Habara et al., 1998; 
Okazaki and Niwa, 2000; Lemaire et al., 2004). However, the alternative splicing of these 
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genes have not been studied further. The major interest, considering the alternative 
splicing in fission yeasts, earned the splicing of certain meiotic genes that are specifically 
spliced during meiosis, but not during the mitotic cell cycle. The first described gene with 
meiosis-dependent splicing was mes1 (Kishida et al., 1994; Shimoseki and Shimoda, 
2001). It is important to mention that expression of many meiosis-specific genes is 
transcriptionally regulated. The transcription of genes in meiosis occurs in three 
successive waves that well correlate with the main events of meiotic differentiation 
(Mata et al., 2002). The early transcription wave occurs at the same time as the pre-
meiotic S phase and recombination events occur. The middle wave correlates with 
meiosis I and meiosis II and late wave with the spore formation. Employing a systematic 
analysis Averbeck at al. (2005) showed that 12 out of 96 middle genes tested were 
specifically spliced during the meiosis I and II, but not in the early stages of meiotic 
differentiation. The list of genes specifically spliced during meiosis was further extended 
by Moldon et al. (2008), who assayed for genome-wide Mei4- dependent meiotic 
splicing, and it now comprises at least 20 different genes (Averbeck et al., 2005; Moldon 
et al., 2008).  
The best studied example of meiosis-dependent splicing is the splicing of rem1 pre-
mRNA (Malapeira et al., 2005; Moldon et al., 2008). The rem1 gene has two exons 
interrupted by an intron that harbors stop codon. The unspliced RNA is translated into a 
short peptide encoded by the first exon of rem1 gene and this peptide is essential for the 
proper meiotic recombination (Moldon et al., 2008). However, if spliced, and this 
happens only during meiosis I (Malapeira et al., 2005), the rem1 is translated into a 
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different protein corresponding to the meiotic B-type cyclin. The splicing regulatory 
element lies within the promoter region of rem1 gene. This sequence, when placed 
upstream of a constitutively spliced gene changes its splicing pattern to that of rem1. In 
addition it had been shown that the meiotic splicing of rem1 requires Mei4 forkhead 
transcription factor, whereas the intron retention is dependent upon the Fkh2 forkhead 
transcription factor (Moldon et al., 2008). Furthermore Mei4 is also needed to recruit the 
active spliceosome to the rem1 nascent transcript during the transcription. The same 
type of regulation was observed for some other genes (Moldon et al., 2008). However 
this is not the only mechanism responsible for the regulated splicing in fission yeasts. For 
instance, the regulatory elements required for splicing of mes1 lie within the exon 5 of 
the gene (Kishida et al., 1994; Shimoseki and Shimoda, 2001) and the regulatory 
elements required for splicing of another meiotic cyclin crs1 are located within the 3’ 
UTR (Averbeck et al., 2005). Recently it has been shown thet the inhibition of crs1 
splicing in mitotic cells is regulated by the proximal polyadenylation signal and an 
element in exon 5, whereas the efficient polyadenylation is the prerequisite for crs1 
splicng in meiosis (McPheeters et al., 2009). Importantly, if polyadenylation status of 
RNA determines, whether it is spliced or not, the splicing cannot take place until the end 
of transcription cycle (McPheeters et al., 2009; Moldon and Ayte, 2009).  
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1.5. PEPTIDYL PROLYL cis/trans ISOMERASES (PPIases) IN THE 
REGULATION OF SPLICING AND TRANSCRIPTION 
The majority of peptidyl bonds in native proteins exist in energetically favourable trans 
conformation (Wang and Heitman, 2005). The exception is the petidyl prolyl bond that 
can exist in both cis and trans conformations, because they have similar energy 
requirements (reviewed in Wang and Heitman, 2005; Shaw PE, 2007; Lu and Zhou, 2007; 
Lu et al., 2007). In general the transition from cis to trans conformation requires free 
energy and is a slow process, unless catalyzed. The peptidyl prolyl bond exists in cis 
conformation in about 5% of cases (Stewart et al., 1990). It is usually found on the 
surface of proteins, often incorporated within structurally important features, where the 
cis to trans isomerisation can have significant impact on the protein structure and 
function (Pal and Chakrabarti, 1999; Pahlke et al., 2005). The cis to trans isomerisation is 
catalyzed by different enzymes that are collectively named peptidyl prolyl cis/trans 
isomerases (PPIases) (see Fig. 1.7., reviewed in Wang and Heitman, 2005; Lu et al., 2007).  
 
Figure 1.7.  Isomerisaton of peptidyl prolyl bonds. 
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They are further classified into four structurally distinct groups: cyclophilins, FKBPs, 
parvulins and PTPA. Collectively, the PPIases regulate a number of different cellular 
processes. For the purpose of the thesis only the functions of PPIases involved in 
regulation of transcription and splicing will be reviewed.  
1.5.1. Regulation of CTD domain phosphorylation by Pin1/Ess1 PPIase. 
The best studied PPIase regulating the RNAPII transcription is hsPin1/scEss1/spPin1 
(reviewed in Lu and Zhou, 2007; Shaw PE, 2007). Pin1 has two domains, the N-terminal 
WW domain and the C-terminal PPIase domain that are both involved in the substrate 
recognition and binding. Human Pin1 was originally identified as a mitotic inhibitor (Lu et 
al., 1996) and subsequent investigations revealed that it has a high number of substrates 
with different cellular functions (Lu and Zhou, 2007).  Later both hsPin1 and spEss1 were 
found to interact with phosphorylated CTD of RNAPII via the WW domains (Albert et al., 
1999; Morris et al., 1999; Wu et al., 2000a; Myers et al., 2001). This interaction became 
functionally relevant upon the observation that overexpression of hsPin1, as well as the 
thermosensitive mutation in ess1 gene, inhibit the RNAPII transcription (Wu et al., 2000a; 
Xu et al., 2003). The studies on different Pin1/Ess1 substrates revealed that this PPIase 
specifically recognizes only the phosphorylated pSer-Pro and pThr-Pro residues (Yaffe et 
al., 1997; Hani et al., 1999). In general the Pin1/Ess1 seems to act on substrates 
phosphorylated by proline-directed kinases, a subfamily of kinases that specifically 
recognize Ser and Thr residues followed by proline (Brown et al., 1999; Weiwad et al., 
2004). This group of kinases includes cyclin-dependent kinases CDK2, CDK7, CDK8 and 
CDK9 that are involved in the phosphorylation of RNAPII CTD.  The CTD domain 
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phosphatase Fcp1 was found to suppress the essts phenotype (Wu et al., 2000a, Kops et 
al., 2002) and further investigation revealed that the binding of Pin1/Ess1 to CTD inhibits 
pSer5 dephosphorylation of CTD by Fcp1 (Kops et al., 2002; Xu et al., 2003). Furthermore, 
the hsPin1 enhances the activity of CDC2/cyclin B kinase towards the CTD resulting in 
hyperphosphorylated RNAPII (Xu et al., 2003); however, the biological meaning of this 
RNAPII inhibitory modification remains elusive. The Pin1/Ess1 was shown to be required 
for proper transcription initiation, termination and splicing, possibly as a result of 
impaired CTD phosphorylation (Hani et al., 1999; Xu et al., 2003; Wu et al., 2003; 
Krishnamurthy et al., 2009). Furthermore, Ess1 genetically interacts with CTD kinases 
Kin28, Ctk1, Srb10 and Bur1 and also with CTD phosphatases Fcp1 and Ssu72, suggesting 
that it is required for RNAPII transcription in a complex way (Wilcox et al., 2004; 
Krishnamurthy et al., 2009).  
1.5.2. PPIases involved in spliceosome assembly 
The PPIases are also frequently found in the spliceosomal complexes purified from 
different organisms (Zhou et al., 2002; Makarova et al., 2004; Deckert et al., 2006; Chen 
et al., 2007; Behzadnia et al., 2007; Bessonov et al., 2008). At least seven different 
PPIases (PPIH, PPIG, PPIE, PPIL1, PPIL2, PPIL3b, PPIL4) were characterized as the 
spliceosomal components in humans (reviewed in Mesa et al., 2008), but their functions 
remain poorly undersood.  
Probably the best understood is the interaction of PPIH (also known as Snu-Cyp20, USA-
Cyp, CypH) with splicing factors hsPrp3, hsPrp4 and hsPrp18. The hsPrp3, hsPrp4 and 
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hsPrp18 are components of U4/U6 di-snRNP and U4/U6.U5 tri-snRNP complexes that act 
at the second step of pre-mRNA splicing. The PPIH was found to co-immunoprecipitates 
with hsPrp3 and hsPrp4 in both U4/U6 di-snRNP and U4/U6.U5 tri-snRNP complexes 
(Horowitz et al., 1997, 2002; Teigelkamp et al., 1998) and this interaction was further 
characterized by the crystal structure of PPIH.U4/U6 snRNP-60K (Reidt et al., 2003). 
Interesting is the observation of  Horowitz et al. (2002), who found that the second step 
of the splicing reaction is inhibited by cyclosporin A (CsA), a common inhibitor of 
cyclophilins. Their investigations also showed that CsA inhibits the second 
transesterification reaction via binding to hsPrp18 both in vivo and in vitro. This suggests 
that PPIH functions in the regulation of the second step of splicing, as the budding yeast 
homologue of Prp18 is involved in the stabilisation of the exon-exon interactions in the 
late spliceosome (Crotti et al., 2007). The fission yeast homologue of PPIH cyclophilin 3 
was also reported to create the complex with spPrp3 and spPrp4 (Pemberton et al., 
2003), suggesting that the role of this PPIase in the regulation of splicing is evolutionary 
conserved.  
The cyclophilin PPIL1 was also identified as a part of the spliceoseome (Makarova et al., 
2004; Deckert et al., 2006). Originally the fission yeast homologue of PPIL1 Cyp2 was 
identified as an interaction partner of Snw1, the homologue of human transcription co-
activator SKIP (Skruzny et al., 2001) and later also the human PPIL1 was found to interact 
with the SKIP (Makarova et al., 2004; Xu et al., 2006). The PPIL1 was identified also as a 
part of the larger 35S U5 snRNP.SKIP complex (Makarov et al., 2002) and together with 
SKIP as a part of the spliceosomal B* complex (Makarova et al., 2004; Deckert et al., 
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2006).  These observations suggested that the PPIL1 and SKIP functionally interact to 
couple late spliceosomal rearrangements with transcriptional regulation. However, the 
direct experimental evidence for this functional coupling is missing.  
Another PPIase identified as a part of spliceosomal complexes is the PPIE (also known as 
Cyp33 and CypE) (Zhou et al., 2002). It is inhibited by CsA and harbours a functional N-
terminal, RNA-binding domain (Mi et al., 1996), nevertheless its function is unknown.     
Another cyclophilin associated with the spliceosome is PPIG (also known as SR-Cyp, 
CARS-Cyp, CYPG) (Bessonov et al., 2008). The PPIG has an N-terminal PPIase domain and 
a long C-terminal RS domain. It was originally identified as an interacting partner of 
Clk/Sty, the SR protein-specific kinase (Nestel et al., 1996). Bourquin et al. (1997) 
reported that PPIG interacts with the phosphorylated CTD and that the RS domain of 
PPIG is required for this interaction. This suggests that the RS domain of PPIG might be 
important for the coupling of splicing to RNAPII transcription.  Cyclophilins with the RS 
domain similar to PPIG were identified in several organisms: the CypRS64, CypRS92 and 
AtCyp59 in A. thaliana (Lorkovic et al., 2004; Gullerova et al., 2006), the Kin241 in 
Paramecium tetraurelia (Krzywicka et al., 2001), the matrin-cyp in rat (Mortillaro et al., 
1998) and the moca-cyp in Drosophila (Cavarec et al., 2002). The plant Cyp64 and Cyp92 
were shown to interact with plant SR proteins SCL28, SCL30, SRp30 and SRp34 and with 
the core spliceosomal proteins U1-70K and U11-35K. Interestingly, the interactions with 
SRp30 and SRp34, the plant homologues of ASF/SF2 splicing factor, were 
phosphorylation-dependent (Lorkovic et al., 2004). The AtCyp59 was also shown to 
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interact with a plethora of plant SR proteins (SCL-28,SCL30, SCL30a, SCL33, SC35, SRp30, 
SRp34,RSZp21, RSZ33, RSp31, RSp40) in RS domain-dependent manner and was also 
shown to cross-link with the RNA in vitro (Gullerova et al., 2006). Furthermore, the 
authors showed that AtCyp59 interacts with RNAPII CTD in vitro and that the ectopic 
expression of AtCyp59 in plant cells reduces CTD phosphorylation in vivo. The AtCyp59 
has a distinct domain structure composed of four domains: an N-terminal PPIase, a 
middle RRM followed by a zink knuckle and a C-terminal RS-like domain. The fission yeast 
homologue of AtCyp59 the Rct1 (also known as SpCyp6) has a similar domain structure, 
but it lacks the Zn knucke. Rct1 is an essential protein that interacts with RNAPII CTD in 
vitro, associates with transcriptionally active chromatin in vivo and modulates the CTD 
phosphorylation status in dosage-dependent manner (Gullerova et al., 2007). The 
heterozygous rct1/Δrct1 cells were shown to harbour increased Ser2 and Ser5 
phosphorylation of CTD, whereas the ectopic overexpression of Rct1 resulted in the 
hypophosphorylation of the CTD. The in vitro experiments showed that Rct1 interacts 
with CTD Ser2-specific kinases Cdk9 and Lsk1, but not with Ser5-specific kinases Mcs6 
and Srb10 and CTD-specific phosphatases Fcp1, Scp1 and Ssu72 (Skrahina T, 2009). 
Furthermore, the Rct1 interactions with Cdk9 and CTD increase the activity of Cdk9 
towards the CTD in a way that specifically requires PPIase domain of Rct1 (Skrahina T, 
2009). Although it is plausible that Rct1 acts to couple splicing with the Cdk9 and/or Lsk1-
dependent CTD phosphorylation the experimental evidence for this model is missing. 
Alltogether, the above data suggest that the RS domain PPIases might be important 
contributors to the coupling of transcription with the spliceosomal assembly. 
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1.6. AIMS OF THE THESIS 
The experimental evidence suggests that the RS domain PPIases might act to couple 
different steps of spliceosomal assembly with the regulation of RNAPII-mediated 
transcription (see part 1.5.2. for details). The previous investigations revealed that 
Rct1 interacts with the Ser2-specific CTD kinases Cdk9 and Lsk1 and regulates RNAPII 
phosphorylation and transcription in a dosage-dependent manner (Gullerova et al., 
2007; Skrahina T, 2009). In this thesis I investigated a possibility that Rct1 acts to 
couple the pre-mRNA processing with the RNAPII transcription. First I have focused 
on identification of splicing related proteins interacting with Rct1. For this purpose I 
performed yeast two hybrid screen with Rct1 protein as a bait and in vitro pull down 
experiments with selected splicing related proteins. The identified interactions were 
characterized further in the pull down experiments with different deletion mutants of 
participating proteins. The obtained data suggested that the Rct1 RS domain is 
important for the interactions with the splicing related factors and therefore I 
prepared rct1-HA and rct1 ΔRS strains to study the importance of RS domain in 
coupling the splicing with transcription. The effect of Rct1 RS domain deletion on the 
dynamics of RNAPII transcription and splicing was further studied by chromatin 
immunoprecipitation and RT-PCRs.  
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2. MATERIALS AND METHODS 
2.1. FISSION YEAST STRAINS AND HANDLING OF CELLS 
2.1.1. Growing fission yeast cells 
The fission yeast strains used in this study are listed in Table 2.1.. They were grown 
either in rich YES medium or minimal EMM medium (see Tab. 2.3.) at 30-32°C, if not 
stated otherwise. If needed antibiotics and drugs were supplemented as follows: 155 
μg/ml geneticin (GE), 100 μg/ml ClonNat, 100 μg/ml hygromycin (H). To repress 
expression from nmt1+ promoter thiamine was used at 5 μg/ml concentration.  
Table. 2.1. Fission yeast strains used in this study. 
haploid strains (n) 
name genotype source 
wt (wild type) h+ ade6+, leu1+, ura4+, lys1+, his7+ Leupold 
12155 h- pat1-114, ade6-M216 kind gift J. Gregan 
12156 h- pat1-114, ade6-M210 kind gift J. Gregan 
11339 h+ leu1, ura4, lys1, his7, ade6-M210 kind gift J. Gregan 
Δrct1 + pMG1 h
- 
Δrct1::natMX, ura4-27 (pMG1) Gullerova et al. 
2007 
Δrct1 + pMG2 h
+ 
Δrct1::natMX, ade6-704, ura4-27, 
(pMG2) 
Skrahina T,  2009 
Δrct1 + pMG3 h+ Δrct1::natMX, ade6-704, ura4-27, 
(pMG3) 
Skrahina T,  2009 
Δrct1 + pMG4 h
+
 Δrct1::natMX, (pMG4) Skrahina T,  2009 
Δrct1 + pMG5 h
+
 Δrct1::natMX, ade6-704, leu1-32, ura4-
27, (pMG5) 
Skrahina T,  2009 
Δrct1 + pMG6 h
+
 Δrct1::natMX, ade6-704, ura4-27, 
(pMG6) 
Skrahina T,  2009 
Δrct1 + pMG4R3 h+ Δrct1::natMX, ade6-704, (pMG4R3) Skrahina T,  2009 
rct1-HA h+ rct1::HA::kanMX this study 
rct1 ΔRS-HA h+ rct1-ΔRS::HA::kanMX this study 
tsn1-GFP h+ tsn1::GFP::kanMX this study 
tsn1-HA h+ tsn1::HA::kanMX this study 
Δtsn1(nat) h+ Δtsn1::natMX this study 
Δtsn1(nat) + pMG h+ Δtsn1::natMX (pMG) this study 
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Δtsn1(nat) + pMG1 h+ Δtsn1::natMX (pMG1) this study 
Δtsn1(nat) + pMGT h+ Δtsn1::natMX (pMGT) this study 
Δtsn1(kan) h+ Δtsn1::kanMX this study 
srp1-FLAG h+ srp1::FLAG::hphMX this study 
srp2-FLAG h+ srp2::FLAG::hphMX this study 
srp1-tdTomato h+ srp1::tdTomato::hphMX this study 
srp1-FLAG  rct1-HA h+ srp1::FLAG::hphMX, rct1::HA::kanMX this study 
srp1-FLAG rct1 ΔRS-HA h+ srp1::FLAG::hphMX, rct1-
ΔRS::HA::kanMX 
this study 
srp2-FLAG  rct1-HA h
+
 srp2::FLAG::hphMX, rct1::HA::kanMX this study 
srp2-FLAG rct1 ΔRS-HA h
+
 srp2::FLAG::hphMX, rct1-
ΔRS::HA::kanMX 
this study 
rct1-FLAG h+ rct1::FLAG::hphMX this study 
rct1-FLAG + pMGT h+ rct1::FLAG::hphMX (pMGT) this study 
diploid strains (2n)  
name genotype source 
2n wt (wild type) h+/h- ade6+/ade6-704, leu1+/leu1-32, 
ura4
+
/ura4-27 
Gullerova et al. 
2007 
2n wt + pMG h+/h-  ade6+/ade6-704, leu1+/leu1-32, 
ura4
+
/ura4-27 (pMG) 
this study 
2n wt + pMG1 h
+
/h
-
 ade6
+
/ade6-704, leu1
+
/leu1-32, 
ura4
+
/ura4-27 (pMG1) 
this study 
2n wt + pMGT h+/h- ade6+/ade6-704, leu1+/leu1-32, 
ura4
+
/ura4-27 (pMGT) 
this study 
rct1/Δrct1 h+/h- rct1+/rct1:: natMX ade6+/ade6-704, 
leu1
+
/leu1-32, ura4
+
/ura4-27 
Gullerova et al. 
2007 
rct1/Δrct1 + pMG h
+
/h
-
 rct1
+
/rct1:: natMX ade6
+
/ade6-704, 
leu1
+
/leu1-32, ura4
+
/ura4-27 (pMG) 
this study 
rct1/Δrct1 + pMG1 h+/h- rct1+/rct1:: natMX ade6+/ade6-704, 
leu1
+
/leu1-32, ura4
+
/ura4-27 (pMG1) 
this study 
rct1/Δrct1 + pMGT h+/h- rct1+/rct1:: natMX ade6+/ade6-704, 
leu1
+
/leu1-32, ura4
+
/ura4-27 (pMGT) 
this study 
Δtsn1(nat)/Δtsn1(kan) h
+
/h
-
 Δtsn1::natMX/Δtsn1::kanMX this study 
Δtsn1(nat)/Δtsn1(nat) h
+
/h
-
 Δtsn1::natMX/Δtsn1::natMX, ade6-
M210/ade6-M216 
this study 
Δtsn1(nat)/Δtsn1(nat) + 
pMG 
h
+
/h
-
 Δtsn1::natMX/Δtsn1::natMX, ade6-
M210/ade6-M216 (pMG) 
this study 
Δtsn1(nat)/Δtsn1(nat) + 
pMG1 
h+/h- Δtsn1::natMX/Δtsn1::natMX, ade6-
M210/ade6-M216 (pMG1) 
this study 
Δtsn1(nat)/Δtsn1(nat) + 
pMGT 
h
+
/h
-
 Δtsn1::natMX/Δtsn1::natMX, ade6-
M210/ade6-M216 (pMGT) 
this study 
tsn1-HA/tsn1-HA h
+
/h
-
 tsn1::HA::kanMX/tsn1::HA::kanMX, 
ade6-M210/ade6-M216 
this study 
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Δtsn1(nat)/Δtsn1(nat) 
pat1-114/pat1-114 
h+/h+ Δtsn1::natMX/Δtsn1::natMX, 
pat1-114/pat1-114, ade6-M210/ade6-
M216 
this study 
tsn1-HA/tsn1-HA  pat1-
114/pat1-114 
h
+
/h
+
 tsn1::HA::kanMX/tsn1::HA::kanMX, 
pat1-114/pat1-114, ade6-M210/ade6-
M216 
this study 
rct1-HA/rct1-HA pat1-
114/pat1-114 
h+/h+ rct1::HA::kanMX/rct1::HA::kanMX, 
pat1-114/ pat1-114, ade6-M210/ade6-
M216 
this study 
 
Table. 2.2. Other strains used in this study. 
Saccharomyces cerevisiae strains 
name genotype source 
AH-109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4, 
gal80, LYS2::GAL1UAS-GAL1TATA-HIS3, MEL1, GAL2UAS-
GAL2TATA-ADE2, URA3::MEL1UAS-MEL1TATA-lacZ  
Clontech 
Escherichia coli strains 
name genotype source 
XL1-Blue recA1, endA1, gyrA96, thi-1, hsdR17(rK-, mK+), supE44, 
relA1, lac,  [ F', proAB, lacIqZΔM15::Tn10(tetr)] 
lab 
collection 
DH5αΤΜ φ80dlacZΔM15, recA1, endA1, gyrAB, thi-1, hsdR17(rK-
, mK+), supE44, relA1, deoR,  
Δ(lacZYA-argF) U169, phoA 
lab 
collection 
Top10 F–, mcrA, Δ(mrr-hsdRMS-mcrBC), φ80lacZΔM15, 
ΔlacX74, deoR, recA1, araD139,  
Δ(ara, leu)7697, galU, galK, rpsL(strr), endA1, nupG 
lab 
collection 
BL21 (DE3) F–, ompT, hsdSB(rB-, mB-), dcm, gal, λ(DE3) Kind gift of 
B. Kusenda 
Rosetta (DE3)pLysS F–, ompT, hsdSB(rB-, mB-), dcm, gal, lacY1, λ(DE3), 
pLysSRARE (argU, argW, ilex, glyT, leuW, proL) (CmR) 
Kind gift of 
B. Kusenda 
 
Table. 2.3. Media used in this study. 
medium composition 
LB 0.5% (w/v) yeast extract, 1% (w/v) peptone, 1% (w/v) NaCl 
YES 0,5% (w/v) yeast extract, 3% (w/v) D-glucose, 225 mg/l adenine, 225 
2. Materials and methods
 
54 
mg/l uracil, 225 mg/l L-leucine, 225 mg/l L-lysin, 225 mg/l L-histidine  
EMM 0,3% (w/v) potassium hydrogen phthalate, 0,276% (w/v) Na2HPO4, 
0,5% (w/v) NH4Cl, 2% (w/v) D-glucose, 0.17% (w/v) MgCl2 6H2O, 
0,00148% (w/v) CaCl2 2H2O, 0.1% (w/v) KCl, 0,004% (w/v) Na2SO4, 
0,0001% (w/v) Na pantothenate, 0.001% (w/v) nicotinic acid, 0.001% 
(w/v) inositol, 0,000001% (w/v) biotin, 0,00005% (w/v) H3BO3, 
0,00004% (w/v) MnSO4, 0,00004% (w/v) ZnSO4 7H2O, 0,00002% (w/v) 
FeCl3 6H2O, 0,000004% (w/v) H2MoO4 H2O, 0,00001% (w/v) KI, 
0,000004% (w/v) CuSO4 5H2O, 0.0001% (w/v) citric acid, appropriate 
amino acids and bases used at the concentration 225 mg/l 
EMM-NA as EMM, but 1% (w/v) D-glucose,  w/o NH4Cl, w/o adenine 
EMM Ade limiting as EMM, but 5 mg/l adenine  
YPD 1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v) D-glucose 
SD 0.17% (w/v) YNB, 0.5% (w/v) ammonium sulfate, 2% (w/v) D-glucose, 
appropriate amino acids and bases  
SD+X-Gal 0,67% (w/v) yeast nitrogen base, 2% (w/v) galactose, 1% (w/v) 
raffinose, 0,7% (w/v) Na2HPO4 7H2O, 0,3% (w/v) NaH2PO4, 0,008% 
(w/v) X-Gal, appropriate amino acids and bases  
 
2.1.2. Mating type and ploidy determination 
Mating type of desired strain was determined by PCR with two sets of primers (Tab. 
2.4.), MM and MT1 that generate 729 bp long product in h- strains and MP and MT1 
that generate 987 bp long product in h+ strains. Alternatively, mating type was 
determined based on crosses with established h- and h+ strains. To select diploid cells, 
mating type PCR genotyping and phloxin B selection on YES plates supplemented with 
0,02 mg/ml phoxine B were employed. Alternatively, ploidy was checked by 
sporulation of cells on EMM-NA plate at 25°C for 3-4 days. The spore formation was 
determined by exposing plates with cells to iodine vapors or microscopically.  
Table. 2.4. Primers used for mating type determination in S. pombe 
primer sequence 
MM TACGTTCAGTAGACGTAGTG 
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MP ACGGTAGTCATCGGTCTTCC 
MT1 AGAAGAGAGAGTAGTTGAAG 
 
3.1.3 Random spore analysis and tetrad dissection 
The haploid fission yeast strains of opposite mating types were allowed to mate and 
sporulate on EMM-NA plate at 25°C for 3-4 days. Loop of mature spore tetrads was 
mixed with 900 μl of water and 100 μl of NEE-154 glusulase (PerkinElmer Life 
Sciences, 10 000 U/ml) and incubated at 30°C for 3-4 hours. After ascus wall digestion 
the spores were harvested and mixed with 1 ml of 20% ethanol, incubated for 30 
minutes at room temperature, harvested again and plated. For tetrad dissection a 
loop of 2 days old tetrads was spread over the edge of YES plate, tetrads were 
micromanipulated to desired location and incubated at 20°C overnight. After ascus 
wall breakage, the tetrades were dissected and allowed to grow for at least 1 week at 
32°C. 
2.1.4. Non-synchronous sporulation (sporulation assay) 
To assay for sporulation efficiency of a diploid strain the fresh cells of desired 
genotype were diluted with liquid EMM-NA medium to OD600 0,5 and allowed to 
sporulate at 30°C for 22 hours, if not stated otherwise. After the required period of 
time they were collected and the percentage of asci generated in the total population 
of cells was estimated microscopically. The time and temperature were changed, if 
increased or decreased sporulation efficiency was needed. 
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2.1.5. Synchronous sporulation of pat1-114/pat1-114 cells 
To obtain synchronous population of pat1-114/pat1-114 cells at different stages of 
meiosis the cells of desired genetic background were first diluted in EMM-NA 
medium to OD600 0,5 and  synchronized at 25°C overnight (app. 17 hours). In the 
morning they were collected and diluted with EMM-NA supplemented with 0,5 g/l 
NH4Cl to OD600 0,5 and incubated further at 34°C to induced meiosis. The samples 
were collected at desired time points after induction of meiosis. 
2.1.6. Protoplast fusion 
To generate diploid strains by protoplast fusion the required haploid strains were 
grown up to OD600 0,2-0,3, then 50 ml of each strain were harvested at 4 000 rpm for 
3 minutes and the pelleted cells were washed with 10 ml of 0,65 M KCl. Then the cells 
were harvested again and resuspended in 5 ml of 0,65 M KCl supplemented with 1 
mg/ml Novazyme and incubated at 30°C approximately 1 hour, or until protoplasts 
had appeared (protoplast formation was checked under the microscope). Next, the 
protoplasts were harvested at 2 500 rpm for 3 minutes, washed with 10 ml of 1,2 M 
sorbitol and resuspended in 2 ml of 1,2 M sorbitol. Finally, the protoplasts of the 
strains to be fused were mixed together by pipeting the cells up and down gently, 
harvested at 2 500 rpm/ 3 min and mixed with 1 ml of 30% PEG 6 000 pre-mixed with 
0,1 M CaCl2 in 9 : 1 ratio and incubated for 30 minutes at room temperature. The 
fused protoplasts were either directly restreaked onto the selective plates 
supplemented with 1,2 M sorbitol or plated embedded in 1% top-agar. 
2. Materials and methods
 
57 
2.1.7. Fission yeast transformation 
For the transformation of fission yeast with plasmid DNA or with DNA replacement 
cassette 50 ml of fresh overnight culture of OD600 0,3-0,5 were used. The cells were 
harvested at 3 000 rpm for 2 minutes at the room temperature, washed with 20 ml of 
water and 1 ml of LiAc-TE buffer [0,1 M lithium acetate (pH 4,9), 10 mM Tris (pH 8), 1 
mM EDTA] and finally the pelleted cells were resuspended in 250 μl of LiAc-TE buffer. 
For transformation 100 μl of cells were mixed with 10 μl of carrier salmon sperm DNA 
(2 mg/ ml) and 10 μl of the gel-purified DNA replacement cassette (or 1 μl of plasmid 
DNA). The mixture was incubated at room temperature for 10 minutes, then 260 μl of 
40% PEG in LiAc-TE were gently mixed with cells, and the mixture was incubated 
further at 30°C for 30-60 minutes. Finally, 43 μl of DMSO were added to the mixture, 
the cells were heat shocked for 5 minutes at 42°C, harvested, diluted with 1 ml of YES 
media, incubated at 30°C for several hours and plated onto selective plates.   
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2.2. PREPARATION OF NEW FISSION YEAST STRAINS 
2.2.1. Preparation of haploid strains 
2.2.1.1. Preparation of rct1-HA strain 
The rct1::HA::kanMX sequence was amplified from pMG1 plasmid with the primers 
Rct1_KO_F1 and Termin-delPPIase. The replacement cassette was gel purified and 
transformed into the diploid wild type cells. The transformed cells were plated onto 
YES plates, replica-plated onto YES+GE plates and re-checked for geneticin resistance. 
The correct integration of the cassette was verified by PCR with three sets of primers: 
Spcheck2fw with Seq3REP3XK and Spcypconfw (or kan MX ver F) with Spcheck3rev. 
The diploids with the cassette correctly integrated were sporulated, the tetrads were 
dissected and spores were tested for geneticin resistance. The presence of 
replacement cassette in the geneticin resistant clones was tested by PCR and the PCR 
products of Spcheck2fw and Seq3REP3XKPCR reaction were then sequenced. The 
expression of Rct1-HA protein was verified on Western blot with anti-HA antibodies. 
The selected rct1-HA strain was then backcrossed with the haploid wild type strain to 
obtain the final prototroph strain used in the experiments. 
2.2.1.2. Preparation of rct1 ΔRS-HA strain 
The rct1-ΔRS::HA::kanMX sequence was amplified from pMG2 plasmid with the 
primers Rct1_KO_F1 and Termin-delPPIase. Otherwise the experimental procedure 
was the same as with rct1-HA strain. 
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2.2.1.3. Preparation of rct1-FLAG strain 
The FLAG::hphMX sequence was amplified from pFA6a-tdTomato-hphMX6 plasmid 
with the primers Rct1-FLAG-F and Rct1-GFP-rev. The replacement cassette was gel 
purified and transformed into the haploid wild type cells. The transformed cells were 
plated onto YES plates and after 20 hours replica-plated onto YES+H plates. Finally, 
the correct integration of the cassette was verified by PCR with two sets of primers: 
Rct1-ver-F with MX4/6cassUP-R and MX4/6cassUP with Rct1-ver-R, and subsequent 
sequencing of the PCR products of the first reaction. Expression of Rct1-FLAG protein 
was verified on Western blot with anti-FLAG antibodies. The selected rct1-FLAG strain 
was then backcrossed with the 12155 strain to obtain the final prototroph strain used 
in the experiments. 
2.2.1.4.  Preparation of tsn1-HA strain 
The HA::kanMX sequence was amplified from pMG-Tsn1 plasmid with the primers 
Tsn1-promoter-fw2 and Tsn1-terminator-rev. The replacement cassette was gel 
purified and transformed into the haploid wild type cells. The transformed cells were 
plated onto YES plates, replica-plated onto YES+GE plates and finally the correct 
integration of the cassette was verified by PCR with primers Tsn1-UP-fw and 
Seq3REP3XK and subsequent sequencing of the PCR products. The expression of HA-
tagged Tsn1 protein was verified on Western blot with anti-HA antibodies. The 
selected tsn1-HA strain was then backcrossed with the haploid wild type strain to 
obtain the final prototroph strain used in the experiments. 
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2.2.1.5. Preparation of tsn1-GFP strain 
The GFP::kanMX sequence was amplified from pSMRG2+GFP5 plasmid with the 
primers Tsn1-GFP-fw1 and Tsn1-GFP-rev. The replacement cassette was gel purified 
and transformed into the haploid wild type cells. The transformed cells were plated 
onto YES plates, replica-plated onto YES+GE plates and finally the correct integration 
of the cassette was verified by PCR with the primers Tsn1-UP-fw and Seq3REP3XK and 
subsequent sequencing of PCR products. However no Rct1-GFP protein was detected 
by fluorescent microscopy and Western blotting. 
2.2.1.6. Preparation of Δtsn1(nat) strain 
The natMX sequence was amplified from pAG25 plasmid with the primers Tsn1CNup 
and Tsn1CNdwn. The replacement cassette was gel purified and transformed into the 
haploid wild type cells. The transformed cells were plated onto YES plates, replica-
plated onto YES+ClonNat plates and finally the correct integration of the cassette was 
verified by PCR with the primers Tsn1-check1-fw and GFP5-check1-rev and 
subsequent sequencing of the PCR products. The selected tsn1-HA strain was then 
backcrossed with the haploid wild type strain to obtain the final prototroph strain 
used in the experiments. 
3.2.1.7. Preparation of Δtsn1(kan) strain 
The kanMX sequence was amplified from pMG plasmid with the primers Tsn1-KOup-
rev and Tsn1-KOdwn-fw. The replacement cassette was gel purified and transformed 
into the diploid wild type cells. The transformed cells were plated onto YES plates, 
replica-plated onto YES+GE plates, sporulated and the tetrads were dissected on YES 
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plates. Finally, the cells of individual spores were checked for the geneticin resistance 
and the correct integration of the cassette was verified by PCRs with three sets of 
primers: Tsn1-UP-fw with Tsn1-DW-rev, Tsn1-UP-fw with KanMX-ver-F and Tsn1-DW-
rev with Kan-fw(rev). The selected Δtsn1(kan) strain was then backcrossed with the 
haploid wild type strain to obtain final prototroph strain used in the experiments. 
2.2.1.8. Preparation of srp1-FLAG strain 
The FLAG::hphMX sequence was amplified from pFA6a-hphMX6 plasmid with the 
primers Srp1-FLAG-F and Srp1-tag-R. The replacement cassette was gel purified and 
transformed into the haploid wild type cells. The transformed cells were plated onto 
YES plates, replica-plated onto YES+H plates and finally the correct integration of the 
cassette was verified by PCR with two sets of primers: Srp1-ver-F1 with 
MX4/6cassUP-R and MX4/6cassUP with Srp1-ver-R, and subsequent sequencing of 
the PCR products of the first reaction. The expression of FLAG-tagged Srp1 was 
verified on Western blot with anti-FLAG antibodies. The selected srp1-FLAG strain 
was then backcrossed with 12155 strain to obtain the final prototroph strain used in 
the experiments. 
2.2.1.9. Preparation of srp1-tdTomato strain 
The FLAG::hphMX sequence was amplified from pFA6a-hphMX6 plasmid with the 
primers Srp1-GFP-F and Srp1-tag-R. The replacement cassette was gel purified and 
transformed into the haploid wild type cells. The transformed cells were plated onto 
YES plates, replica-plated onto YES+H plates and the transformants expressing Srp1-
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tdTomato were then selected by fluorescent microscopy and on Western blots with 
anti-dsRed antibodies.  
2.2.1.10. Preparation of srp2-FLAG strain 
The FLAG::hphMX sequence was amplified from pFA6a-tdTomato-hphMX6 plasmid 
with the primers Srp2-FLAG-F and Srp2-tag-R. The replacement cassette was gel 
purified and transformed into the haploid wild type cells. The transformed cells were 
plated onto YES plates, replica-plated onto YES+H plates. Finally, the correct 
integration of the cassette was verified by PCR with two sets of primers: Srp2-ver-F1 
with MX4/6cassUP-R and MX4/6cassUP with Srp2-ver-R, and subsequent sequencing 
of the PCR products of the first reaction. Selected srp2-FLAG strain was then 
backcrossed with the 12155 strain to obtain the final prototroph strain used in the 
experiments. 
2.2.1.11. Preparation of srp2-tdTomato strain 
The tdTomato::hphMX sequence was amplified from pFA6a-tdTomato-hphMX6 
plasmid with the primers Srp2-GFP-F and Srp2-tag-R. The replacement cassette was 
gel purified and transformed into the haploid wild type cells. The transformed cells 
were plated onto YES plates, replica-plated onto YES+H plates. However no 
transformants expressing the tdTomato-tagged Srp2 protein were recovered, as was 
revealed by fluorescent microscopy and Western blotting. 
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Table. 2.5. Primers used for the amplification of DNA replacement cassettes. The sequences 
used for fragment amplification are written in the normal characters. In bold are the sequences 
used for homologous recombination of the amplified fragments into the S. pombe genome and in 
italic are the sequences encoding the protein tags. 
primer sequence 
Tsn1-promoter-fw2 AATTTACGTGGATTTTTTTTTTTTTTGATAGTTTATTTCTGACATATGCAGTTGTT
TATGATCTTCGGATACATAAATTG 
Tsn1-terminator-rev AGCAATTTTATCGGCTCAATTTTAGTCAAGCGTACAGCTGGCAAATAAATTGTT
AGCAATGGTTAAGGAGTTAGACTCG 
Tsn1-GFP-fw1 GTTTATTTCTGACATATGCAGTTGTTTATGATCTTCGGATACATAAATTGGTTAT
GAGTAAAGGAGAAGAACTT 
Tsn1-GFP-rev TTTAGTCAAGCGTACAGCTGGCAAATAAATTGTTAGCAATGACAAGTTCTTGAA
AACAAG 
Tsn1CNup TCATTCGAATATCAACACTACTCAACAGCATACATTACAGATTAAGTCGAATGA
ATAAATCAATATTTATTCAGCTACAAGATCAAATTGATAAAGAACAGATCTGTT
TAGCTTGCCTTG 
Tsn1CNdwn AAATTGTTAGCAATTTAAACCAATTTATGTATCCGAAGATCATAAACAACTGCA
TATGTCAGAAATAAACTATCAAAAAAAAAAAAAATCCACGTAAATTAGCTCGT
TTTCGACACTGG 
Tsn1-KOup-rev ACTGAAAACATCATTCGAATATCAACACTACTCAACAGCATACATTACAGATTA
AGTCGAGGTTAAGGAGTTAGACTCG 
Tsn1-KOdwn-fw AGCAATTTTATCGGCTCAATTTTAGTCAAGCGTACAGCTGGCAAATAAATTGTT
AGCAATTAATCCTTTCTATTAGTAATGC 
Srp1-FLAG-F CCAACCCGAAGTGTCAGCTGCTTCAGAGCAACCAGAATCCAACCCTACTACTAC
AGAGTCTCAAGATTATAAAGATGACGATGATAAATAGCGGATCCCCGGGTTAAT
TAA 
Srp1-tag-R ACTGTGTTACGGAATTTTGGAACAAAAGTAAAGGAATATAGACAATTTTTAAA
ACATGAAAACCTTTTTTTAATTAAGTACAAAAGTGAATTCGAGCTCGTTTAAAC 
Srp1-GFP-F CCAACCCGAAGTGTCAGCTGCTTCAGAGCAACCAGAATCCAACCCTACTACTAC
AGAGTCTCAACGGATCCCCGGGTTAATTAA 
Srp2-FLAG-F AACAGCCTTTGCAAAACCATTCTGATGTAGGTAACGGTAGCGCTGAAGGACAG
GTCGCTGCTGAATGGGATTATAAAGATGACGATGATAAATAGCGGATCCCCGG
GTTAATTAA 
Srp2-GFP-F AACAGCCTTTGCAAAACCATTCTGATGTAGGTAACGGTAGCGCTGAAGGACAG
GTCGCTGCTGAATGGCGGATCCCCGGGTTAATTAA 
Srp2-tag-R GACATATGACAGGAAAATCTAGTAAGCAGACACTAAAAAATAGTTTACCAAA
GGAAAAATTTCTATGTGAATTCGAGCTCGTTTAAAC 
Rct1-FLAG-F TCACTTACGAGATAAATCTCCTGAACGAAGGTATAGATATGATAGACGTTATA
GAGATGATAGATATCGAGATTATAAAGATGACGATGATAAATAGCGGATCCCC
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GGGTTAATTAA 
Rct1-GFP-rev TGAAGTCTTAATCAATTATTCAACTATGTTTTAGTAATTTCATCAGTCATAAATA
ATATTCACAAGAAAGGTACGAATATAATAAAGATGAATTCGAGCTCGTTTAAA
C 
 
Table. 2.6. Primers used for the verification of correct integration of DNA replacement 
cassettes.   
Name  sequence 
Tsn1-UP-fw ATCAACACTACTCAACAGCA 
Seq3REP3XK CTCATCTAAACCACTTTCTAA 
Tsn1-check1-fw TCGTCAATCTGTAAACTCAGTAATATC 
GFP5-check1-rev ATCACCTTCACCCTCTCCAC 
Tsn1-DW-rev CATCATAGGACTGCCAGTTTCATAGC 
KanMX-ver-F GGTTGTTTATGTTCGGATGTGATGTG 
Kan-fw-(rev) GCCATTCTCACCGGATTCAGTCGTC 
Srp1-ver-F1 CGTAGTCGTAGTCCTGATGG 
MX4/6cassUP-R GTATTCTGGGCCTCCATGTC 
MX4/6cassUP  GACATGGAGGCCCAGAATAC 
Srp1-ver-R TGCCACGAATCAGCACAGTC 
Srp2-ver-F1 TCGCCGTCGTTATCGTGATG 
Srp2-ver-R CACATTCCTTTCATTCTTGATCGTAAG 
Rct1-ver-F GCAGAAGCAGAGGCTGTTACA 
Rct1-ver-R CCCTCGAATTTAGTACGACGA 
 
2.2.2. Preparation of diploid strains 
2.2.2.1. Preparation of Δtsn1(nat)/Δtsn1(kan), Δtsn1(nat)/Δtsn1(nat) and 
Δtsn1(kan)/Δtsn1(kan) strains 
To prepare the stable Δtsn1(nat)/Δtsn1(kan) diploid strain suitable for the sporulation 
assay I crossed the haploid Δtsn1(nat) strain with the Δtsn1(kan) strain of the opposite 
mating type and selected the desired diploids based on the ClonNat and geneticin 
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resistance (i.e. on YES+GE+ClonNat plates). To obtain the Δtsn1(nat)/Δtsn1(nat) stable 
diploid strain suitable for plasmid transformations I first crossed  the Δtsn1(nat) strain 
with the 12155 and 12156 strains to obtain the Δtsn1(nat) ade6-M210 pat1+ and  
Δtsn1(nat) ade6-M216 pat1
+
 haploid strains and then crossed these two to obtain the 
diploids. The desired diploids were selected based on the ade6 complementation on 
EMM-A plates. In parallel I prepared the Δtsn1(kan)/Δtsn1(kan) diploid strain employing 
the same approach. The diploid state of prepared strains was further verified by the PCR 
genotyping, sporulation assay, diploid cell size measurement and Syber Green flow 
cytometry to quantify the DNA content in the cells. 
2.2.2.2. Preparation of Δtsn1(nat)/Δtsn1(nat) pat1-114/pat1-114 and  tsn1-HA/tsn1-HA 
pat1-114/pat1-114 strains 
To prepare the stable diploid strains suitable for the synchronization in early meiosis I 
first crossed  the tsn1-HA and Δtsn1(nat) strains with the 12155 and 12156 strains to 
obtain the tsn1-HA ade6-M210  pat1-114, tsn1-HA ade6-M216 pat1-114, Δtsn1(nat) 
ade6-M210 pat1-114 and Δtsn1(nat) ade6-M216 pat1-114 haploid strains. These strains 
were then used to prepare the Δtsn1(nat)/Δtsn1(nat) pat1-114/pat1-114 and tsn1-
HA/tsn1-HA pat1-114/pat1-114 strains by protoplast fusion of two strains of the same 
mating type. The diploids were first selected based on the ade6 complementation on 
EMM-A plates at 25°C and then checked for the diploid cell size, DNA content by Syber 
Green based flow cytometry and temperature dependent sporulation phenotype. 
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2.3. PLASMID PREPARATION 
Table. 2.7. General purpose vectors used in this study. 
plasmid general purpose selection source 
pGBT9 constitutive expression of  nuclear GAL4 DNA-
binding domain fusion protein from ADH1 
promotor in yeasts 
AmpR, 
TRP1 
lab collection 
 
pGAD424 constitutive expression of nuclear GAL4 
activation domain fusion protein from ADH1 
promotor in yeasts 
AmpR,  
LEU2 
lab collection 
pGEX-4T-1 inducible expression of glutathione S-
transferase (GST) fusion proteins from tac 
promoter in E. coli 
AmpR,  lab collection 
pET28a(+)-GST inducible expression of fusion proteins with C 
terminal GST tag from T7 promotor in E. coli 
KanR,  lab collection 
pMG repressible overexpression of  proteins from 
nmt1
+ promoter in S. pombe 
LEU2 
GenR 
lab collection 
Gullerova et.al 
2007 
 
2.3.1. Preparation of pGBT9-Rct1 and pGAD424-Rct1 
The rct1+ coding sequence was amplified from S. pombe gDNA with primers Rct1-2H-3-
PstI and Rct1-2H-5-SmaI. The purified PCR product was digested with PstI and XmaI and 
the fragments of required size were selected and introduced into pGBT9 or pGAD424 
vectors using PstI and XmaI cloning sites.  
2.3.2. Preparation of pGBT9-Rct1 ΔRS and pGAD424-Rct1 ΔRS 
The rct1 ΔRS DNA fragment was amplified from pGBT9-Rct1using primers Rct1-RSdel-2H-
3-PstI and Rct1-2H-5-SmaI. The purified PCR product was digested with PstI and XmaI 
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and the fragments of required size were selected and introduced into pGBT9 or 
pGAD424 vectors using PstI and XmaI cloning sites.  
2.3.3. Preparation of pGBT9-Tsn1, pGAD424-Tsn1, pGBT9-insertTsn1 and 
pGAD424-insertTsn1 
The intronless tsn1+ coding sequence was amplified from pTN-TH7 library of cDNAs of S. 
pombe using primers Tsn1-Y2H-5 -EcoRI and Tsn1-Y2H-3-BamHI. The purified PCR 
product was digested with EcoRI and BamHI restriction enzymes and the fragments of 
required size were selected and introduced into pGBT9 or pGAD424 vectors using EcoRI 
and BamHI cloning sites. To generate plasmids with a random sequence inserted 
upstream of tsn1+, the insert for cloning was amplified with primers Tsn1-Y2H-5-EcoRI-IS 
and Tsn1-Y2H-3-BamHI from the same template. The inserted sequence was a part of the 
first primer. 
2.3.4. Preparation of pGEX-4T-1-Tsn1 and pGEX-4T-1-Tsn1-HA 
The intronless tsn1+ coding sequence was amplified from pTN-TH7 library of cDNAs of S. 
pombe using primers tsn1 EcoRI-F (or Tsn1-HA-EcoRI-F) and Tsn1-XhoI-R. The purified 
PCR product was digested with EcoRI and XhoI, the fragments of required size were 
selected and introduced into vector pGEX-4T-1 using EcoRI and XhoI cloning sites.  
2.3.5. Preparation of pMG-Tsn1 
The tsn1+ coding sequence was amplified from pGBT9-Tsn1 plasmid with primers Tsn1-
XhoI-ATG and Tsn1-BamHI-HA. The purified PCR product was digested with XhoI and 
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BamHI, the fragments of required size were selected and introduced into vector pMG 
using XhoI and BamHI cloning sites.  
2.3.6. Preparation of pET28a-Rct1-GST 
The rct1+ coding sequence was amplified from pMG1 plasmid with primers RCT1CGEXUP 
and RCT1CGEXDW. The purified PCR product was digested with NcoI and SalI, the 
fragments of required size were selected and introduced into vector pET28a-GST using 
NcoI and SalI cloning sites.  
2.3.7. Preparation of pGEX-4T-1-Srp1, pGEX-4T-1-Srp2, pGEX-4T-1-Prp4, pGEX-
4T-1-Ppk15, pGEX-4T-1-Srp1 ΔRS and pGEX-4T-1-Srp2 ΔRS 
Corresponding coding sequences were amplified from pTN-TH7 library of cDNAs of S. 
pombe using primers Srp1-BamHI-F and Srp1-XhoI-R for cloning of srp1, primers Srp2-
BamHI-F and Srp2-XhoI-R for cloning of srp2, primers Srp1-BamHI-F and Srp1-ΔRS-XhoI R 
for cloning of srp1 ΔRS, primers Srp2-BamHI-F and Srp2-ΔRS-XhoI-R for cloning of srp2 
ΔRS, primers Prp4-BamHI-F and Prp4-XhoI-R for cloning of prp4 and primers Ppk15-
BamHI-F and Ppk15-XhoI-R for cloning of ppk15. The purified PCR products were digested 
with BamHI and XhoI, fragments of required size were selected and introduced into 
vector pGEX-4T-1 using BamHI and XhoI cloning sites. 
2.3.8. Preparation of pGEX-4T-1-Dsk1, pGEX-4T-1-Ppk5, pGEX-4T-1-Prp2 and 
pGEX-4T-1-Prp2 ΔRS 
Corresponding coding sequences were amplified from gDNA of S. pombe using primers 
Dsk1-BamHI-F and Dsk1-XhoI-R for cloning of dsk1, primers Ppk5-BamHI-F and Ppk5-
2. Materials and methods
 
69 
XhoI-R for cloning of ppk5, primers Prp2-BamHI-F and Prp2-XhoI-R for cloning of prp2 
and primers Prp2-ΔRS-BamHI F and Prp2-XhoI-R for cloning of prp2 ΔRS. The purified PCR 
products were digested with BamHI and XhoI, fragments of required size were selected 
and introduced into vector pGEX-4T-1 using BamHI and XhoI cloning sites. 
Table. 2.8. List of primers used for cloning of inserts into the general purpose plasmids. In bold 
are the sequences of restriction enzymes used for cloning, in italics are the inserted sequences 
and in standard upper case are the sequences used for PCR amplification and in lower case are 
the stop codons. 
primer  sequence 
Rct1-2H-3-Pst1 GACTAGCTGCAGCctaTCGATATCTATCATCTCTATAACGTC T 
Rct1-RSdel-2H-3-PstI ATCTCTGCAGctaACGAGCCACGCTTTGGGA 
Rct1-2H-5-Sma1 GACTAGCCCGGGATCTGTACTAATTGAAACTACAGTTGGTG 
Tsn1-Y2H-5 -EcoRI ACTGGAATTCAATAAATCAATATTTATTCAGC 
Tsn1-Y2H-3-BamHI ACTGGGATCCctaAACCAATTTATGTATCCG 
Tsn1-Y2H-5-EcoRI-IS ACTGGAATTCGTGCATGCTAATGGTTCAGCATTCCTGACTGTGATCAGTAACCTG
AATAAATCAATATTTATTCAGC 
Tsn1-EcoRI-F ATCTGAATTCAATAAATCAATATTTATTCAGC 
Tsn1-HA-EcoRI-F ATCTGAATTCTATCCGTATGATGTGCCTGACTACGCAAATAAATCAATATTTATT
CAGC 
Tsn1-XhoI-R ATCTCTCGAGctaAACCAATTTATGTATCCG 
Tsn1-Xho1-ATG ACTGCTCGAGATGAATAAATCAATATTTATTC 
Tsn1-BamHI-HA ACTGGGATCCCTCGACtcaTGCGTAGTCAGGCACATCATACGGATAAACCAATTT
ATGTATCCG 
RCT1CGEXUP ACTGCCATGGTGTCTGTACTAATTGAAACTACAGTTG 
RCT1CGEXDW ACTGGTCGACTCGATATCTATCATCTCTATAACG 
Rct1-2H-5-Sma1 GACTAGCCCGGGATCTGTACTAATTGAAACTACAGTTGGTG 
Rct1-RNA3H-EcoRI ATCTGAATTCctaACGAGCCACGCTTTGGGA 
Tsn1-BamHI-fw ACTGGGATCCTGAATAAATCAATATTTATTCAGC 
Tsn1-EcoRI-rev ACTGGAATTCctaAACCAATTTATGTATCCG 
Srp1-BamHI-F ATCTGGATCCAGTCGCAGAAGCCTTCGTAC 
Srp1-XhoI-R ATCTCTCGAGctaTTATTGAGACTCTGTAGTAGTAGGG 
Srp2-BamHI-F ATCTGGATCCTCGGAGACTAGATTGTTTGTT 
Srp2-XhoI-R ATCTCTCGAGctaTTACCATTCAGCAGCGACC 
Prp4-BamHI-F ATCTGGATCCAGTGACGATAGATTTGCAGA 
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Prp4-XhoI-R ATCTCTCGAGctaTTATTTTTTTATAAAGAAAGGATG 
Ppk15-BamHI-F ATCTGGATCCGATTCGGATTCGCCCATT 
Ppk15-XhoI-R ATCTCTCGAGctaTTAGAAAAATTCATCTACATTTTCG 
Dsk1-BamHI-F ATCTGGATCCGGAAGTGACGGGTCGAGT 
Dsk1-XhoI-R ATCTCTCGAGctaCTAACGAATTTCAGTAGCCCA 
Ppk5-BamHI-F ATCTGGATCCGTGGGGTTAATAAGTACAAGC 
Ppk5-XhoI-R ATCTCTCGAGctaCCATTTCAAACATTTTGAAAG 
Prp2-BamHI-F ATCTGGATCCGATTTGTCTTCCAGATTATCATC 
Prp2-XhoI-R ATCTCTCGAGctaTCACCATGCATTAGCTTTATAG 
Rct1-Xho1-fw-45 ACTGCTCGAGATGTCTGTACTAATTGAAACTACAGT 
Rct1-BamHI-HA-rev-45 ACTGGGATCCCTCGACtcaTGCGTAGTCAGGCACATCATACGGATATCGATATCT
ATCATCTCTATAACG 
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2.4. YEAST TWO HYBRID SCREEN 
To perform yeast two hybrid screen I first amplified pTN-TH7 library in pGAD424 vector 
(a kind gift of Taro Nakamura) in E. coli DH5-α (UltraMAXTM DH5α-FTTM Competent Cells) 
cells and isolated the amplified plasmid DNA by QIAGENE midi-prep kit according to the 
instructions of provider. The resulting midi-prep DNA (3,9 μg/μl) was then used for 
transformation of four different AH-109 + pGbt9-Rct1 clones in four independent 
transformation reactions.  
The AH-109 + pGbt9-Rct1 cells used for transformation were first pre-grown overnight in 
SD-T medium, then diluted in 50 ml of pre-warmed YPDA to OD600 0.5 and then allowed 
to grow up to the OD600 1,0-1,3. When they reached desired density they were harvested 
at 3 000 rpm for 5 min, washed with sterile water, mixed with 3 ml of 100 mM Li acetate 
and incubated for 15 min at 30°C. After the pre-incubation they were collected and the 
following components were layered over the pellet: 2,4 ml of 50% PEG 3350, 360 μl of 
1M Li acetate, 200 μl of ssDNA (5 mg/ml), 36 μl of  pTN-TH7 library and 604 μl of water.  
Finally, the cells were mixed with the components by vortexing, incubated for 30 min at 
30°C and heat-shocked for 20 min at 42 °C. After heat-shock the cells were harvested, 
mixed with 10 ml of water and plated onto SD-TLH plates. The transformation efficiency 
was estimated after three days of growth at 30°C. The total number of transformants 
bearing both plasmids was estimated to be 1,834 x 106. After six days of growth at 30°C 
all large colonies (~250 transformants) were streaked onto SD-TLH, SD-TLHA, SD-TLHA + 
5 mM 3-AT and SD-TLHA + X-gal plates and checked for phenotypes. After two weeks of 
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growth additional large colonies and also small, but distinctly white colonies (33 
transformants) were selected and checked for phenotypes as above.  Finally, 18 clones 
growing well on SD-TLHA medium were selected and phenotypes of single colonies were 
re-checked two more times.  Finally, the cDNA inserts in pGAD424 vector of selected 
clones were amplified with pGAD424 5'AD and pGAD424 3'AD primers (Tab. 2.9.), the 
resulting PCR products were sequenced and obtained sequences were blasted against S. 
pombe genome to identify proteins expressed in selected clones.    
Table. 2.9. Oligonucleotides used for insert amplification in the yeast two hybrid  
primer sequence 
pGAD424 5'AD  CTATTCGATGATGAAGATACCCCACCAAACCCA 
pGAD424 3'AD  GTGAACTTGCGGGGTTTTTCAGTATCTACGAT 
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2.5. PROTEIN ASSAYS 
2.5.1. Overexpression and purification of GST-tagged proteins from E. coli 
E. coli BL21 (DE3) cells transformed with desired plasmids were grown overnight in 10 ml 
of LB media supplemented with chloramphenicol (40 μg/ml) and ampicilin (100 μg/ml), if 
pGEX-4T-1 based plasmids were used, or kanamycin (50 μg/ml), if pET28a-GST based 
plasmids were used. For the GST-protein overexpression the overnight culture was 
diluted 100 times with fresh medium and incubated at 37°C up to OD600 0,7-1, then IPTG 
was added to the final concentration of 1 mM and the cells were incubated further at 
28°C for another 3-4 hours to allow the protein expression. Finally, the cells were 
collected for 10 min at 4 000 rpm at 40C and stored at -80°C for the GST-protein 
purification. Expression of the GST-Prp2, GST-Srp2 and GST-Ppk5 was not sufficient in 
BL21(DE3) strain, therefore E. coli Rossetta (DE3) Lys strain was used instead. 
The protein extracts for protein purification were prepared as follows: the frozen cells 
were mixed with 10 ml of lysis buffer [20 mM Tris-HCl (pH 7.5), 1 M NaCl, 0.2 mM EDTA, 
1 mM DTT, 1% Triton X-100, 1 tablete of EDTA-free protease inhibitor cocktail (Roche)], 
sonicated with Bandelin HD 200 Sonoplus sonicator for twice for 15 seconds at 50% duty 
cycle and cleared by centrifugation at 10 000 rpm for 20 minutes to remove debris. To 
bind the GST-proteins to the Glutathione Sepharose 4B beads, 400 μl of 50% beads slurry 
in lysis buffer were mixed with the protein extracts and rolled for 30 minutes at 4°C. The 
beads with bound GST-protein were washed 3 times with 10 ml of lysis buffer and tree 
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times with 1 ml of PEB200 buffer on QIAGEN polypropylene columns. The beads with 
bound GST-proteins were kept in PEB200 buffer at 4°C. 
2.5.2. Protein pull down assay 
For the protein pull down assay 100 ml of the cell culture overexpressing HA-tagged 
protein of interest at OD600 0,3-0,5 were collected, mixed with the glass beads and 500-
750 μl of PEB400 buffer [50 mM HEPES-KOH (pH 7.9), 400 mM KCl, 1 mM DTT, 0.1% 
Triton X-100, 2.5 mM MgCl2, 1 mM EDTA (pH 8.0), 1 tablete of EDTA-free protease 
inhibitor cocktail (Roche)] and  sonicated three times with Bandelin HD 200 Sonoplus 
sonicator for 6 seconds at 50% duty cycle. Prepared cell lysates were left on ice for 10 
minutes with occasional vortexing, centrifuged for 15 minutes at 14 000 rpm at 4°C and 
the supernatants were diluted with PEB0 (same as PEB400, but without KCl), so that KCl 
concentration of final mixture was 200 mM. For the pull down expriment  300 μl were 
mixed with the Glutathione Sepharose 4B beads only, 300 μl were mixed with the beads 
binding the GST fusion proteins and 50 μl of protein extracts were kept as the input 
sample,. The mixtures were rolled for 2-3 hours at 4°C. The beads with bound proteins 
were washed four times with PEB200 buffer (same as PEB400, but with 200 mM KCl) and 
finally the beads were resuspended in 60 μl of Leammlie buffer, denatured for 5 minutes 
at 95°C and analyzed on Western blotts.  
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2.5.3. Protein co-imunoprecipitation assay 
The procedure for protein co-immunoprecipitation assay was essentially the same as for 
the protein pull down assay. To prepare the protein extracts 200-250 ml of cell culture 
with OD600 0,5 were collected, washed with water, mixed with the glass beads and  500 
of PEB400 buffer and  sonicated four times with Bandelin HD 200 Sonoplus sonicator for 
6 seconds at 50% duty cycle. The prepared cell lysates were left on ice for 10 minutes, 
vortexed occasionally, then centrifuged for 15 minutes at 14 000 rpm at 4°C and finally 
the supernatants were diluted with PEB0, so that final KCl concentration was 200 mM. 
The protein concentration in the samples was estimated by BIO-RAD Protein assay kit, 
and the samples were then diluted so that the final concentration of proteins in PEB200 
buffer was the same in all samples. For the immunoprecipitation experiments 50 μl of 
protein extracts were used as an input sample, 300 μl were mixed with 50 μl of 50% 
slurry of protein A Sepharose CL-4B beads (GE Healthcare) and 300 μl were mixed with 
50 μl of 50% slurry of protein A Sepharose CL-4B (GE Healthcare) beads cross-linked with 
anti-HA antibody. The mixtures were rolled for 2-3 hours at 4°C, the beads with bound 
proteins were washed four times with PEB200 buffer and finally, the proteins were 
washed off the beads with 60 μl of Leammlie buffer, denatured for 5 minutes at 95°C and 
analyzed on Western blotts. 
2.5.4. Preparation of total protein extracts with TCA 
To prepare total protein extract of a sample 1ml of a cell culture with an OD600 3 (~ 3x10
7 
cells) was collected, collected cells were washed with water and freezed at -80°C. For the 
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precipitation of proteins the pellet was mixed with 450 μl of water, 50 μl of 3,5% β-
mercaptoethanol in 1,85 M NaOH and incubated for 10 minutes on ice. Then 50 μl of 
50% trichloroacetic acid (TCA) were added and the mixture was incubated for 10 minutes 
on ice. Finally, the proteins were pelleted by centrifugation at 13 000 rpm for 12 minutes 
at 4°C, washed with 1 ml of acetone, air-dried and mixed with 30 μl of 10% SDS. 
2.5.5. Dephosphorylation of proteins with CIP 
The protein extracts were prepared in PEB200 buffer as described in 2.6.2. For the 
protein dephosphorylation 50 μl of the protein extract supplemented with 10 mM MgCl2 
were treated with 50 U of CIP phosphatase for 1 hour at 30°C or 37°C, diluted with 
Leammlie buffer and used for Western blotting. If the concentration of desired protein in 
PEB200 buffer was not sufficient for visualization on Western blotts, then 500 μl of 
protein extracts with MgCl2 were treated with 100 U of CIP phosphatase and total 
proteins were subsequently precipitated with 5% TCA (w/v), dissolved in 20 μl of 10% 
SDS (w/v), diluted with Leammlie buffer and processed for the Western blotts. 
2.5.6. SDS PAGE and Western blotting  
If not stated otherwise the proteins were separated using 10% SDS PAGE gels (running 
buffer: 14,4% glycin (w/v), 3% Tris (w/v), 1% SDS (w/v)) and transferred (transfer buffer: 
14,4% glycin (w/v), 3% Tris (w/v)) to PVDF membrane (Millipore) at 400 mA for 45 
minutes. After the transfer the membranes were blocked with 5% milk (w/v) in PBS (75 
mM NaCl, 3 mM KCl, 4,5 mM Na2HPO4, 1,5 mM KH2PO4) supplemented with 0,5% 
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Tritonx-100 (v/v), probed with the primary antibodies (Tab. 2.10.) and horseradish 
peroxidase conjugated secondary antibodies (Tab. 2.10.), washed with PBST(PBS with 
0,5%  TritonX-100 (v/v)) and finally washed with PBS. The membranes were then 
developed with the chemiluminiscence kit (GE Helthcare) and exposed to the Kodak 
Biomax MR films. If re-probing of membrane was necessary, the membranes were 
stripped off the antibodies for 30 minutes at 70°C in a stripping buffer [62,5 mM Tris-Cl 
(6,8), 2% SDS (w/v), 100 mM β-mercapthoethanol] and re-probed with new antibodies as 
described above. 
Table. 2.10. Primary and secondary antibodies used for Western blotting. 
name type source dilution 
primary antibodies 
anti-HA rat monoclonal IgG Roche 1:5 000  
anti-FLAG  mouse monoclonal IgG Sigma 1:10 000 
anti-RNAPII CTD (8WG16)  mouse monoclonal IgM Covance 1:1 000 
anti-RNAPII CTD (4H8) mouse monoclonal IgG Millipore 1:1 000 
anti-RNAPII CTD (H5)  mouse monoclonal IgM Covance 1:1 000 
anti-RNAPII CTD (H14)  mouse monoclonal IgM Millipore 1:1 000 
anti- tubulin mouse monoclonal IgG Sigma 1:1 000 
anti-PSTAIR (or anti-Cdc2) mouse monoclonal IgG Abcam 1:1 000 
anti-Rct1   rabbit polyclonal Gullerova et al., 2007 1:1 000 
anti-GFP  mouse monoclonal IgG Roche 1:1 000 
anti-dsRed mouse monoclonal IgG Clontech 1:500 
secondary antibodies 
anti-rat  rabbit polyclonal IgG Sigma 1:10 000 
anti-mouse  goat polyclonal IgG BioRad 1:10 000 
anti-mouse  goat polyclonal IgM Biosource 1:10 000 
anti-rabbit goat polyclonal IG Sigma 1:10 000 
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2.6. CHROMATIN IMMUNOPRECIPITATION (ChIP) ASSAY  
2.6.1. Growing the cells and fixation 
Cells for ChIP assay were grown overnight in YES medium until they reached OD600 0,5. 
For cell culture fixation 1/10 of the culture volume of the formaldehyde solution [11% 
Formaldehyde (v/v), 100 mM NaCl, 1 mM EDTA-Na, pH 8, 0.5 mM EGTA-Na, 50 mM Tris-
Cl, pH 8] was added to the culture. The resulting mixture was incubated for 10 minutes at 
room temperature with constant shaking and then the formaldehyde cross-linking 
reaction was quenched by the addition of 1M glycine to the final concentration of 125 
mM, followed by 10 minutes incubation at room temperature with constant shaking. 
Finally, the cells were collected by centrifugation at 3 000 rpm for 2 minutes, washed 3 
times with 1 ml of ice cold ChIP buffer 1 [50 mM HEPES-KOH (pH 7.5), 140 mM NaCl, 1 
mM EDTA (pH 7.5), 1% Triton X-100 (v/v), 0.1% Sodium deoxycholate (w/v)] and frozen 
at –80°C until use.  
2.6.2. Preparation of whole cell extracts and protein immunoprecipitation 
For the preparation of whole cell extracts the cells corresponding to 50 ml of fixed and 
quenched culture were mixed with ~ 50 μl of glass beads in 500 μl of ChIP buffer 1 and 
sonicated on ice four times with the Bandelin HD 200 Sonoplus sonicator for 6 seconds at 
50% duty cycle. To remove debris from the extracts the suspension was centrifugated at 
14 000 rpm for 15 minutes at 4°C. The supernatant was then mixed with small aliquot of 
protein A – Sepharose beads in 20 : 1 ratio and  incubated on a rotating wheel for 1 hour 
at 4°C. After the incubation the beads were pelleted and the pre-cleared cell extracts 
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were used for the protein immunoprecipitation as follow: 90 μl of cell extracts were 
frozen for precipitation of input DNA, 200 μl of cell extracts were mixed with desired 
antibody for protein immunoprecipitation and with protein A - Sepharose beads in 20 : 1 
ratio (pA+X) and 200 μl of cell extracts were mixed with beads only and were used as a 
negative control for  unspecific DNA preciptitation (pA). For the RNAPII and FLAG epitope 
immuneprecipitations 5 μl of the purified anti-RNAPII CTD (4H8) (Millipore) antibodies 
and 3 μl of anti-FLAG antibodies (Sigma) were added directly to the immunoprecipitation 
reaction. For the HA epitope immunoprecipitation the beads were first incubated with 1 
ml of 12CA5 hybridoma lysates overnight at 4°C to bind the anti-HA antibodies and then 
the beads were used for the chromatin immunoprecipitation. The mixtures of the beads 
with the cell extracts were incubated on a rotating wheel for 2 hours at 4°C and then the 
beads with bound protein complexes were collected and washed with 1 ml of ice-cold 
ChIP buffer 1 for 10 minutes under the same conditions. Subsequently, the beads were 
once washed with 1ml of ice cold ChIP buffer 1, ChIP buffer 2 (50 mM HEPES-KOH (pH 
7.5), 500 mM NaCl,  1 mM EDTA [10 mM Tris, 1 mM EDTA, pH 7.5), 1% Triton X-100 (v/v), 
0.1% Sodium deoxycholate (w/v)], ChIP buffer 3 [10 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1 
mM EDTA, pH 7.5, 0.5% Nonidet P-40 (v/v), 0.5% Sodium deoxycholate (w/v)] and finally 
with TE buffer (pH 7,5).  To remove RNA from the mixture, 100 μl of TE buffer containing 
10 μg RNase A were added to the beads and the reaction was allowed to proceed for 15 
minutes at 37°C. The input sample was treated similarly, but 400 μl of TE buffer with 
RNase A were added to 90 μl of cell extracts.  
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2.6.3. Purification of the co-immunoprecipitated DNA 
To release the DNA from the cross-linked complexes 2,5 μl of 10% SDS and 2 μl of 
Proteinase K (600 mAnson-U/ml, Merck) were added to pA+X and pA samples. The 
protein digestion was performed for 8 hours at 37°C and was followed by decross-linking 
of samples for 8 hour at 65°C. The released DNA was then purified by the extraction with 
10 μl of 3 M sodium acetate (pH 5,2) and 100 μl of phenol/chloroform/isoamylalcohol. 
The phases were separated by centrifugation at 14 000 rpm for 15 minutes at room 
temperature. The DNA was precipitated from 130 μl of the supernatant by 40 μg of 
glycogen and 250 μl of 100% ethanol at -20°C overnight. The precipitated DNA was 
pelleted for 15 minutes at 13 000 rpm at room temperature, washed with 70% ethanol 
and dissolved in 150 μl of water. 
The input sample was treated slightly differently. To release the DNA from the cross-
linked complexes, 10 μl of 10% SDS and 2 μl of Proteinase K were added to 90 μl of the 
input sample. The protein digestion and decross-linking were performed in the same way 
as above. The released DNA was purified by the extraction with 40 μl of 3 M sodium 
acetate (pH 5,2) and 400 μl of phenol/chloroform/isoamyl alcohol and the DNA was 
precipitated from 450 μl of the supernatant by 40 μg of glycogen and 1 ml of 100% 
ethanol at -20°C overnight. Finally, the precipitated DNA was dissolved in 150 μl of 
water. 
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2.6.4. Real time PCR quantification of the co-imunoprecipitated DNA 
The relative amount of precipitated DNA was estimated by a quantitative real-time PCR 
(qRT-PCR) using 10 μl of LightCycler 480 SYBR Green I master kit, 2 μl of  
immunoprecipitated DNA, 2 μl of 2 μM primer mixture and 6 μl  of water per reaction. 
The PCR conditions were as follow: 1. 95°C/10 minutes, 2. 95°C/15s, 3. 45°C/30s, 4. 
68°C/10s, 5. 95°C/15sec, 6. melting curve: 50°C-->95°C/10 minutes, repeating 40× steps 2 
to 4. The PCR reaction was performed with Eppendorf Realplex Mastercycler and the 
data were analyzed using the Realplex 2.0 or 2.2 software. The primers used for DNA 
amplification are listed in Tab. 2.11.. The relative amounts of immunoprecipitated DNA 
were expressed as a function of the Ct values and the primer efficiency was calculated 
according to the following formula: the relative amount of DNA = E-(Ct1-Ct2), where the Ct1 
stands for threshold Ct value of the immunoprecipitated sample and the Ct2 for 
threshold Ct value of the input DNA. The primer efficiency (E) of individual primer pairs 
was estimated based on five serial dilutions of the genomic DNA according to the 
following formula: E = 10-(1/S), where S stands for the slope of a standard curve plotting 
the log10(DNA amount) against the corresponding Ct values. (Pfaffl MW, 2001) 
Table. 2.11. Primer pairs used in quantitative real-time PCRs.   
position primer sequence Size of 
product 
primer probes in rDNA region 
rRNA22f AGTAAGGATTGACAGATTGAGAG C 
rRNA22r AAGCAGACAAATCACTCCAC 
88 bp 
primer probes in the dis2 region 
D0 D1fw ACATTCCATCCATCAAATTT 92 bp 
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 D1rev GAACCCTAGACTTTTCTCTTCA  
D2fw AGTGATTATAGAAACTAGGAATATAGG D1 
D2rev TAGGTAGTTGAATGGTTGGG 
91 bp 
D3fw CTTCATAAGTGTCAAAAGCG D2 
D3rev TCTAACAAGCGGTCGATAAT 
90 bp 
D4fw GATTCTTGGTCTCATTTGTG D3 
D4rev CACGATATATGCCAATATGC 
92 bp 
D4/5 fw TTTATTAGTCAACCTATCCTTCTAG D4 
D4/5 rev CCGTACTCAAAAAGTCGAA 
90 bp 
D52fw TATAAAATCAAGTACCCCGAA D5 
D52 rev CTTACATTCATCGTAAAATCCA 
96 bp 
D5/6-3F CTTTCGCCAGATTTGAACTC D6 
D5/6-3R CACAGAGTAACCCAGTATCA 
88 bp 
D6fw AATCTGACGCTTAAAAGACG D7 
D6rev GTTAAGCACTCTCTCGAAGATA 
87 bp 
primer probes in the rho1 region 
R1fw TTACACTCTGTACAGGCTCA R1 
R1rev AGACGCTACTACACTTCACT 
103 bp 
R2fw GTCTAGAGCAGGAGAAAGTA R2 
R2rev TTTACCACATGCACCATCTC 
90 bp 
R3-2 fw TGGGCCTGTTTTAAATTGGC R3 
R3-2 rev CTTGAGGCAATGAACATGCT 
92 bp 
R4fw CACGAGTCTGTGTCATTGTT R4 
R4rev AAACAGTGGGAACATAGACC 
95 bp 
R5fw AAGATTACGACCGTCTACGT R5 
R5rev CATTGTCAAGAGAATCGGGA 
93 bp 
R6fw CAGTCGAAGCACATTCAACA R6 
R6rev ACAATGCAAAACTCCCACCA 
89 bp 
primer probes in the osm1 region 
O1fw AGACAGCATCTAACCACGAA O1 
O1rev AGGCATCGAAGAGAAAAGCA 
90 bp 
O2fw TACATGGACTTTTAGGCGTC O2 
O2rev AGCAGTGGACATGTTGAATC 
89 bp 
O3fw CGACACGTATGGATCTTGTT O3 
O3rev ACCACAATATGCCAGACGTA 
98 bp 
O4fw TGGAGGAAATAGCGTCAAAG O4 
O4rev TACACTGTCGGAAACATGCT 
85 bp 
O5-2fw TGGAATACATGGACTTGAGC O5 
O5-2rev TCACTGTAATCGGCAGCATA 
91 bp 
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O6fw ACACCGAAGGAATCCTCTTT O6 
O6rev TGCTCTATCGAACAAGAAGC 
89 bp 
2.7. RNA ASSAYS 
2.7.1. RNA isolation with hot phenol  
For RNA sample preparation the cells equivalent to 1 ml of culture with OD600 3 (~ 3×10
7 
cells) were collected at 3 000 rpm for 2 minutes at 4°C, washed with ice cold water and 
frozen at -80°C. For the RNA extraction the pellets were defrosted on ice, mixed with 400 
μ1 of AE buffer (50 mM NaOAc, 10 mM EDTA, pH 5.0), 40 μl of 10% SDS and 440 μl of AE 
buffered phenol, vortexed briefly, heated for 5 min at 65°C, incubated on dry ice until 
phenol crystallized (half of the volume should be crystals) and then the phases were 
separated at 13 000 rpm for 2 min at room temperature. To remove any residual traces 
of DNA the upper aqueous phase was treated with 5 U of RQ1 DNase (Promega) for 30 
minutes at 37 °C, then mixed with 1 volume of phenol : chlorophorm (1:1), vortexed  
briefly and the phases were separated at 12 000 rpm for 5 min at room temperature. To 
precipitate the RNA the upper aqueous phase was mixed with 1/10th  of volume of 3 M 
NaOAc (pH 5,3) and 1 volume of isopropanol, incubated at -20 °C for 10 min and 
centrifuged at 14 000 rpm for 10 min at 4°C. The RNA pellet was washed with 500 μl of 
ice cold 70% ethanol, air-dried for 10 min and dissolved in 20 μl of RNase-free water. 
2.7.2. Quantitative and semiquantitative RT-PCRs  
For the reverse transcription 1 μg of RNA was diluted in 5 μl of RNAse-free water, the 
sample was denatured at 70 °C for 5 minutes, centrifuged briefly and placed on ice. The 
2. Materials and methods
 
84 
reaction components (reverse transcription system, Promega) were added to RNA while 
on ice as follows: 4 μl of MgCl2 (25 mM), 2 μl of reverse transcription buffer (10×), 2 μl of 
dNTPs mixture (10 mM), 0,5 μl of recombinant RNasin ribonuclese inhibitor (40U/μl), 0,5 
μl of AMV Reverse Transcriptase (20U/μl), 1 μl of Oligo(dT)15 primer (0,5 μg/μl) and 5 μl 
of RNAse-free water. The reverse transcription was carried out at 42°C for 15 min, 
stopped at 95°C for 5 min and finally the cDNA was incubated on ice for at least 5 min. 
For the quantitative amplification of RT-PCR product 1/100th volume of reaction was 
used for the real-time PCR amplification of the desired targets with LightCycler 480 SYBR 
Green I master kit under the same condition as designed for the quantification of ChIP 
DNA (3.7.4.). For the semiquantitative amplification of the RT-PCR product 1/10th volume 
of the reaction was used as template in PCR with Dream Taq DNA polymerase 
(Fermentas) and the PCR products were analysed on ethidium bromide stained 2% 
agarose gel. The PCR conditions were as follows: 1. 95°C/5 minutes, 2. 92°C/ 30s, 3. 
45°C/30s, 4. 72°C/60s, 5. 95°C/10 minutes, repeating steps 2 to 4 26 times with oligos 
priming at dis2+ and osm1+ gene and 25 times with the oligos priming at rho1+gene. The 
primer combinations used are listed in the Tab. 2.12.. 
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Table. 2.12. Primer used for semiquantitative amplification of RT-PCR products. The primers 
were the same as primers used for the quantification of ChIP DNA (Tab. 2.11.), except of act1 
primers, but used in different combinations. 
mark forward primer reverse primer 
dis2   
1. D4 fw D5/6-3 rev 
2. D3 fw D45 rev 
3. D4/5 fw D5/6-3 rev 
osm1   
1. O3 fw O4 rev 
2. O2 fw O4 rev 
3. O4 fw O5 rev 
rho1   
1. R3-2 fw R4 rev 
2. R5 fw R5 rev 
3. R2 fw R4 rev 
act1   
4. Act1 ORF fw Act1 ORF rev 
primer name sequence 
Act1 ORF fw AGCACCCTTGCTTGTTGA 
Act1 ORF rev TGGGAACAGTGTGGGTAACA 
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2.8. IMMUNOSTAINING OF FORMALDEHYDE FIXED CELLS 
For the immunostaining the exponentially growing cells were fixed with freshly prepared 
38% formaldehyde solution. To prepare the formaldehyde solution 380 mg of 
paraformaldehyde were dissolved in 700 μl of PEM buffer (100 mM Pipes, 1mM EGTA, 1 
mM MgSO4, pH 6.9 with NaOH) mixed with 48 μl of 5M NaOH, incubated at 65°C for 30 
minutes, centrifuged at 5 000 rpm for 3 minutes and the supernatant was used further. 
To fix the cells 1/10th of volume to be fixed of formaldehyde was added to the cell 
culture and then the mixture was incubated at 32°C for 70 minutes. After the fixation the 
cells were collected at 13 000 rpm for 5 minutes (the same setting were used in the next 
steps), washed three times with PEM buffer, then resuspended in 1 ml of PEMS buffer 
(PEM buffer with 1,2 M sorbitol) containing 0,5 mg of zymolyase (Seikagaku corporation) 
and incubated at 37°C for 1 hour. After the cell wall digestion the cells were washed 
three times with 1 ml of PEMS buffer, resuspended in 1 ml of PEMT buffer (PEM with 1% 
Triton), incubated for 2 minutes at room temperature and finally washed three times 
with PEM buffer and kept in 100 μl of PEM buffer containing 0,1% NaN3  at 4°C overnight. 
Before a primary antibody was added the cells were collected and resuspended in 100 μl 
of PEMBAL buffer (PEM with 1% BSA, 100 mM lysine and 0,1% NaN3), incubated for 1 
hour at room temperature on a rotating wheel, then collected and resuspended in 100 μl 
of PEMBAL buffer. Finally, either 1 μl of monoclonal rat anti-HA antibodies (Roche), or 1 
μl of monoclonal mouse anti-FLAG antibodies (Sigma) was added and the samples were 
incubated overnight on the rotating wheel wrapped in aluminum foil.Before the addition 
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of a secondary antibody, the cells were washed three times with 100 μl of PEMBAL, then 
collected and resuspended in 100 μl of PEMBAL buffer containing either 1 μl of anti-rat 
Alexa 568 antibodies or 1 μl of anti-mouse Alexa 568 antibodies and incubated overnight 
on the rotating wheel wrapped in aluminum foil. At the end the cells were washed four 
times with PEM buffer, resuspended in 100 μl of  PEM buffer containing 0,1% NaN3 and 
kept at 4°C. The immunostained cells were then examined with the Zeiss Axioscope 
fluorescent microscope. 
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2.9. MEASURING DNA CONTENT BY FLOW CYTOMETRY 
Cells of interest were fixed with ice-cold 70% ethanol (final concentration of ~ 107 cells/ 
ml) and stored at 4 °C. Before staining 100 μl of fixed cells were washed with 3 ml of 50 
mM Na citrate buffer, harvested at 2500 rpm for 3 minutes, mixed with 0,5 ml of 50 mM 
Na citrate buffer supplemented with 0,1 mg/ml of RNase A and incubated at 37°C for 2 
hours. To stain the cells with Sytox Green, 0,5 ml of 50 mM Na citrate buffer containing 2 
μM Sytox Green was added at least 30 minutes before measurement. The measurement 
was performed with FACS Calibur flow cytometer. 
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3. RESULTS 
3.1. IDENTIFICATION OF NEW PROTEINS INTERACTING WITH Rct1 
3.1.1. Fission yeast protein Rct1 interacts with Tsn1 protein in yeast two hybrid 
assay 
Fission yeast protein Rct1 is a multidomain cyclophilin with many putative protein 
targets in cell. Only few proteins involved in the regulation of transcription are known to 
interact with Rct1 and these interactions are mediated solely by PPIase domain of Rct1 
(Gullerova et al., 2007; Skrahina T, 2009). To extend the palette of known proteins 
interacting with Rct1 I performed yeast two hybrid screen with Rct1 protein as bait. For 
this purpose I cloned Rct1 coding region into pGBT9 vector and created pGBT9-Rct1 
plasmid expressing GAL4-BD-Rct1 fusion protein. I used this plasmid to screen S. pombe 
pTN-TH7 library of mitotic and meiotic cDNAs in pGAD424 vector expressing proteins 
fused with GAL4-AD (kindly provided by Taro Nakamura). The screen itself was 
performed in S. cerevisiae strain AH-109 that allows selection of positive clones by use of 
three independent reporter genes: ADE2, HIS3 and lacZ. The cells transformed with both 
plasmids were first screened for positive interactions under low selective conditions (SD-
HLT), and later under mild (SD-HLTA) and high (SD-HLTA + 5 mM 3-AT) selective 
conditions. Employing this approach I was able to select 18 clones from total number of 
1,834 x 106 transformants that grew well under mild selective conditions (1-18 in Fig. 
3.1.A., Tab. 3.1.) and they were further characterized. Only five of them turned blue in X-
Gal assay (marked in bold in Tab. 3.1.) and the same five also grew best in the presence 
of 5 mM 3-AT, a competitive inhibitor of His3 protein (Fig.3.1.A.). To indentify GAL4-AD 
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fusion proteins in selected clones, the inserts in pGAD424 vector were amplified by PCR 
with pGAD424 specific primers and sequenced. The obtained sequences were blasted 
against S. pombe genome to identify the expressed genes. The clones expressing proteins 
with shifted ORF or those with early stop codon were excluded from the analysis 
Table 3.1. List of proteins identified in yeast two hybrid screen with full length Rct1 protein. 
Table of genes encoded by sequences in pGAD424 vector in the clones selected in the yeast two 
hybrid screen. The numbers 1-18 correspond to the clones shown in Fig. 3.1.A.  Gene names and 
the assigned protein products are according to Schizosaccharomyces pombe GeneDB database 
(http://old.genedb.org/genedb/pombe/).  In bold are the clones that turned blue in X-Gal assay 
and grew best in the presence of 5 mM 3-AT. In italics are the clones that were excluded from 
the analysis due to an early stop codon or a frame shift. 
clone gene name product coding sequence 
1 SPBC31F10.12 predicted RNA-binding protein Tma20 early stop codon 
2 - non coding sequence early stop codon 
3 ef1a-c 
translation elongation factor EF-1 alpha Ef1a-
c 
partial coding sequence 
4 - non coding sequence early stop codon 
5 bms1 GTP-binding protein Bms1 partial coding sequence  
6 get1 predicted GET complex subunit Get1 not in the correct frame 
7 - SQV orphan early stop codon 
8 SPBP35G2.11c 
transcription related zf-ZZ type zinc finger 
protein     
partial coding sequence  
9 - non coding sequence early stop codon 
10 SPBC1347.05c DNAJ domain protein Scj1 partial coding sequence  
11 tsn1 translin 
full length coding 
sequence 
12 SPBC1347.05c DNAJ domain protein Scj1 partial coding sequence  
13 rpl13 60S ribosomal protein L13     not in the correct frame 
14 idh2 isocitrate dehydrogenase (NAD+) subunit 2 partial coding sequence  
15 SPBC1718.04 
predicted glycerol-3-phosphate O-
acyltransferase 
partial coding sequence  
16 tsn1 translin 
full length coding 
sequence 
17 tsn1 translin partial coding sequence  
18 SPBP35G2.11c 
transcription related zf-ZZ type zinc finger 
protein 
partial coding sequence  
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 (marked in italic in Tab. 3.1.). The remaining sequences encoded even different proteins 
expressed either as the full length proteins or their truncated versions. Among the 
selected clones I found three times sequence encoding translin (Tsn1), twice in full length 
(#11 and #16) and once in its truncated version (#17), two times partial sequence 
encoding part of an uncharacterized transcription related protein SPBP35G2.11c (#8 and 
#18), two times sequence corresponding to DNAJ domain protein Scj1 (#10 and #12) and 
sequences encoding parts of translation elongation factor EF-1 alpha (#3), GTP-binding 
protein Bms1 (#5), isocitrate dehydrogenase Idh2 (#14) and a predicted glycerol-3-
phosphate O-acyltransferase SPBC1718.04 (#15). For further characterization I selected 
translin as the most likely protein interacting with Rct1. 
Next, I repeated the yeast two hybrid assay with de novo prepared plasmids expressing 
Tsn1 fusion proteins. For this purpose I cloned the cDNA corresponding to tsn1+ coding 
region into pGAD424 and pGBT9 vectors to generate pGAD424-Tsn1 and pGBT9-Tsn1 
plasmids. These were used in the combination with pGAD424-Rct1 and pGBT9-Rct1 
plasmids in the yeast two hybrid assay under the same conditions as described above. In 
this reconstituted system GAL4-AD-Tsn1 fusion protein was able to interact with GAL4-
DB-Tsn1 protein. This is well consistent with the previous reports showing that translin 
oligomerises in vivo and in vitro (VanLoock et al., 2001; Sugiura et al., 2004; Gupta et al., 
2008). Surprisingly, no positive interaction between Rct1 and Tsn1 was detected in this 
assay (Fig.3.1.B.). Interestingly, all translin sequences obtained in the yeast two hybrid 
screen included the following sequence: CGAATATCAACACTACTCAACAGCATACATTA- 
CAGATTAAGTCGAATG, a part of the 5’ UTR of tsn1 gene inserted between GAL4-AD 
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domain and translin coding sequence. This 5’ UTR sequence, when translated into the 
peptide (Arg-Ile-Ser-Thr-Leu-Leu-Asn-Ser-Ile-His-Tyr-Arg-Leu-Ser-Arg-Met), could possibly 
serve as a hinge between the GAL4-AD domain and translin peptide, spacing the translin 
into a position more suitable for the interaction with Rct1. Therefore, I decided to clone 
a random sequence (GTGCATGCTAATGGTTCAGCATTCCTGACTGTGATCAGTAACCTG 
translated as Val-His-Ala-Asn-Gly-Ser-Ala-Phe-Leu-Thr-Val-Ile-Ser-Asn-Leu) between the 
GAL4-AD and Tsn1 coding domains in pGAD424-Tsn1 and pGBT9-Tsn1 vectors and repeat 
the yeast two hybrid assay with the new plasmids. However, the insertion of the random 
sequence upstream of the tsn1+ coding region did not recover the interaction between 
Rct1 and Tsn1 in the yeast two hybrid assay (data not shown). This experiment points to 
the possibility that the insert sequence identified in the yeast two hybrid screen is 
essential for the yeast two hybrid interaction and cannot be simply replaced by a random 
sequence.  
The N-terminal PPIase domain of Rct1 has a putative enzymatic activity and likely targets 
different proteins. To obtain more detailed information on protein targets bound by 
PPIase domain of Rct1 I deleted the sequence encoding the C-terminal RS domain and 
cloned the truncated Rct1 coding region into pGBT9 vector generating pGBT9-Rct1 ΔRS 
plasmid for yeast two hybrid assay. By this approach I aimed to eliminate RS domain-
dependent interactions and enrich those mediated by PPIase domain. Surprisingly, when 
I tested the cells transformed with pGBT9-Rct1 ΔRS plasmid in the combination with 
empty pGAD424 vector for growth under the selective conditions I observed a robust cell 
growth on the selective media (Fig. 3.1.C.). Based on this experiment I concluded that the 
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truncated GAL4-BD-Rct1 ΔRS protein is able to induce transcription of reporter genes by 
its own in the presence of GAL4-AD protein, although no protein is fused to GAL4-AD 
domain.
 
Figure 3.1. Proteins interacting with Rct1 identified in the yeast two hybrid screen.  
A. Yeast two hybrid assays with S. cerevisiae strain AH109 transformed with different pGBT9- and 
pGAD424-based plasmids in combinations indicated on the left side of the picture (lanes 1-5) and 
with clones 1-18 selected in the yeast two hybrid screen (lanes 6-23) grown under the low 
selective conditions (SD-HLT), mild selective conditions (SD-HLTA) and high selective conditions 
(SD-HLTA supplemented with 5 mM 3-AT). B. Verification of the yeast two hybrid interactions 
between Rct1 and Tsn1 using the newly created pGAD424-Tsn1 and pGBT9-Tsn1 vectors. The 
AH109 strain (lane 1) was transformed with different pGBT9 and pGAD424 derivatives in 
combinations indicated on the left side. C. Yeast two hybrid assay pictures showing that pGBT9-
Rct1 ΔRS in combination with empty pGAD424 or pGAD424-Rct1 ΔRS plasmid can activate 
transcription of reporter genes without the partner protein. Again the assays were performed in 
AH109 strain using the indicated combinations of plasmids. 
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I also cloned Rct1 ΔRS protein into pGAD424 vector generating pGAD424 Rct1 ΔRS 
plasmid and used it in the combination with empty pGBT9 vector in the same yeast two 
hybrid assay. However, the cells expressing GAL4-AD-Rct1 ΔRS and the untagged GAL4-
DB protein were not able to grow under the selective conditions (Fig. 3.1.C.). Therefore, I 
concluded that GAL4-DB domain of GAL4-BD-Rct1 ΔRS protein is essential to target Rct1 
ΔRS to the proximity of reporter genes and once nearby the Rct1 ΔRS peptide can 
activate their transcription as an activator. Importantly, when pGBT9-Rct1 plasmid is 
used, and full length Rct1 is targeted to chromatin by GAL4-DB domain, the reporter 
genes are not activated. It is therefore the deletion of RS domain that changes activity of 
Rct1 protein in S. cerevisiae cells and it is possible that the proteins binding or modifying 
RS domain of Rct1 in vivo might also modulate activity of the whole Rct1 protein. 
3.1.2. Tsn1 is fission yeast homologue of translin, a highly conserved protein in 
higher eukaryotes 
Translin is referred as a highly conserved protein in higher eukaryotes (Li et al., 2008; 
Jaendling and McFarlane, 2010) with homologues in plants and animals, but like in case of 
Rct1 (Gullerova et al., 2007), there is no recognized homologue protein in budding 
yeasts. To verify this information I compared fission yeast translin protein sequence with 
sequences of Homo sapiens, Mus musculus, Galus galus, Drosophila melanogaster, 
Xhenophus laevis and Arabidopsis thaliana (Fig. 3.2.A.).  Although there is high similarity 
between mammalian translins, as shown by 98% similarity between mouse and human 
translin, the fission yeast translin is not similar to any of the analyzed translins by more 
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Figure 3.2. Tsn1 is evolutionary conserved in higher eukaryotes. 
A. Protein sequence alignment of S. pombe translin with the translin sequences from higher 
eukaryotes generated by ClustalW2 software (www.ebi.ac.uk/ Tools/ clustalw2/).  Arrows mark 
the recognized protein domains: red – RNA binding domain 1 (RBD1), green – RNA binding 
domain 2 (RBD2), blue – putative nuclear localization signal, yellow – putative GTP binding site, 
violet – leucin zipper domain. Blue bars mark the conserved thyrosine/proline sites. B. Phylogram 
of the translin protein sequences generated by the neighbor joining method. C. Table showing 
the pairwise alignment scores calculated between the individual translin protein sequences in A. 
D. Predicted structure of the fission yeast translin (right) modeled with SWISS-MODEL software 
(http://swissmodel.expasy.org/) based on the homology with mouse translin (left). S. p. – 
Schizosaccharomyces pombe (NP_594557), A. t. – Arabidopsis thaliana (NP_565857, the first 76 
amino acids of the protein sequence are not shown in the alignment), D. m. – Drosophila 
melanogaster (NP_610591), G. g. – Galus galus (NP_990404), H. s. – Homo sapiens (NP_004613), 
M. m. – Mus musculus (NP_035780), X. l. – Xhenophus laevis (AAF65620). 
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than 34% (Fig. 3.2.C.). Furthermore, in the phylogram generated by the neighbor joining 
method the S. pombe translin is clustered together with the most divergent sequences 
from Drosophila and Arabidopsis (Fig. 3.2.B.).  
Five distinct domains of Tsn1 were predicted based on the translin amino acid sequence 
(Laufman et al., 2005; Fig. 3.2.A.): the C-terminal terminal leucin-zipper domain (violet), 
the putative nuclear localization signal (dark blue), two putative RNA binding domains 
RBD1 (red) and RBD2 (green) and the putative GTP binding site (yellow). In general, the 
C-terminal part of translin is more conserved among different organisms than the N-
terminal part of protein. This is in a good correlation with the evolutionarily preserved 
function of the C-terminal part of protein in translin oligomerization (Aoki et al., 1999; 
Pascal et al., 2001; Sugiura et al., 2004; Gupta et al., 2008). The more divergent N-
terminal part is due to the presence of RBD domains likely involved in binding of nucleic 
acids (Chennathukuzhi et al.,  2001; Sengupta and Rao, 2002; Jacob et al., 2004, Laufman 
et al., 2005). However, RBD1 and RBD2 are not well conserved between S. pombe and 
higher eukaryots (Fig. 3.2.A.), possibly due to different functional adaptation. Currently, 
the crystal structures of translin from Drosophila, mouse and humans are available 
(Pascal et al., 2001; Sugiura et al., 2004; Gupta et al., 2008) and can be used to predict 
the structure of translin homologues. Therefore, I decided to model the structure of 
fission yeast translin based on the homology with mouse translin (Fig. 3.2.D.) using Swiss-
MODEL software (Schwede et al., 2003; Kiefer et al., 2009, Arnold et al., 2006; Kopp et 
al., 2004), as was already done before (Laufman et al., 2005). It is interesting to notice 
that the evolutionary conserved putative GTP-binding site of modeled translin is located 
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in the protein loop between helices 5 and 6 (Fig. 3.2.A., yellow) and that one amino acid 
at this site is highly conserved tyrosine (S.p. Y183) closely followed by a highly conserved 
proline (S.p. P186). In theory the petidyl bond proceeding the highly conserved proline 
S.p. P186 might be a putative target of Rct1 PPIase domain. The isomerisation of this 
particular peptidyl-prolyl bond might have a significant effect on the structure of the 
whole translin monomer. Importantly, at least in Drosophila translin mutation of this 
proline is detrimental for protein structure and translin oligomerization (Gupta et al., 
2008). The other potential target site of Rct1 on Tsn1 is the conserved proline (S.p. P93) 
found in loop between RBD1 and RBD2, also closely followed by a highly conserved 
tyrosine (S.p. Y94). Again, the isomerization of peptidyl-prolyl bond by Rct1 at this site 
might have a significant impact on the protein structure and function. 
3.1.3. Interaction between Rct1 and Tsn1 can be reconstituted in vitro 
To verify interaction between Rct1 and Tsn1 observed in the yeast two hybrid assay I 
decided to perform in vitro pull down experiment with purified GST-Tsn1 protein. For 
this purpose I cloned tsn1+ coding region into pGEX-4T-1 plasmid, expressed GST-Tsn1 
fusion protein in E. coli, and bound the protein to glutathione sepharose beads. The 
protein bound to beads (Fig. 3.3.A.) was then used to pull down Rct1-HA protein from 
the total protein extracts of Δrct1 + pMG1 cells overexpressing Rct1-HA protein. As 
shown on the Western blot with anti-HA antibodies (Fig. 3.3.B.) the purified GST-Tsn1 
protein was able to pull down a small amount of Rct1-HA protein from the protein 
extracts, whereas the beads bound by GST only were not. This experiment clearly shows 
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that, at least under the experimental conditions used, the Tsn1 is able to interact with 
Rct1 in vitro.  
 
Figure 3.3. Rct1 interacts with Tsn1 in vitro. 
A. Commasie blue stained SDS-PAGE gel of the purified GST-Tsn1 protein used in the pull down 
assays. B. Western blots with anti-HA antibodies of the pull down assay with the purified GST-
Tsn1 protein and the total protein extracts from Δrct1 + pMG1 (Rct1-HA) strain; input –  total 
protein extract sample, GST-Tsn1 –  pull down sample with the GST-Tsn1 bound to beads, GST –  
pull down sample with GST only bound to beads. C. Western blots of the co-immunoprecipitation 
experiment performed with the total protein extracts from rct1-FLAG + pMGT strain and anti-HA 
antibodies (HA) to immunoprecipitate Tsn1-HA. The presence of Rct1-FLAG and RNAPII in the 
immunoprecipitates was checked with anti-FLAG antibodies (FLAG) and anti-RNAPII CTD (4H8) 
antibodies (4H8): input – total protein extracts sample, pA – protein A sepharose beads only 
sample, IP –  immunoprecipitation sample.   
 
In the in vitro pull down assay described above I used recombinant GST-Tsn1 protein 
produced in a heterologous organism and Rct1-HA protein overexpressed in yeasts. To 
verify the interaction of Rct1 with Tsn1 in under the more native conditions, I decided to 
perform the protein co-immunoprecipitation experiment with both proteins expressed in 
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yeasts. For this purpose I generated rct1-FLAG strain and transformed it with pMGT 
plasmid. This strain expressed Rct1-FLAG protein from its native promoter on 
chromosome and overexpressed Tsn1-HA protein form nmt1+ promoter on pMGT 
plasmid. To assay for co-immunoprecipitation of the Tsn1 and Rct1 proteins from total 
protein extracts I immunoprecipitated Tsn1-HA with anti-HA antibodies and detected the 
presence of Rct1-FLAG on Western blots with anti-FLAG antibodies. Although I used the 
same buffer condition as in the pull down assay, I was not able to detect Rct1-FLAG 
protein in the complex with immunoprecipitated Tsn1-HA protein (Fig. 3.3.C.). 
3.1.4. Interaction between Rct1 and Tsn1 requires all three domains of Rct1 
The Rct1 is a protein with three functional domains: the N-terminal PPIase domain, the 
middle RRM domain and the C-terminal RS domain. To identify the parts of Rct1 protein 
important for the interaction with Tsn1 the individual domains of Rct1 in pMG plasmid 
were systematically deleted, either alone or in combinations with the other domains 
(Skrahina T., 2009). The resulting Rct1 PPIase only-HA, the Rct1 RRM only-HA, the Rct1 
ΔRS-HA, the Rct1 ΔPPIase-HA, the Rct1 ΔRRM-HA and the Rct1 ΔPPIaseR3-HA proteins 
tagged with HA epitope (see Fig. 3.4. for schematic representations) were expressed in 
rct1/Δrct1 genetic background and the protein extracts from these strains were used in 
the in vitro pull down assay with purified GST-Tsn1 protein (Fig. 3.5.), as already 
described for the full length Rct1-HA protein (Fig. 3.3.). 
In these assays (Fig. 3.5.) the GST-Tsn1 protein interacted with the PPIase only-HA and 
the Rct1 RRM only-HA proteins, clearly showing that both the PPIase and the RRM 
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domain of Rct1 are able to interact with Tsn1 protein independently of each other. In 
accordance, the deletion of PPIase domain only (Rct1 ΔPPIase-HA) or RRM domain only 
(Rct1 ΔRRM-HA) did not abolish the interaction, but the deletion of PPIase domain in the 
combination with three point mutations in RRM domain (Rct1 ΔPPIaseR3-HA) almost 
diminished the interaction. 
 
Figure 3.4. Schematic representation of Rct1 deletion mutatns (according to Skrahina T, 2009). 
Surprisingly, if the RS domain of Rct1 was removed, the interaction was not detected at 
all, although both PPIase and RRM domains were intact, pointing at the crucial role of 
the RS domain in the interaction with Tsn1. Nevertheless, it is plausible that the 
interaction between Rct1 and Tsn1 is not mediated by the Rct1 RS domain, as there was 
almost no signal detected in the pull down experiment with the Rct1 ΔPPIaseR3-HA 
mutant protein, a protein consisting only of the RS domain and the mutated RRM 
domain. Therefore I concluded that the Rct1 RS domain might be important for proper 
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folding of Rct1 protein, and if missing, the PPIase and RRM domains are folded in a way 
that does not favor the interaction with Tsn1. This assumption is further supported by an 
observation that the interaction of Tsn1 with either PPIase or RRM domain was 
enhanced when they were expressed together with the RS domain. This becomes 
obvious if the input to pull down ratio of the individual pull down experiments is 
compared (see Fig. 3.5., compare input lane with GST-Tsn1 lane). 
 
 
Figure 3.5. Rct1 requires all three domains for the interaction with Tsn1 in vitro. 
Western blots with anti-HA antibodies of the pull down assays with the purified GST-Tsn1 protein 
and the total protein extracts from rct1/Δrct1 + pMG1 (Rct1-HA), rct1/Δrct1 + pMG2 (Rct1 ΔRS-
HA), rct1/Δrct1 + pMG3 (Rct1 PPIase only-HA), rct1/Δrct1 + pMG4 (Rct1 ΔPPIase-HA), rct1/Δrct1 
+ pMG4R3 (Rct1 ΔPPIaseR3 –HA), rct1/Δrct1 + pMG5 (Rct1 ΔRRM-HA), rct1/Δrct1 + pMG6 (Rct1 
RRM only-HA) strains: input –  total protein extract sample, GST-Tsn1 –  pull down sample with 
the GST-Tsn1 bound to beads, GST –  pull down sample with GST only bound to beads. 
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The RRM domain of a protein is usually involved in an interaction with a specific RNA 
target; however, in many cases it has been adapted to recognize and bind a specific 
protein target (Maris et al., 2005). Because both, Rct1 and Tsn1, proteins are able to bind 
RNA, I decided to test if the Rct1 interaction with Tsn1 detected in the pull down assay is 
a protein-protein interaction or an RNA mediated interaction. For this purpose I repeated 
the in vitro pull down assays as described above, but this time with the total protein 
extracts pre-treated with RNase A. In the experiments with the RNA free protein extracts 
the efficiency of GST-Tsn1 protein to pull down the Rct1 mutant proteins was exactly the 
same, as in the experiments with the protein extracts not pretreated with RNase A (data 
not shown). Therefore, I concluded that the interaction of Rct1 with Tsn1 is not mediated 
by RNA. 
3.1.5. Rct1 and Tsn1 interact with splicing related proteins in vitro  
Gullerova et al. (2007) showed that the deletion of rct1+ gene in diploid rct1/Δrct1 cells 
enhances transcription and meiosis-specific splicing of certain genes, whereas the 
overexpression of Rct1 from pMG1 plasmid reduces this phenotype. In addition, 
AtCyp59, an Arabidopsis homologue of Rct1, was initially identified as an interacting 
partner of plant SR proteins (Gullerova et al., 2006). I therefore assumed that Tsn1 could 
acts together with Rct1 in the regulation of splicing process. To investigate this possibility 
I first assayed for the interactions of Rct1 and Tsn1 with the splicing related SR proteins 
Srp1 and Srp2, with the core splicing factor Prp2 (an homologue of U2AF65), with the 
main kinase of splicing factors Prp4, with the SR protein-specific kinase Dsk1 and with 
two evolutionary related and uncharacterized kinases Ppk5 and Ppk15. 
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Figure 3.6. Purified GST-fusion proteins used in the pull down assays. 
A. The GST-Srp1, GST-Srp2, GST-Prp2, GST-Dsk1, GST-Prp4, GST-Ppk5, GST-Ppk15 and GST 
proteins purified from E. coli BL21 strain. All of them, except of GST-Srp2 and GST-Prp2 were 
used for the pull down assays. B. The GST-Srp2 and GST-Prp2 proteins purified from E. coli 
Rosetta (DE3)pLysS strain were used in the pull down assays. C. The GST-Srp1 ΔRS, GST-Srp2 ΔRS 
and GST-Prp2 ΔRS proteins purified from E. coli Rosetta (DE3)pLysS strain were used in the pull 
down assays. See Fig. 3.7. for Western blotts of the pull down assays. 
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 For this purpose I cloned the corresponding genes into pGEX-4T-1 plasmid, 
overexpressed them in E. coli and performed in vitro pull down experiments with the 
purified GST-tagged proteins (Fig. 3.6.) and protein extracts from wild type cells 
overexpressing Tsn1-HA (wt + pMGT) to assay for Tsn1-HA interactions or from Δrct1 + 
pMG1 cells to assay for Rct1-HA interactions. Western blots with anti-HA antibodies 
revealed that the Rct1-HA protein interacts only with GST-Srp1, GST-Srp2, GST-Dsk1 and 
GST-Prp2 proteins, whereas the Tsn1-HA interacts only with GST-Prp2 and GST-Prp4 
proteins (Fig. 3.7.A.). The only protein interacting with both, Rct1 and Tsn1, proteins in 
this assay was Prp2, an homologue of human U2AF65 factor. Prp2 is the large subunit of 
U2AF factor that is known to recognize and bind the polypyrimidine tract and 3’ splice 
site in introns and mediate the communication of Srp2 with the spliceosome (Potashkin et 
al., 1993; Webb et al., 2005a). Therefore, it might be considered an excellent mediator 
linking Rct1 and Tsn1 with the splicing machinery. Furthermore, the interactions of Rct1 
with two SR proteins, Srp1 and Srp2, support the assumption that Rct1 might be an 
important factor in splice site selection of certain genes. Importantly, the GST-Srp2 and 
GST-Prp2 were able to pull down the RNAPII from the extracts as well (Fig. 3.7.A.), 
suggesting that Srp2 and Prp2, as well as Rct1 (Gullerova et al., 2007) might be co-
transcriptionally recruited to nascent transcript via interactions with RNAPII. 
To determine the parts of Rct1 protein required for the interactions with GST-Srp1, GST-
Srp2, GST-Prp2 and GST-Dsk1 proteins I performed the pull down experiments with 
protein extracts from rct1/Δrct1 + pMG2, rct1/Δrct1 + pMG3, rct1/Δrct1 + pMG4, 
rct1/Δrct1 + pMG5, rct1/Δrct1 + pMG6 and rct1/Δrct1 + pMG4R3 strains overexpressing 
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Figure 3.7. Tsn1 and Rct1 interact with splicing associated proteins. 
A. Western blots with anti-HA  (Rct1-HA and Tsn1-HA) and anti-RNAPII CTD (4H8) antibodies 
(RNAPII) of the pull down assays with the GST-Srp1, GST-Srp2, GST-Prp2, GST-Prp4, GST-Dsk1, 
GST-Ppk15, GST-Ppk5 proteins and the total protein extracts of rct1/Δrct1+ pMG1 (Rct1-HA and 
RNAPII) and wt + pMGT (Tsn1-HA) strains. B. Western blots of the pull down assays with the GST-
Srp1, GST-Srp2, GST-Prp2 and GST-Dsk1 proteins  and the total protein extracts of rct1/Δrct1+ 
pMG1 (Rct1-HA), rct1/Δrct1 + pMG2 (Rct1 ΔRS-HA), rct1/Δrct1 + pMG3 (Rct1 PPIase only-HA), 
rct1/Δrct1 + pMG4 (Rct1 ΔPPIase-HA), rct1/Δrct1 + pMG4R3 (Rct1 ΔPPIaseR3 –HA), rct1/Δrct1 + 
pMG5 (Rct1 ΔRRM-HA), rct1/Δrct1 + pMG6 (Rct1 RRM only-HA) strains to identify the Rct1 
domains required for the interactions in A. C. Western blots with anti-HA antibodies of the pull 
downs with GST-Srp1, GST-Srp2, GST-Prp2, GST-Srp1 ΔRS, GST-Srp2 ΔRS, GST-Prp2 ΔRS proteins 
and the total protein extracts of rct1/Δrct1+ pMG1 treated with RNase A. Input – total protein 
extract sample, GST-X – pull down sample with GST-X protein bound to beads, GST – pull down 
sample with GST only bound to beads. 
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different Rct1 deletion mutant proteins (see Fig. 3.4. for schemes) from nmt1+ promoter. 
Western blots with anti-HA antibodies (Fig. 3.7.B.) show that the GST-Srp1 and the GST-
Dsk1 proteins were able to pull down only those Rct1 deletion mutant proteins harboring 
functional RS domain, but not those lacking the RS domain (Rct1 ΔRS-HA, the Rct1 PPIase 
only-HA and the Rct1 RRM only-HA). Therefore, I concluded that Rct1 employs solely the 
RS domain for the interaction with either Srp1 or Dsk1. The interactions of GST-Srp2 and 
GST-Prp2 with Rct1 were more complex and required more than one domain of Rct1 (Fig. 
3.7.B.). In the experiments performed, the GST-Srp2 protein interacted only with the full 
length Rct1-HA protein and the Rct1 ΔRRM-HA protein. It did not interact with any of the 
deletion mutants without the RS domain (Rct1 ΔRS-HA, Rct1 PPIase only-HA) or without 
the PPIase domain (Rct1 ΔPPIase-HA and Rct1 ΔPPIaseR3-HA), but also did not interact 
with the PPIase domain or the RRM domain alone (Rct1 PPIase only-HA, Rct1 PPIase 
only-HA). Based on these experiments I concluded that the PPIase and the RS domain of 
Rct1 must act in synergy during the interaction with Srp2. On the contrary the GST-Prp2 
protein interacted with all mutant proteins tested except of the RRM only-HA protein 
(Fig. 3.7.B.). This means that Rct1 employs both, the PPIase and the RS domain, but not 
the RRM domain, for the interaction with the GST-Prp2. However, the PPIase and the RS 
domain are able to interact independently of each other.  
To determine if the RS domains of Srp1, Srp2 and Prp2 proteins are required for the 
interactions with Rct1 I created new plasmids expressing the truncated GST-tagged 
proteins: GST-Srp1 ΔRS, GST-Srp2 ΔRS and GST-Prp2 ΔRS (see Fig. 3.8. for schemes) and I 
used them in the pull down assays with Δrct1 + pMG1 protein extracts treated with 
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RNase A, as described before. Western blots with anti-HA antibodies revealed that 
whereas GST-Srp1 ΔRS was able to interact with Rct1, the GST-Srp2 ΔRS and GST-Prp2 
ΔRS was not (Fig. 3.7.C.). Therefore, I concluded that the interaction between Srp1 and 
Rct1 is mediated by Srp1 RRM domain and Rct1 RS domain, whereas Rct1 interacts with 
Srp2 RS and Prp2 RS domains employing both PPIase and RS domains. 
 
Figure 3.8. Schemes of Srp1, Srp2 and Prp2 proteins used for the pull down assays. 
Schematic representation of domain organization of full length and ΔRS Srp1, Srp2 and Prp2 
proteins that were used in the pull down assays in Fig. 3.7.C.. GST – position of GST tag, RRM – 
typical RRM motif with two RNP motifs, ψRRM – pseudo RRM of Prp2, SWQDLKD – an atypical 
RRM of Srp2 without the RNPs, but with the SWQDLKD motif, RS – domain rich in arginine-serine 
dipeptides, blue  - a short linker region of Prp2 . 
 
3.1.6. Srp1 and Srp2 are highly phosphorylated nuclear proteins 
The Srp1 and Srp2 are the only characterized SR proteins in the fission yeasts. The larger 
Srp2 has two N-terminal RRM domains and one C-terminal RS domain (Lutzelberger et al., 
1999). The Srp1 is smaller and is composed of one N-terminal RRM domain and one C-
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terminal RS domain (Gross et al., 1998; Tang et al., 1998). Both, Srp1 and Srp2, are 
targets of Dsk1 protein kinase that phosphoryltes their RS domains (Tang et al., 1998, 
2000, 2002, 2007). The phosphorylation of Srp1 RS and Srp2 RS domains by Dsk1 seems to 
regulate the entry of the proteins into nucleus, as well as their interaction with each 
other (Tang et al., 2007). The available information about Srp1 and Srp2 proteins are 
based mainly on in vitro experiments and overexpression studies. To further characterize 
Srp1 and Srp2 proteins in living cells I generated strains with FLAG-tagged srp1+ and srp2+ 
genes on the chromosome expressing srp1-FLAG and srp2-FLAG proteins, respectively 
(see Fig. 3.9.A. for schematic representation of tagged alleles).  The srp2, but not srp1, is 
an essential gene (Lutzelberger et al., 1999). Therefore, I checked whether the addition of 
FLAG tag affects the growth rates of the resulting strains. However, I did not observe any 
difference in growth rates of wild type, srp1-FLAG and srp2-FLAG strains neither in YES 
nor in EMM medium at 32°C (Fig. 3.9.B.), indicating that these strains could be used for 
physiological and biochemical experiments.  
Next, I compared the expression of Srp1-FLAG and Srp2-FLAG proteins. As expected, 
when the total protein extracts of srp1-FLAG and srp2-FLAG strains were probed on 
Western blots with the anti-FLAG antibodies, there was always only one discreet band 
recognized. The molecular mass of Srp1-FLAG specific band was approximately 47 kDa 
and the molecular mass of Srp2-FLAG was approximately 55 kDa. Then I compared the 
expression levels of Srp1-FLAG, Srp2-FLAG and Rct1-FLAG proteins in the exponentially 
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Figure 3.9. Characterization of Srp1-FLAG and Srp2-FLAG proteins.  
A. Schematic representation of srp1 and srp2 genomic loci of the srp1-FLAG and srp2-FLAG 
strains. B. Growth curves comparing the growth rates of srp1-FLAG and srp2-FLAG strains in YES 
medium at 30°C. C. Western blots with anti-FLAG and anti-Cdc2 (loading control) antibodies 
comparing the expression of Srp1-FLAG and Srp2-FLAG proteins in srp1-FLAG and srp2-FLAG 
strains. Loaded are either not diluted (srp1-FLAG, srp2-FLAG), 1:2 diluted (srp2-FLAG 1:2) and 
1:10 diluted (srp2-FLAG 1:10) total protein extracts from strains srp1-FLAG and srp2-FLAG. D. 
Western blots with anti-FLAG, anti-tubulin (loading control) and anti-Cdc2 (loading control) 
antibodies comparing the expression of Srp1-FLAG, Srp2-FLAG and Rct1-FLAG in srp1-FLAG, srp2-
FLAG and rct1-FLAG strains, respectively. Loaded are the total protein extracts of the same 
protein concentration. E. Western blots of the dephosphorylation assay with anti-FLAG (for Srp1-
FLAG and Srp2-FLAG) and anti-HA (for Rct1-HA and Rct1 ΔRS-HA) antibodies. Loaded are the total 
protein extract of srp1-FLAG, srp2-FLAG, rct1-HA and rct1 ΔRS-HA strains (input) incubated either 
with 1U/μl CIP at 30°C and 37°C or without the CIP at 37°C for 1 hour.  
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growing srp1-FLAG, srp2-FLAG and rct1-FLAG strains in the YES medium at 30°C. I 
observed that the expression of Srp2-FLAG is approximately ten times higher than the 
expression of Srp1-FLAG protein as revealed by serial dilutions of Srp2-FLAG extracts (Fig. 
3.9.C.), whereas the expression of Rct1-FLAG is roughly the same as the expression of 
Srp2-FLAG (Fig. 3.9.D.).  
The actual molecular masses of Srp1-FLAG and Srp2-FLAG were slightly higher than 
predicted by SGD (Schizosaccharomyces pombe GeneDB database at 
http://old.genedb.org/genedb/pombe/), possibly due to an extensive phosphorylation of 
their RS domains. However, Srp1-FLAG and Srp2-FLAG proteins appear as discrete bands 
on the Western blots arguing that the whole population of Srp1 or Srp2 in the cell is 
evenly phosphorylated (Fig. 3.9.C., D. and E.; in C. the lover band in Srp1-FLAG sample is 
likely a protein degradation product). To determine whether Srp1-FLAG and Srp2-FLAG 
proteins exist in the cell predominantly in a phosphorylated or a nonphosphorylated 
form I treated the total protein extracts of srp1-FLAG and srp2-FLAG strains with the calf 
intestine phosphatase (CIP, 1 U/ μl) at 30°C or 37°C for 1 hour and compared the protein 
migration of CIP treated, CIP untreated and input samples on 10% SDS-PAGE gel. As 
obvious from the Western blot with anti-FLAG antibodies (Fig. 3.9.E.), the treatment of 
protein extracts with CIP resulted in significant Srp1-FLAG specific band shift, arguing 
that the Srp1 protein is predominantly highly phosphorylated in the cells. On the 
contrary, the Srp2-FLAG specific band was only modestly shifted in the CIP treated 
protein extracts, although the same conditions for separation were used. This 
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experiment shows that although the Srp2 protein is phosphorylated in the cells, it is less 
phosphorylated than the Srp1 protein.  
The RS domain of Rct1 might be, in principle, also phosphorylated by the Dsk1 kinase, or 
by another RS domain targeting kinase. To test the assumption that the RS domain of 
Rct1 is phosphorylated in vivo, I treated the rct1-HA and rct1 ΔRS-HA protein extracts 
with the CIP, as described above, and compared the protein migration of treated and 
untreated samples. However, I could not observe any Rct1-HA specific band shift on 
Western blots with anti-HA antibodies in CIP treated samples, when compared to 
untreated samples (Fig. 3.9.E.). Therefore I concluded that the RS domain of Rct1 is not 
highly phosphorylated in vivo, but rather exists in a nonphosphorylated or a low 
phosphorylated form. 
The actual phosphorylation status of the Srp1 RS and Srp2 RS domains is thought to 
regulate the localization of Srp1 and Srp2 proteins in the cell (Tang et al., 2007). 
According to this study, if Dsk1 kinase is active in the cells the overexpressed Srp2 
protein is found predominantly in the nucleus, whereas the overexpressed Srp1 protein 
is mostly localized in the cytoplasm. This suggests that the Dsk1-dependent 
phosphorylation is crucial for the localization of the Srp1 and Srp2 proteins; however, 
these localization studies were done under overexpression conditions. To reveal the 
localization of Srp1-FLAG and Srp2-FLAG proteins under the endogenous expression 
levels I immunostained the formaldehyde fixed cells with the anti-FLAG antibodies and 
ALEXA 568 coupled secondary antibodies and compared the distribution of ALEXA 568-
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specific signal with the HOECHST-specific DNA signal. In both srp1-FLAG and srp2-FLAG 
strains I observed co-localization of Srp1 or Srp2 proteins with the nuclear DNA (Fig. 
3.10.A.). I did not observe any ALEXA 568-specific signal outside of the nucleus, neither in 
the srp1-FLAG nor in the srp2-FLAG cells. This observations suggest that Srp1 and Srp2 
are nuclear proteins. 
To further investigate the localization of Srp1 and Srp2 in vivo I decided to prepare 
strains expressing fluorescently labeled Srp1 and Srp2 proteins. For this purpose the 
tdTomato::hphMX cassette from pFA6a-hphMX6 plasmid was inserted into the 
chromosome at the same location downstream of srp1+ and srp2+ as the FLAG::hphMX 
cassette before. By this approach I obtained srp1-tdTomato strain, but no srp2-tdTomato 
strain. I also failed to tag the srp2+ with the GFP tag, suggesting that the large protein 
tags, such as tdTomato or GFP, could interfere with the function of otherwise essential 
Srp2 protein. This is well consistent with the data from global ORFeome analysis that also 
failed to obtain strain expressing YFP labeled Srp2 protein (Matsuyama et al., 2006). The 
srp1-tdTomato strain expressed the Srp1-tdTomato protein of expected size of app. 130 
kDa, detected on the Western blot with anti-dsRed antibodies (Fig. 3.10.C.). Importantly, 
the entire fluorescent signal of Srp1-tdTomato protein in living cells localized to the 
nucleus (Fig. 3.10.B.), further supporting my observation that Srp1 is entirely a nuclear 
protein.  
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Figure 3.10. Srp1 and Srp2 are pure nuclear proteins 
A. Immunolocalization of Srp1-FLAG and Srp2-FLAG proteins in formaldehyde fixed srp1-FLAG 
and srp2-FLAG cells probed with anti-FLAG antibodies and Alexa 568 conjugated secondary 
antibodies (left), DNA localization after staining with Hoechst (middle) and the merged pictures 
(right). B. Fluorescent microscopy picture of srp1-tdTomato live cells expressing the Srp1-
tdTomato fluorescent protein from the native srp1+ promoter merged with DIC picture of the 
same cells. C. Western blot with anti-dsRed antibodies and srp1-tdTomato total protein extracts.  
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I also attempted to verify the in vitro interactions detected between the Rct1 and GST-
Srp1 and GST-Srp2 proteins (Fig. 3.7.) by co-immunoprecipitation of the proteins from 
the yeast protein extracts. For this purpose I prepared rct1-HA srp1-FLAG and rct1-HA 
srp2-FLAG strains and used them for co-immunoprecipitation experiments with anti-
FLAG (Fig. 3.11.A.) or anti-HA (Fig. 3.11.B.) antibodies. However, I was neither able to co-
immunoprecipitate the proteins with each other, nor with the RNAPII (Fig. 3.11.).  
 
 
Figure 3.11. Srp1-FLAG and Srp2-FLAG do not co-immunoprecipitate with Rct1 
A. Immunoprecipitation of the Srp2-FLAG and Srp1-FLAG with anti-FLAG antibodies from the 
total protein extracts of srp2-FLAG rct1-HA and srp1-FLAG rct1-HA strains. B. 
Immunoprecipitation of Rct1-HA with anti-HA antibodies from the total protein extracts from 
srp2-FLAG rct1-HA and srp1-FLAG rct1-HA strains. FLAG –  Western blots with anti-FLAG 
antibodies to detect Srp2-FLAG or Srp1-FLAG, HA –  Western blots with anti-HA antibodies to 
detect Rct1-HA, 4H8 –  Western blots with anti-RNAPII CTD (4H8) antibodies to detect RNAPII, 
input –  total protein sample, pA –  extracts incubated with protein A sepharose beads, IP –  
immunoprecipitation sample, asterisks marks the immunoglobulin bands.  
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3.2. ROLE OF Rct1 RS DOMAIN IN REGULATION OF TRANSCRIPTION AND 
SPLICING 
3.2.1. The C-terminal RS domain of Rct1 protein is important for its function 
The common part of Rct1 protein involved in the protein-protein interactions described 
above is the C-terminal RS domain. This domain is important for the interactions with 
Srp1, Srp2, Prp2 and Dsk1 and also essential part of Rct1 in the interaction with Tsn1 
(Figs. 3.5. and 3.7.B.). Furthermore the deletion of RS domain in the GAL4-AD-Rct1 ΔRS 
construct used in the yeast two hybrid assay activated the transcription of reporter 
genes in the presence of GAL4-BD domain alone, while the full length Rct1 protein did 
not (Fig. 3.1.C.). This all together point at a possibly important role of the RS domain for 
the function of the whole Rct1 protein.  
To investigate the role of RS domain in vivo I prepared two strains. In the first I replaced 
rct1
+ gene with rct1::HA::kanMX sequence from pMG1 plasmid and in the other with rct1 
ΔRS::HA::kanMX sequence from pMG2 plasmid. By this approach I obtained rct1-HA and 
rct1 ΔRS-HA strains expressing Rct1-HA and Rct1 ΔRS-HA proteins under the control of 
native rct1+ promotor (see Fig. 3.12.A. for schemes of resulting loci). First, I compared the 
growth rates of generated strains in YES and EMM media at 30°C. Graphs in (Fig. 3.12.B.) 
show that both strains have the same growth rates as wild type in both types of media, 
and hence I assumed that the RS domain of Rct1 is a nonessential part of otherwise 
essential protein. Knock down of Rct1 expression results in the branched multicellular 
structures (Gullerova et al., 2007). Therefore, I have also compared cell morphology of 
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the exponentially growing strains, but I did not notice any difference between rct1-HA 
and rct1 ΔRS-HA strains, neither in the cell shape nor in the septation (Fig. 3.12.C.). 
 
 
Figure 3.12. Characterization of rct1-HA and rct1 ΔRS-HA strains 
A. Schematic representation of the rct1 genomic loci in the rct1-HA and rct1 ΔRS-HA strains. B. 
Comparison of the growth rates of wt, rct1-HA and rct1 ΔRS-HA strains in YES (left) or EMM 
(right) medium at 30°C. C. Fluorescent microscopy pictures of the aniline blue stained rct1-HA 
and rct1 ΔRS-HA cells grown in YES medium at 30°C. D. Western blots with anti-HA and anti-
tubulin (loading control) antibodies comparing the expression levels of Rct1-HA and Rct1 ΔRS-HA 
proteins in rct1-HA and rct1 ΔRS-HA strains grown in YES medium at 30°C. 
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I also compared the Rct1 protein expression levels in the total protein extracts of the 
new strains on the Western blots with anti-HA antibodies. I observed that the Rct1 ΔRS-
HA protein expression is reproducibly enhanced when compared to Rct1-HA protein 
expression, although the expression of tubulin control was not affected (Fig. 3.12.D.). 
This suggested that the Rct1 RS domain is important either for Rct1 protein stability or 
for the Rct1 mRNA expression. 
From the experiments with the strains overexpressing Rct1-HA and Rct1 ΔRS-HA from 
pMG1 and pMG2 plasmids is evident that the RS domain is important for nuclear 
localization of Rct1 protein (Lorkovic ZJ, unpublished results). To investigate the effect of 
RS domain deletion on the Rct1 protein localization in the cells expressing Rct1 from its 
native promoter I immunostained formaldehyde fixed rct1-HA and rct1 ΔRS-HA cells with 
anti-HA antibodies and ALEXA 568 coupled secondary antibodies. Unfortunately, the 
fluorescence signal obtained was repeatedly too low to be detected with fluorescent 
microscope (not shown). However, I obtained strong and reliable nuclear signal when the 
rct1-FLAG strain was stained with anti-FLAG antibodies and ALEXA 568 coupled 
secondary antibodies (Fig. 3.13.). Therefore, I suppose that the low signal intensity of 
rct1-HA and rct1 ΔRS-HA samplas was rather a result of inefficient anti-HA antibody 
staining of the samples then a result of the low level of Rct1 and Rct1 ΔRS protein 
expression.                 
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Figure. 3.13. Rct1-FLAG protein localizes to nucleus 
Fluorescent microscopy pictures of formaldehyde fixed rct1-FLAG cells stained with Hoechst dye 
for DNA localization and immunostained with anti-FLAG antibodies and ALEXA 568 coupled 
secondary antibodies for Rct1-FLAG localization. 
 
3.2.2. RNAPII distribution along intron containing gene dis2 is affected by Rct1 
RS domain deletion 
Rct1 was characterized as an important factor of RNAPII mediated transcription that 
regulates RNAPII phosphorylation in dosage-dependent manner (Gullerova et al., 2007).  
The PPIase domain of Rct1 interacts with the CTD domain of RNAPII (Gullerova et al., 
2007) and with the CTD Ser2-specific kinases Cdk9 and Lsk1. Furthermore it has been 
shown that Rct1 regulates Cdk9 activity in vitro on CTD substrate (Skrahina T., 2009). 
Here I showed that Rct1 can interact with several splicing factors in vitro by its C-terminal 
RS domain (Fig. 3.7.). Therefore, I hypothesized that the RS domain of Rct1 might be 
required to couple the RNAPII transcription with the splicing of introns. In my working 
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model the Rct1 could act as a mediator transmitting signals from the transcription 
machinery to the splicing machinery, or vice versa from the splicing factors to the 
transcription machinery. 
To test this hypothesis I designed chromatin immunoprecipitation experiments (ChIPs) to 
investigate a possibility that the RNAPII distribution along the intron containing genes is 
affected by the Rct1 RS domain deletion. For this purpose I selected three intron 
containing genes: the low expressed dis2 and osm1 genes and highly expressed rho1 
gene and designed PCR probes along their coding regions (see Fig. 3.14. for schematic 
representations of the loci). The genes were selected based on two criteria: a single large 
intron at the 5’ end of mRNA and no transcriptionally active chromatin in proximity of 
gene’s coding region. The probes were designed along the whole transcriptional units; 
however, the special care was taken to design probes in introns and regions just 
upstream and downstream of introns to acquire the information on splicing related 
dynamics of analyzed factors.  
To get an overall picture of the transcriptional dynamic along the selected genes I first 
assayed for RNAPII distribution. For this purpose I first fixed rct1-HA and rct1 ΔRS-HA 
cells with formaldehyde, then immunopreciptiated the RNAPII with anti-RNAPII CTD 
(4H8) antibodies and finally quantified the DNA bound in complex with 
immunoprecipitated RNAPII by SYBR Green-based real-time PCRs. For the graphical 
representations of results the obtained relative DNA values were normalized to the 
relative DNA values at an unrelated genomic region encoding 22S rRNA (marked as C in 
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Fig. 3.14.). The distribution of RNAPII signal along the dis2 and osm1 transcriptional units 
in rct1-HA cells was similar (Fig. 3.14. compare graphs in A and B): the RNAPII signal was 
low at the promoter (D1, O1 in Fig. 3.14.A. and B.), increased at the beginning of ORF 
(D2, O2 in Fig. 3.14.A. and B.), high around the intronic sequence (D3, D4, O3 in Fig. 
3.14.A. and B.), dropping down downstream of intron (D5, O4 in Fig. 3.14.A. and B.) and 
again increasing towards the end of gene (D6, D7, O6 in Fig. 3.14.A. and B.), suggesting 
that the two genes are transcribed in a similar way. The RNAPII distribution was slightly 
different along the highly transcribed rho1 gene. Here, the RNAPII signal did not decrease 
downstream of the intron (R4 in Fig. 3.14.C.), but remained high, as is typical for highly 
transcribed genes (Wilhelm et al., 2009). In addition the RNAPII signal along the osm1 
and rho1 genes was exactly the same in rct1 ΔRS-HA as in rct1-HA cells (Fig. 3.14. 
compare blue and purple bars).  By contrast, I noticed that the RNAPII signal at the 
position D5 located 300-400 bp downstream of dis2 intron, was reproducibly almost two 
times higher in rct1 ΔRS-HA cells than in rct1-HA cells (Fig. 3.14.A.). The increased RNAPII 
signal was not observed at the positions D4 and D6 which are in the close proximity of 
D5, as well as at any other position along dis2 gene. I speculated that the difference in 
RNAPII signal at the position D5 differently reflects the regulated activity of RNAPII in this 
region. It is possible that the RNAPII is here fully active only when the full length Rct1 is 
expressed and is stalled when the Rct1 RS domain is deleted.  
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Figure 3.14. RNAPII occupancy 
downstream of intron in dis2 gene is 
altered upon the Rct1 RS domain 
deletion 
Results of RNAPII-ChIP experiments 
showing the RNAPII occupancy along the 
dis2, rho1 and osm1 intron containing 
genes in rct1-HA and rct1 ΔRS-HA strains. 
Shown are the relative values of the DNA 
amount precipitated with anti-RNAPII CTD 
(4H8) antibodies. All relative DNA values 
were normalized to the signal obtained at 
an unrelated rDNA region (C). A. 
Schematic representation of dis2 
transcriptional unit (orange). The 
positions of DNA fragments amplified by 
qPCRs are indicated by dashes below (D1-
D7). Graphical representation of the 
RNAPII-ChIP results showing the 
occupancy of RNAPII along the dis2 
transcriptional unit. Arrows mark the 
beginning and the end of gene’s ORF. The 
results shown are based on five 
independent biological repeats.  B. 
Schematic representation of osm1 
transcriptional unit (green). The positions 
of DNA fragments amplified by qPCRs are 
indicated by dashes below (O1-O6). 
Arrows mark the beginning and the end of 
gene’s ORF. Graphical representation of 
RNAPII-ChIP results showing the 
occupancy of RNAPII along the osm1 
transcriptional unit. The results shown are 
based on three independent biological 
repeats. C. Schematic representation of 
rho1 transcriptional unit (yellow). The 
positions of DNA fragments amplified by 
qPCRs are indicated by dashes below (R1-
R7). Arrows mark the beginning and the 
end of gene’s ORF. Graphical representation of RNAPII-ChIP results showing the occupancy of 
RNAPII along the rho1 transcriptional unit. The results shown are based on three independent 
biological repeats. 
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Figure 3.15. Distribution of Rct1-HA 
protein along dis2, rho1 and osm1 gene is 
not changed upon the Rct1 RS domain 
deletion 
Results of Rct1-ChIP experiment showing 
the occupancy of Rct1-HA and Rct1 ΔRS-
HA along the dis2 (A), osm1  (B) and rho1 
(C) intron containing genes in rct1-HA and 
rct1 ΔRS-HA strains. Shown are the relative 
values of the DNA amount precipitated 
with anti-HA (12CA5) antibodies (pA+H). 
For the comparison the relative DNA 
values obtained in a parallel experiment 
without the antibody (pA) are shown. All 
relative DNA values were normalized to 
signal obtained at an unrelated rDNA 
region (C). Results of one of three 
independent biological experiments are 
shown. The schematic representations are 
as in Fig. 3.14..  
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It is possible that the deletion of Rct1 RS domain in rct1 ΔRS-HA strain interferes with the 
association of Rct1 with the transcriptionally active chromatin. To investigate whether 
the distribution of Rct1-HA along dis2, rho1 and osm1 genes is affected by the Rct1 RS 
domain deletion I performed ChIP experiments with both strains as before, but with anti-
12CA5 antibodies to precipitate Rct1-HA and Rct1 ΔRS-HA proteins.  Although I repeated 
the experiment three times I did not observe any reproducible difference between the 
distribution of Rct1-HA and Rct1 ΔRS-HA proteins along any of the genes tested (Fig. 
3.15. compare blue and purple bars). The little differences between Rct1-HA and 
Rct1ΔRS-HA that can be observed in Fig. 3.15.B. and C. were not confirmed in the other 
two repetitions of the experiment. Interestingly, the distribution profile of Rct1-HA and 
Rct1 ΔRS-HA proteins along these genes closely resembled that of RNAPII (compare Fig. 
3.14. with Fig. 3.15.), suggesting that both, Rct1 and Rct1 ΔRS, proteins ‘’travel’’ along 
these genes in a complex with RNAPII.  
3.2.3. Splicing efficiency is not affected by Rct1 RS domain deletion 
The increased amount of RNAPII at the position D5 at dis2 gene in rct1 ΔRS-HA strain 
might be a result of inefficient coupling of splicing reaction to RNAPII transcription. To 
test whether the splicing reaction is affected by the Rct1 RS domain deletion I designed 
RT-PCR experiments to compare the splicing  efficiency levels of dis2, osm1 and rho1 
mRNAs in rct1-HA and rct1 ΔRS-HA strains.  
First, I quantified the amount of spliced and unspliced mRNAs in the reverse transcribed 
RNA samples by the semiquantitative PCR reactions (see Fig. 3.16.A for schematic 
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Figure 3.16. Splicing of dis2, rho1 and osm1 mRNA is not affected by Rct1 RS domain deletion. 
A. Scheme of the PCR primer pairs (1 - 4) used for the semiquantitative amplification of spliced 
and unspliced mRNAs of dis2, osm1 and rho1 genes (1-3) and control act1 gene (4) after the 
reverse transcription. B. Ethidium bromide stained agarose gels showing the PCR products 
obtained after the amplification of dis2, osm1, rho1 and act1 cDNAs with the primer pairs 1 - 4 
from A. C. Ethidium bromide stained agarose gel showing the separated total RNA of rct1-HA and 
rct1 ΔRS-HA strains. The visible bands correspond to the abundant ribosomal rRNA of S. pombe.  
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representations of primer probes). As can be seen in Fig. 3.16.B., the signal obtained 
after amplification of the region corresponding to the exon 2 of either dis2, osm1 or rho1 
mRNAs was the same in both rct1-HA and rct1 ΔRS-HA strains (Fig. 3.16.B. , panel 3). This 
shows that the deletion of Rct1 RS domain does not affect the steady-state level of these 
mRNAs in the cell. I obtained similar results whit primer pairs priming upstream and 
downstream of dis2, osm1 or rho1 introns, i.e. primers pairs amplifying both spliced and 
unspliced mRNA variants (Fig. 3.16.B., panel 2). The signal corresponding to spliced 
mRNA variants was the same in rct1-HA and rct1 ΔRS-HA strain in all three analyzed 
genes (Fig. 3.16.B., bottom of panel 2). However, no detectable signal corresponding to 
unspliced mRNA was obtained (Fig. 3.16.B., top of panel 2). When the primer pairs 
priming within the intronic sequences were used, only a low intensity signal 
corresponding to unspliced mRNAs of osm1 and rho1 genes, but not dis2 gene, was 
obtained (Fig. 3.16.B., panel 1). Amplification of a segment of intronless actin mRNA 
resulted in the same signal intensity in both strains (Fig. 3.16.B., panel 4), showing that 
the comparable amounts of total RNA were analyzed. 
Next, I quantified the amount of total mRNA and unspliced mRNA of dis2, osm1 and rho1 
genes in the same RT-PCR samples, but this time by the quantitative real-time PCRs. For 
this purpose I used the same primer pairs as for ChIP experiments (i.e. D4, R5, O5, D2, R3 
and O3). The probes were selected to amplify either the exonic regions (D4, R5, O5) or 
the intronic regions (D2, R3, O3) of dis2, osm1 and rho1 mRNAs (see Fig. 3.17.A for 
schematic representation of primer probes). The graphs in Fig. 3.17. show that the 
amount of total (Fig. 3.17.B.), as well as unspliced (Fig. 3.17.C.), mRNA of dis2, osm1 and 
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rho1 genes did not change upon the deletion of Rct1 RS domain. The data also show that, 
as expected, the expression level of dis2 and osm1 genes were lower than the expression 
level of rho1 gene (Fig. 3.17.B. compare D4 and O5 with R5). Together the results show 
that the deletion of Rct1 RS domain does not affect the pre-mRNA splicing of the 
analysed genes. 
 
Figure 3.17. Splicing efficiency of dis2, rho1 and osm1 mRNA is not affected by Rct1 RS domain 
deletion as revealed by real time PCRs analysis. 
A. Schematic representations of dis2, osm1 and rho1 transcriptional units and positions of primer 
probes used for real-time PCR amplification.  B., C. Graphs showing the relative amounts of total 
(exon 2) (B.) and unspliced (intron) (C.) dis2, rho1 and osm1 mRNAs detected by real-time PCR of 
the reverse transcribed mRNA (RT-PCR) and total, not reverse transcribed RNA (RNA) using the 
probes D4, R5, O5, D2, R3, O3 as depicted in A. Error bars represent standard deviations of three 
independent biological repeats.  
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Interestingly, the amount of total RNA isolated from rct1 ΔRS-HA strain was repeatedly 2-
3 times higher than the amount of RNA isolated from the same amount of cells of rct1-
HA strain, as became evident after separation of isolated RNA on 2% agarose gel 
followed by visualization of rRNA with ethidium bromide (Fig. 3.16.C.). The difference 
was further supported by spectrophotometric measurements (not shown). This is 
important, because in accordance with RT-PCR protocol the experiments were 
performed with the same amount of total RNA and therefore corrected for the original 
difference in total RNA amounts between the two strains. Yet, there was no difference in 
dis2, osm1 and rho1 mRNA levels between the rct1-HA and rct1 ΔRS-HA strains in RT-PCR 
experiments shown in Figs. 3.16.B. and 3.17.B.. Although, the difference in total RNA 
amounts between the two strains seems to be significant, it likely does not result from 
the altered RNAPII transcription, because it affects the levels of rRNA proportionally to 
that of mRNA.  
3.2.4. Deletion of RS domain does not affect the distribution of Srp2 along dis2, 
osm1 and rho1 transcriptional units 
The Rct1 associated with the transcriptionally active RNAPII might associate with the 
splicing factors Srp1 and Srp2 in two ways: it can either facilitate their recruitment to the 
nascent transcript or it can modulate their activity once they are already associated with 
RNAPII and with the nascent transcript. To test the first possibility I prepared four strains 
expressing Rct1-HA and Rct1 ΔRS-HA proteins in the combination with Srp1-FLAG or 
Srp2-FLAG proteins, i.e. rct1-HA srp1-FLAG, rct1 ΔRS -HA srp1-FLAG, rct1-HA srp2-FLAG 
and rct1 ΔRS-HA srp2-FLAG strains. I used these strains to map the distribution of Srp1-
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FLAG and Srp2-FLAG along dis2 gene in ChIP experiment with anti-FLAG antibodies. If my 
hypothesis was correct than the distribution of Srp1 or Srp2 would be altered by the Rct1 
RS domain deletion. First, my results showed that only Srp2-FLAG protein, but not Srp1-
FLAG protein, is enriched along dis2 transcriptional unit, if compared to the background 
values (Fig. 3.18. compare A with B and pA with pA+F). Second, as is evident from the 
graph in Fig. 3.18.B., there is no significant difference in the Srp2-FLAG distribution along 
dis2 gene in the rct1 ΔRS-HA srp2 FLAG cells when compared with the rct1-HA srp2-FLAG 
cells, except of position D5. However, this difference was not obvious in four of five 
independent experiment repetitions and therefore it cannot be considered significant. In 
rct1-HA srp2-FLAG cells the Srp2-ChIP signal was almost at the background level on the 
promoter of dis2 gene (D1 in Fig. 3.18.B.), two times higher at the beginning of gene 
(exon 1) and in the middle of intron (D2, D3 in Fig. 3.18.B.), five times higher at the intron 
– exon 2 junction (D4 in Fig. 3.18.B.), dropping down downstream of intron (two times 
higher than at the promoter, D5 in Fig. 3.18.B.) and increasing further downstream at the 
exon 2 (D6 in Fig. 3.18.B.) and in the 3’ untranslated region (D7 in Fig. 3.18.B.). This 
distribution of Srp2-FLAG protein closely resembled that of the RNAPII, suggesting that 
the RNAPII and Srp2 proteins are in a complex when associated with the dis2 gene 
(compare Fig. 3.14.A. with Fig. 3.18.B.). Furthermore, I have also compared the 
distribution of Srp2-FLAG along osm1 and rho1 genes, but did not find any significant 
difference in the Srp2 distribution between the rct1-HA srp1-FLAG and rct1 ΔRS-HA srp1-
FLAG strains (Fig. 3.18. compare blue and yellow bars in C. and D.), suggesting that the 
Rct1 RS domain is not needed to recruit the Srp2 protein to the transcribing RNAPII.    
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Figure 3.18. Srp2, but not Srp1, is associated with transcriptionally active chromatin 
A. Results of the Srp1-ChIP experiment showing the occupancy of Srp1-FLAG along dis2 
transcriptional unit in srp1-FLAG rct1-HA and srp1-FLAG rct1 ΔRS-HA strains. The results shown 
are based on two independent biological experiments. B, C, D. Results of the Srp2-ChIP 
experiment showing the occupancy of Srp2-FLAG along dis2 (B), osm1 (C) and rho1 (D) 
transcriptional units in srp2-FLAG rct1-HA and srp2-FLAG rct1 ΔRS-HA strains. Results are based 
on five (B) or two (C and D) independent biological experiments. Shown are the relative values of 
DNA amounts precipitated with anti-FLAG antibodies (pA+F). For comparison the relative DNA 
values obtained in the parallel experiment without the antibody (pA) are shown. All relative DNA 
values were normalized to the signal obtained at an unrelated rDNA region (C). Schematic 
representations are as in Fig. 3.14.. 
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3.2.5. RNAPII distribution along intron containing gene dis2 is also affected by 
the overexpression of Rct1 protein 
As already stated, the deletion of Rct1 RS domain resulted in the increased expression of 
truncated Rct1 protein when compared to the expression level of full length protein (Fig. 
3.12.D.). Therefore, I cannot exclude a possibility that the increased RNAPII signal at the 
position D5 at dis2 gene in RNAPII-ChIP experiments is a result of the overexpression of 
truncated protein, which consists of the PPIase and RRM domains. To test this possibility 
I performed similar RNAPII-ChIP experiment along the dis2 gene as already described 
above, but this time with cells overexpressiong the Rct1-HA protein (i.e. Δrct1 + pMG1 
cells grown in EMM without thiamine) or with the same cells after the Rct1-HA depletion 
(i.e. grown in EMM with thiamine) and compared them with the wild type cells and Δrct1 
cells expressing Rct1 ΔPPIase-HA protein from nmt1+ promotor (i.e. Δrct1 + pMG4 cells 
grown in EMM without thiamine). The overexpression of Rct1-HA protein, similar to the 
deletion of RS domain in rct1 ΔRS-HA cells (Fig. 3.14.A.), resulted in the accumulation of 
RNAPII signal at the position D5 (Fig. 3.19.A),  whereas the distribution of RNAPII along 
the rest of dis2 gene was not significantly affected (Fig. 3.19.A.). By contrast, there was 
no accumulation at the D5 possition, when the Rct1-HA was depleted by the addition of 
thiamine, or when the Rct1 ΔPPIase-HA protein was expressed instead of the full length 
protein (Fig. 3.19.A.). It is important to mention that the overall amount of RNAPII 
precipitated DNA corresponding to dis2 transcriptional unit was not increased upon the 
Rct1-HA overexpression.  
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Figure 3.19. RNAPII occupancy at the position D5 at dis2 gene is also altered upon the Rct1-HA 
overexpression 
A. Results of the RNAPII-ChIP experiment showing the RNAPII occupancy along dis2 gene in wt 
cells, in Δrct1+ pMG1 cells overexpressing Rct1-HA in the EMM medium, in Δrct1+ pMG1 cells 
after repression of the overexpression of Rct1-HA by the addition of thiamine and in  Δrct1+ 
pMG4 cells overexpressiong Rct1 ΔPPIase-HA protein in the EMM medium. Shown are the 
relative values of DNA amounts precipitated with anti-RNAPII CTD (4H8) antibodies. All relative 
DNA values were normalized to the signal obtained at an unrelated rDNA region (C). The results 
shown are based on two independent biological experiments. The schematic representation of 
dis2 gene is as in Fig. 3.14.A.. B. Western blot with anti-tubulin and anti-FLAG antibodies and 
protein extracts from rct1-FLAG, Δrct1 + pMG1F (overexpressing Rct1-FLAG protein) and Δrct1 + 
pMG4F (expressing Rct1 ΔPPIase-FLAG protein) cells grown in the presence (+B) or absence (-B) 
of thiamine.  
 
All together this experiment shows that the overexpression of Rct1-HA has similar effect 
on the RNAPII distribution along the dis2 gene as the deletion of Rct1 RS domain. The 
depletion of Rct1-HA in the cells, as well as the overexpression of Rct1 ΔPPIase-HA 
peptide resulted in the wild type RNAPII distribution along dis2 gene, suggesting that it is 
the overexpression of PPIase domain that is necessary for RNAPII accumulation at the 
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position D5. However, from similar experiment we know that the level of Rct1 ΔPPIase-
FLAG protein under the overexpression conditions (when nmt1+ promotor is on) is 
significantly lower than the endogenous Rct1 protein level under the same conditions 
(Fig. 3.19.B. compare rct1-FLAG and rct1ΔpMG4F). Therefore I cannot exclude the 
possibility that the RNAPII accumulation at the position D5 is a result of the RRM domain 
overexpression.
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3.3. PHENOTYPIC ANALYSIS OF TRANSLIN DELETION AND 
OVEREXPRESSION STRAINS 
3.3.1. Proper expression of Tsn1 protein is not important for viability of haploid 
cells 
The tsn1 is referred to be a nonessential gene and its deletion does not seem to have any 
effect on the cell viability (Jaendling et al., 2008) or, as referred by the others (Laufman 
et al., 2005), it only slightly enhances the growth rate of Δtsn1 spores. For my 
experiments I generated two Δtsn1 deletion strains. To obtain the Δtsn1(kan) strain I first 
replaced one allele of tsn1+ gene in the wild type diploid cells with the kanMX cassette 
amplified from pMG plasmid and then prepared the haploid strains by tetrad dissection 
of the sporulated diploid cells. To obtain the Δtsn1(nat) strain I directly replaced the ORF 
of tsn1+ gene with the natMX cassette from pAG25 plasmid in the wild type haploid cells.  
First, I compared the cell morphology of exponentially growing Δtsn1(kan) and 
Δtsn1(nat) strains with the haploid wild type strain in both EMM and YES media at 30°C, 
but I did not observe any differences (Fig. 3.20. A. and B.). I also did not observe any 
difference in the growth rates of created strains and wild type strain (Fig. 3.20. C and E.). 
Next, I examined the effect of Tsn1-HA overexpression on the growth rates of the 
haploid wild type and Δtsn1(nat) cells. For this purpose I transformed the cells with 
empty pMG plasmid and pMGT plasmid overexpressing Tsn1-HA protein, and compared 
their growth rates with the growth rates of the wild type and Δtsn1(nat) strains in EMM 
medium at 30°C (i.e. under the conditions when nmt1+ promoter is on). However, I did 
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not observe any difference in the growth rates (Fig. 3.20.D.), nor in the cell morphology 
(Fig. 3.20.A. and E.), when compared to wt or Δtsn1(nat) cells. 
 
Figure. 3.20. Characterization of haploid tsn1 deletion and overexpression strains 
A. DIC and fluorescent microscopy pictures comparing morphology of the exponentially growing 
haploid wild type cells, Δtsn1(nat)) cells and wt + pMGT cells in minimal EMM medium under the 
conditions when nmt1+ promoter is on. B. The same as A, but haploid wild type cells and 
Δtsn1(nat) cells in rich YES medium are compared. C., D., E. Growth curves comparing the growth 
rates of wt, tsn1-HA and Δtsn1(nat) strains in YES medium (C.) and growth curves comparing the 
growth rates of wild type cells (D.) or Δtsn1(nat) cells (E.) transformed with empty pMG plasmid,  
pMG1 plasmid and pMGT plasmid in the EMM medium at 30°C.  
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3.3.2. Both overexpression and deletion of tsn1+ decrease the rate of meiotic 
differentiation 
The amount of tsn1 and rct1 RNAs significantly increases during the meiosis I and II 
(Mata et al., 2002), pointing at the possible role of these two proteins in the regulation of 
meiotic differentiation. Furthermore, the expression of Rct1 protein seems to be an 
important factor for the correct meiotic differentiation and the meiosis-specific splicing 
of certain genes (Gullerova et al., 2007). Therefore I decided to investigate a possibility 
that the expression of Tsn1 protein is also important for the correct progression of 
meiosis.  
First, I generated stable Δtsn1(nat)/Δtsn1(kan) diploid strain by mating Δtsn1(nat) and 
Δtsn1(kan) haploid strains and compared its sporulation rate with the sporulation rates 
of the diploid wild type and heterozygous rct1/Δrct1 strains. To assay for the sporulation 
rates I induced meiosis in the nonsynchronous cell culture, simply by shifting the cells 
from the rich YES medium to the minimal medium without nitrogen (EMM-NA), and 
counted the number of asci generated after 22 hours at 28°C. Under these conditions 
29,7% of wild type cells and 58,4% of rct1/Δrct1 cells were already sporulated, but only 
9,7% of Δtsn1(nat)/Δtsn1(kan) cells generated spores (Fig. 3.21.A.). The increased rate of 
sporulation in rct1/Δrct1 cells is well consistent with the already published data 
(Gullerova et al., 2007), whereas the decreased sporulation of Δtsn1(nat)/Δtsn1(kan) has 
not yet been reported. In parallel with the experiment described above I performed the 
sporulation assays with the diploid wild type cells overexpressiong Rct1-HA (2n wt + 
pMG1) and Tsn1-HA (2n wt + pMGT) strains. Under the same conditions as above the 
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overexpression of Rct1-HA protein (2n wt + pMG1) resulted in decreased sporulation 
efficiency (3,9% of cells were sporulated, Fig. 3.21.A.). Similarly, the overexpression of 
Tsn1-HA protein also resulted in decreased sporulation efficiency (9,4% of cells were 
sporulated, Fig. 3.21.A.). From these experiments I concluded that the precise amount of 
Tsn1 protein is important for the efficient meiotic differentiation, because both, the 
increased and the decreased level of the Tsn1 protein expression, resulted in the 
decreased rate of spore formation.  
 
Figure 3.21. The tsn1 and rct1 genes are required for proper meiotic progression 
A. Results of the sporulation assays comparing the sporulation efficiency of diploid wild type 
strain, rct1/Δrct1 strain, Δtsn1(nat)/Δtsn1(kan) strain and diploid wild type strains overexpressing 
Rct1-HA (2n wt + pMG1) or Tsn1-HA (2n wt + pMGT) proteins. Bars in the graph represent the 
percentage of cells sporulated after 22 hours at 30 °C under the conditions of nitrogen starvation 
(EMM-NA, 1% glucose). B. Graph comparing sporulation efficiency of rct1/Δrct1 strain with 
strains transformed either with empty pMG plasmid (rct1/Δrct1 + pMG ) or pMG1 plasmid 
overexpressing Rct1-HA protein (rct1/Δrct1 + pMG1) or pMGT plasmid overexpressing Tsn1-HA 
protein (rct1/Δrct1 + pMGT). Bars in the graph represent the percentage of cells sporulated after 
20 hours at 28 °C under the conditions of nitrogen starvation (EMM-NA, 1% glucose). The error 
bars represent standard deviation based on three independent biological experiments. 
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The Rct1 and Tsn1 proteins might act either together at a specific stage of meiotic 
differentiation, or independently of each other. I therefore asked, whether the 
overexpression of Tsn1-HA from pMGT plasmid can complement the increased 
sporulation of rct1/Δrct1 cells. As can be seen in Fig. 3.21.B., the enhanced sporulation of 
rct1/Δrct1 strain or rct1/Δrct1 + pMG strain (38,8% and 54% of cells were sporulated) 
was complemented by the overexpression of Rct1-HA protein from pMG1 plasmid (17% 
of cells were sporulated), but not by the overexpression of Tsn1-HA protein from pMGT 
plasmid (63,7% of cells were sporulated). This experiment shows that the deletion of one 
allele of rct1 gene in the rct1/Δrct1 strain is epistatic over the tsn1 overexpression and 
suggests that the Rct1 has a function in meiotic differentiation that is superior to the 
function of Tsn1.  
The rct1/Δrct1 asci were reported to harbor a distinct morphology; being shorter and 
more compact than wild type asci (Gullerova et al., 2007). By contrast, the Δtsn1(nat)/ 
Δtsn1(kan) asci were linear like the wild type asci, but the spores in the asci seemed to 
be only loosely packed when compared to the wild type spores (Fig. 3.22.B.). 
Nevertheless, the statistical analysis did not reveal any significant differences in the size 
of asci between the analyzed strains, except of the shorter rct1/Δrct1 asci (Fig. 3.22.A.). 
Interestingly, the reduced size of rct1/Δrct1 asci was not complemented by Rct1 
overexpression from pMG1 plasmid, but partially complemented by the overexpression 
of Tsn1 from pMGT plasmid (Fig. 3.22.A.). 
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Figure 3.22. Morphology of acsi from the sporulation assays 
A. Statistical analysis of the length of asci from the sporulation assays in Fig. 3.21. The length was 
measured between the most distant points of the ascus using the ImageJ software. B. DIC picture 
of measured spores, showing the normal morphology of 2n wt asci, shorter and compact 
morphology of rct1/Δrct1 asci and normal morphology of Δtsn1(nat)/ Δtsn1(kan) asci.  
 
3.3.3. Expression of Tsn1 protein is increased during meiosis I and II 
In the previous section I showed that the deletion of tsn1 gene in diploid cells results in 
reduced meiotic efficiency. Furthermore, it was reported previously that the expression 
of tsn1 mRNA is upregulated in middle meiosis (Mata et al., 2002). Therefore, I decided 
to determine the stage of meiotic differentiation at which the Tsn1 protein acts. I took 
the advantage of the pat1-114 mutation that allows to synchronize the diploid pat1-
114/pat1-114 cells early in the meiosis by nitrogen starvation, and constructed tsn1-
HA/tsn1-HA pat1-114/pat1-114 diploid strain expressing wild type levels of the HA-
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tagged Tsn1 protein. I synchronized these cells by the nitrogen starvation, induced them 
for meiosis by a temperature shift from 25°C to 34°C and sampled the cell culture at 
indicated time points (see Fig. 3.23.). First, I analyzed the total protein extracts of the 
samples from individual time points on the Western blots with anti-HA antibodies to 
reveal the changes in Tsn1-HA expression in the time course of meiosis. As shown in 
Figure 3.23., the Tsn1-HA specific signal increases 2 to 3 hours after the induction of 
meiosis and decreases approximately 6 hours after the induction of meiosis, being 
highest between the 3rd and 5th hour. As control Western blots with anti-tubulin 
antibodies did not show any differences between time points this change seem to be 
specific. 
 
Figure 3.23. Tsn1 expression is increased during meiosis I and II of meiotic differentiation 
Western blots with anti-HA antibodies (top) and with anti-tubulin antibodies (middle) comparing 
the expression of Tsn1-HA protein and tubulin in the time course of tsn1-HA/tsn1-HA pat1-
114/pat1-114 synchronous meiosis. The equal amounts of total proteins were loaded per lane (in 
µg). At the bottom is a section of the ponceau stained membrane showing the equal loading of 
protein extracts. The individual time points (t1 to t8) correspond to hours after the induction of 
meiosis by temperature shift.  
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To determine the stage of meiosis at which the expression of Tsn1-HA is increased, I 
counted the percentage of cells with one, two or four nuclei at each time point and plot 
the values against the time course of the experiment. Figure. 3.24.A. shows that the 
highest Tsn1-HA signal roughly correlates with the first and second meiotic divisions.  
 
Figure 3.24. Deletion of tsn1 gene in pat1-114/pat1-114 genetic background does not have any 
effect upon the meiotic progression 
Graphs showing the progression of tsn1-HA/tsn1-HA, pat1-114/pat1-114 (A.) and 
Δtsn1(nat)/Δtsn1(nat) pat1-114/pat1-114 (B.) strains in the time course of the synchronous 
meiosis. The progression was monitored by counting the cells with one nucleus (diamonds), two 
nuclei (squares) and four nuclei (triangles) in Hoechst stained samples. The samples were taken 
at the indicated time points after the induction of meiosis by temperature shift.    
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The experiments with the Δtsn1(nat)/Δtsn1(kan) strain described in part 3.3.2. resulted 
in the decreased rate of meiotic differentiation in the non-synchronous meiosis (Fig. 
3.21.A.). To find the particular stage of meiosis at which these cells slow down their 
differentiation I created Δtsn1(nat)/Δtsn1(nat) pat1-114/pat1-114 strain suitable for the 
synchronous meiosis. I synchronized these cells as described above and followed their 
progression through meiosis, either by counting the percentage of cells with one, two or 
four nuclei at each time point or by measuring the DNA content by flow cytometry (not 
shown). Surprisingly, I found no difference in the differentiation of the control tsn1-
HA/tsn1-HA pat1-114/pat1-114 strain and the deletion Δtsn1(nat)/Δtsn1(nat) pat1-
114/pat1-114 strain, neither in the rate of sporulation, nor in the DNA content changes 
(Fig. 3.24.B.). One possible explanation is that the pat1-114/pat1-114 genetic 
background interferes with the Δtsn1(nat)/Δtsn1(nat) phenotype. The other possible 
explanation for this discreepancy is that the genetic manipulations that were required to 
create Δtsn1(nat)/Δtsn1(nat) pat1-114/pat1-114 strain had an unknown suprressory 
effect over the tsn1 deletion.  
3.3.4. Is Tsn1 a nuclear protein? 
In fission yeast translin was reported to localize predominantly to the nucleus and only 
partially to the cytoplasm of the cells overexpressing Tsn1 from nmt1+ promoter 
(Matsuyama et al., 2006). However, this report is based on the data from a large scale 
screen, and therefore I attempted to investigate the Tsn1 localization in the more 
focused experiments. First, I attempted to tag tsn1+ gene with the GFP protein coding 
sequence directly on the chromosome to obtain a strain expressing wild type levels of 
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fluorescently labeled Tsn1 protein. For this purpose I amplified GFP::kanMX region from 
pSMRG2 + GFP5 plasmid and recombined it downstream of tsn1 ORF. By this approach I 
obtained the strain with GFP::kanMX sequence incorporated at the expected location; 
however, I was neither able to detect the Tsn1-GFP protein on the Western blots with 
anti-GFP antibodies, nor did I detect the GFP fluorescence under the fluorescent 
microscope (not shown). I consider it likely that the GFP tag renders the Tsn1 more prone 
for degradation, and therefore undetectable. Alternatively, the GFP tag might interfere 
with the splicing of tsn1 gene and as a result no functional protein is generated. The lack 
of the Tsn1-GFP protein in the cells tagged with the GFP coding sequence on the 
chromosome might also be a specific effect of GFP tag, and could possibly be overcome 
by using another fluorescent protein tag. Therefore, I decided to tag tsn1 gene with the 
tdTomato fluorescent protein, a dimmer of the Cherry protein, with a different structure 
than the GFP. However, I again failed to obtain the strain expressing Tsn1-tdTomato 
detectable on the Western blots with anti-dsRed antibodies or under the microscope 
(not shown). 
Because I could not obtain the strain expressing fluorescently labeled Tsn1 protein from 
tsn1
+ native promotor, I have decided to assay for Tsn1-HA localization in the haploid 
wild type cells overexpressing Tsn1-HA from pMGT plasmid. For this purpose I fixed 
exponentially growing cells in EMM medium with formaldehyde and immunostained 
them with anti-HA antibodies and ALEXA 568 coupled secondary antibodies. In parallel I 
processed the haploid wild type cells overexpressing Rct1-HA from pMG1 plasmid as a  
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Figure 3.25. Immunolocalization of Tsn1 and Rct1 proteins in haploid cells 
Fluorescent micrographs of immunostained Tsn1-HA and Rct1-HA proteins in the formaldehyde 
fixed cells. The cells were probed with anti-HA antibodies and Alexa 568 conjugated secondary 
antibodies to stain HA-tagged proteins and with Hoechst to stain DNA. Pictures on the left show 
Alexa 568 specific signal, in the middle Hoechst specific signal and on the right are the merged 
pictures. A. Immunolacalization of Tsn1-HA and Rct1-HA proteins in haploid wild type cells 
transformed with either empty pMG plasmid (wt + pMG) expressing no HA-tagged protein or 
with pMGT plasmid (wt + pMGT) overexpressing Tsn1-HA protein or with pMG1 plasmid (wt + 
pMG1) overexpressing Rct1-HA protein. Cells were grown in EMM medium to allow expression 
from the nmt1+ promotor. B. Same as A, but in Δtsn1(nat) genetic background. 
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positive control and the haploid wild type cell transformed with empty pMG plasmid as a 
negative control. To visualize the localization of nucleus the DNA was stained with 
Hoechst dye. As can be seen in Figure 3.25.A (bottom), I found the Rct1-HA specific signal 
to co-localize with the DNA signal at the cell nucleus as reported previously (Gullerova et 
al, 2007). By contrast, the Tsn1-HA specific signal was rather evenly distributed 
throughout the cell without any predominant localization in any specific cellular 
compartment (Fig. 3.25.A., middle). However, I could not exclude that a small portion of 
the protein is indeed localized to the nucleus. Because the untagged Tsn1 protein 
expressed from its native promoter might interfere with the Tsn1-HA protein localization 
in the wild type cells, I also immunostained the haploid Δtsn1(nat) cells overexpressing 
Tsn1-HA and Rct1-HA proteins from pMGT and pMG1 plasmids respectively. However, 
the patterns of Rct1-HA and Tsn1-HA localization were the same as in the wild type 
background (Fig. 3.25.B.). Similar results were obtained with the diploid wild type strains 
transformed with pMG and pMGT plasmids (Fig. 3. 26.).  
The overexpression of a protein might result in its misslocalization in the cell. Therefore I 
decided to repeat the immunostaining experiment with a strain expressing Tsn1-HA 
protein from its native promoter on the chromosome. For this purpose I amplified the 
tsn1::HA::kanMX region from pMGT plasmid and recombined it downstream of tsn1+ 
promoter so that the entire tsn1+ ORF was replaced. After backcrossing I obtained a 
stable strain expressing HA-tagged protein that was proved to be the tsn1-HA by PCR 
genotyping, sequencing and Western blotting. I immunostained the strain with anti-HA 
antibodies and ALEXA 568 coupled secondary antibodies, as already described above, but 
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the signal obtained was repeatedly to low to be detected under the fluorescence 
microscope (data not shown). In my experience the FLAG tag immunostaining with anti-
FLAG antibodies gives better signal then the HA tag immunostaining with anti-HA 
antibodies, when the low expressed proteins are immunostained. Therefore, I tried to 
tag the tsn1+ with the FLAG::hphMX sequence directly on the chromosome, however, I 
failed to obtain any strain expressing the Tsn1-FLAG protein by this approach (data not 
shown). Furthermore, I also attempted to determine Tsn1-HA localization in tsn1-
HA/tsn1-HA, pat1-114/pat1-114 cells undergoing synchronous meiosis, but I was not 
able to detect any Tsn1-HA specific signal in these cells as well (data not shown).  
 
Figure 3.26. Immunolocalization of Tsn1 protein in diploid cells 
Fluorescent micrographs of immunostained Tsn1-HA protein in the formaldehyde fixed 2n + pMG 
and 2n + pMGT cells. Cells were grown in EMM medium to allow expression from the nmt1+ 
promoter and probed with anti-HA antibodies and Alexa 568 conjugated secondary antibodies to 
stain HA-tagged proteins and with Hoechst to stain DNA. Pictures on the left show Alexa 568 
specific signal, in the middle Hoechst specific signal and on the right are the merged pictures.  
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3.3.5. Tsn1 is associated with transcriptionally active chromatin 
From the experiments above is not clear whether the Tsn1 is a nuclear protein or not, 
however, it is possible that a small portion of Tsn1 is also present in the nucleus. Because 
I originally identified Tsn1 protein as the interacting partner of Rct1, which is known to 
associate with the transcriptionally active chromatin, I asked whether at least a portion 
of Tsn1 protein in the cells could be possibly associated with the transcriptionally active 
chromatin as well. For this purpose I performed the Tsn1-ChIP experiments with anti-HA 
antibodies and formaldehyde cross-linked tsn1-HA cells. Precipitated DNA was amplified 
with the oligonucleotides covering dis2 and rho1 transcriptional units. The results clearly 
show that the Tsn1-HA protein is significantly enriched along these transcriptional units, 
when compared to the background signal obtained in the parallel experiments without 
the antibodies (Fig. 3.27.). Again, the distribution of Tsn1-HA protein along these genes 
closely resembled that of RNAPII and Rct1-HA (compare Fig. 3.27. with Fig. 3.14 and Fig. 
3.15.), suggesting that Tsn1 could associate with RNAPII and Rct1 along the transcribed 
genes. 
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Figure 3.27. Tsn1 protein is associated with chromatin 
A., B. Graphical representation of Tsn1-ChIP experiment results showing the occupancy of Tsn1-
HA along dis2 (A.) and rho1 (B.) transcriptional units. Shown are the relative values of the DNA 
amount precipitated with anti-HA antibodies (pA+H). For comparison the relative DNA values 
obtained in the parallel experiment without the antibody (pA) are shown. All relative DNA values 
were normalized to the signal obtained at an unrelated rDNA region (C). Schematic 
representations are as in the Fig. 3.14. One of three independent biological experiments is 
shown. 
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4. DISCUSSION 
4.1. ROLE OF Rct1 IN COUPLING pre-mRNA SPLICING AND TRANSCRIPTION 
Rct1 is a protein with three distinct domains: the PPIase, the RMM and the RS domain. 
The PPIase domain is characteristic of peptidyl prolyl isomerases (PPIases) (see part 1.5. 
for details), whereas the RRM and RS domains are characteristic of SR proteins (see part 
1.3. for details). Rct1 is an essential protein with a role in the regulation of RNAPII 
transcription (Gullerova et al., 2007). It has been reported to co-immunopreciptate with 
the phosphorylated CTD of RNAPII and to modulate the CTD phosphorylation and RNAPII 
transcription in vivo (Gullerova et al., 2007). The interaction between the Rct1 and CTD is 
mediated by the PPIase domain of Rct1, while the RRM and RS domains are negligible for 
the interaction (Skrahina T, 2009). Rct1 also interacts in vitro with the Ser2-specific CTD 
kinases Cdk9 and Lsk1, but does not interact with the Ser5-specific CTD kinases Msc6 and 
Srb10 and CTD-specific phosphatases Fcp1, Scp1 and Ssu72 (Skrahina T, 2009). Again the 
PPIase domain is responsible for these interactions, as well as for the inhibition of Cdk9 
kinase activity on CTD substrate (Skrahina T, 2009). The plant homologue of Rct1 
AtCyp59 regulates RNAPII CTD phosphorylation as well, and furthermore it also 
associates with the plant SR proteins (Gullerova et al., 2006). Here I investigated a 
possibility that Rct1 interacts with fission yeast SR proteins and couples splicing to 
RNAPII-mediated transcription.  
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4.1.1. Interactions of Rct1 with Srp1, Srp2, Prp2 and Dsk1 proteins and their 
possible consequences. 
There are two characterized SR proteins in fission yeasts Srp1 and Srp2. The Srp2 is a 
nuclear protein with proposed role in the regulation of pre-mRNA splicing. On the 
contrary, the Srp1 is considered to be a shuttling protein without any known direct 
function in the pre-mRNA splicing (Lutzelberger et al., 1999, Tang et al., 1998, 2000, 
2002, 2007, see also part 1.3.3. for details). I showed that Rct1 interacts with both fission 
yeast SR proteins Srp1 and Srp2, as well as with the SR protein-like splicing factor Prp2 () 
and the RS domain-specific kinase Dsk1 (Fig. 3.7.A.). All of these proteins either harbor 
an RS domain (Srp1, Srp2, Prp2) or have a strong preference for the RS domain as a 
substrate (Dsk1) (Tang et al., 1998, 2000, 2002, 2007). The RS domain is also absolutely 
required for the interactions between the AtCyp59 and the plant SR proteins (Gullerova 
et al., 2006). Therefore, I decided to test if the RS domains of Rct1, Srp1, Srp2 and Prp2 
are needed for the interactions. The pull down assays with different deletion mutants 
revealed that indeed the RS domains of Rct1, Srp2 and Prp2 are involved in the 
intearctions (Fig 3.7.B and C.). Furthermore, I could show that the PPIase domain of Rct1 
and RRM domain of Srp1 also contribute to the interactions.  
Although several repetions of the pull-down experiment reproducibly revealed 
interaction of Rct1 with Srp1 and Srp2, I could not detect the same interactions in the co-
immunoprecipitation assays (see Fig. 3.11.). Similarly, Das et al. (2007) failed to co-
immunoprecipitate RNAPII using the antibodies against the mammalian SR proteins, but 
succeeded whit GST-SR protein fusions. As suggested by Das et al. (2007), it is possible 
4. Discussion 
 
150 
that the epitops recognized by SR protein-specific antibodies are not accessible in the 
native complexes. Another possible explanation is that the interactions detected in the 
pull down assays are only transient and therefore under detection limit of the co-
immunoprecipitation assay. The interactions of different SR proteins are usually 
phosphorylation-dependent (Lorkovic et al., 2004). The phosphorylation state of a 
bacteria-produced SR protein is likely different form its native phosphorylation state and 
might also account for the different outcome of the pull down and immunoprecipitation 
assays.  
The Dsk1 kinase interacted with Rct1 RS domain, but not with the PPIase or RRM domain 
of Rct1, in the pull down assays (Fig. 3.7.B and C.). This is well consistent with RS domain-
specific kinase activity of Dsk1 on Srp1, Srp2 and Prp2 substrates (Tang et al., 1998, 2000, 
2002, 2007) and opens a possibility that Rct1 RS domain is also phosphorylated by Dsk1. 
The phosphorylation of Srp2 and Prp2 RS domains by Dsk1 is important for correct 
nuclear localization of Srp2 and Prp2 proteins (Lutzelberger et al., 1999; Tang et al., 
2007). Also the Rct1 RS domain seems to be important for correct nuclear localization of 
Rct1 protein (Lorkovic Z, unpublished data). It is therefore possible that Rct1 nuclear 
localization is regulated by Dsk1-dependent phosphorylation of Rct1 RS domain. 
However, the dephosphorylation assays revealed that whereas Srp1 and Srp2 exist in the 
cells predominantly in a highly phosphorylated form, the Rct1 is only modestly, if at all, 
phosphorylated (see Fig. 3.9.E.).  Interestingly Dsk1 shuttles between the cytoplasm and 
nucleus in cell cycle-dependent manner and its activity is up-regulated by 
autophosphorylation (Takeuchi and Yanagida, 1993; Tang et al., 1998). Although it 
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accumulates in the cytoplasm from G1 to G2 phase of the cell cycle, it is most active in 
the M phase, when it accumulates in the nucleus (Takeuchi and Yanagida, 1993). Some 
phenotypes of Rct1 deletion mutants suggest that Rct1 is important for the correct cell 
cycle progression (Gullerova et al., 2007; Lorkovic ZJ, unpublished results). It is therefore 
tempting to speculate that Dsk1 might regulate the activity of Rct1 in a cell cycle-
dependent manner. 
The interaction of Rct1 with Srp2 requires the RS domain of Srp2 protein and both PPIase 
and RS domain of Rct1 at the same time (Fig. 3.7.B. and C.).  Because the deletion of Srp2 
RS domain fully abolished the interaction, the Srp2 RRM1 and RRM2 domains are likely 
not involved. Considering the RS domain of Srp2 to be the physiological substrate of 
Rct1, we can speculate that the PPIase domain is required to modulate the conformation 
of the Srp2 RS domain, whereas the RS domain might be needed to stabilize and specify 
the interaction. The Srp2 is known to bind the model ESEs (Webb et al., 2005b) and to 
interact with U2AFSM (Webb and Wise, 2004). The U2AFSM creates complex with Prp2 
(U2AFLG) and binds to the 3’ splice site of an intron (Wentz-Hunter KPJ, 1996; Webb et 
al., 2005a). The regulation of Srp2 activity by Rct1 can therefore have a direct effect on 
the 3’ splice site selection. Recently, it was shown that in mammals the RS domain of ESE 
bound SR protein might employ the RS domain to contact the RNA duplex created 
between the pre-mRNA and U2 snRNA and thus modulate the spliceosomal 
rearrangements (Shen et al., 2004b). Although there is no evidence that ESE bound Srp2 
employs the RS domain for such interaction in fission yeasts, it is tempting to speculate 
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that Rct1 modulates the RNA-RNA interactions in the spliceosomal A complex by 
modifying the Srp2 RS domain.    
The interaction of Rct1 with Srp1 requires only the RS domain of Rct1, but not the PPIase 
and RRM domain of Rct1, and does not require the Srp1 RS domain (3.7.B and C.). It is 
possible that the Rct1 RS domain interacts with the RRM domain of Srp1. However it is 
also posible that Rct1 interaction with Srp1 detected in the pull down assay is not direct, 
but mediated by another protein. This bridging protein could be Srp2, because it is 
known to employ the RRM1 domain for the interaction with Srp1 RMM (Lutzelberger et 
al., 1999; Tang et al., 2002) and RS domain for the interaction with Rct1 RS domain (Fig. 
3.7.B.). Srp1 is a nuclear protein (see Fig. 3.10.); however, unlike to Srp2 and Rct1 it was 
neither cross-linked with the chromosomal DNA of dis2 gene (see Fig. 3.18.), nor it 
interacted with RNAPII in the pull down assay (see Fig.3.7.A.). It is therefore plausible 
that the Srp1 nuclear function is distinct from the Srp2 function. As was proposed by 
Tang et al. (2007) Srp1 is likely imported into the nucleus in a complex with Srp2. 
Furthermore, Srp1 inhibits the ability of Srp2 to regulate splicing of tfIId pre-mRNA via 
Srp1 RRM interaction with Srp2 RRM2 (Gross et al., 1998; Lutzelberger et al., 1999). This 
suggests that the essential protein Srp2 must be released from Srp1/Srp2 complex 
before tfIId pre-mRNA is spliced, and therefore the likely function of Srp1 is to regualte 
the activity of Srp2 protein. However, Srp1 might have another, yet not determined, 
functions in gene expression. 
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The interaction between the Rct1 and Prp2 is particularly interesting, because it directly 
links Rct1 with the core splicing machinery. The Rct1 interacts with Prp2 via PPIase and 
RS domain independently of each other, but only the RS domain of Prp2 is required for 
the interaction (see Fig. 3.7.B. and C.). The Prp2 is an homologue of U2AF65, a component 
of spliceosomal E and A complexes implicated in the 3’ splice site selection (Potashkin et 
al., 1993; Valcarcel et al., 1996; Webb et al., 2005a; Behzadnia et al., 2007). In 
mammalian cells the RS domain of U2AF65 subunit is required to promote transition from 
the spliceosomal E to A complex (Valcarcel et al., 1996). In agreement with this 
observation the deletion of Prp2 RS domain in S. pombe has dominant negative effect on 
pre-mRNA splicing (Webb et al., 2005a). Furthermore, Prp2 is also necessary for splicing 
of introns without the Py tract or introns with an atypical Py tract (Romfo et al., 1999, 
Sridharan and Singh, 2007) and tightly cooperates with U2AFSM in the 3’ splice site 
selection (Webb et al., 2005a). It is therefore possible that the RS domain of Prp2 might 
act to promote the rearrangements between the spliceosomal E and A complexes in the 
fission yeasts as well (Webb et al., 2005a). If we assume that the RS domain of Prp2 is 
indeed the physiological target of Rct1, we can speculate that Rct1 is needed to regulate 
the substrate specificity of Prp2 RS domain in vivo. This can be provided either by 
changing the conformation of RS domain by PPIase activity of Rct1, or simply by the 
means of chaperoning protein-protein interactions. As a consequence, Rct1 could 
modulate the Prp2-dependent 3’ splice site selection or the Prp2-dependent 
spliceosomal A complex assembly.  
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4.1.2. The potential role of Rct1 in coupling splicing with RNAPII transcription 
The RNAPII transcription cycle has several stages that are controlled by CTD domain 
phosphorylation (Egloff and Murphy, 2008; Buratowsky S, 2009; see also part 1.1. for 
details). The proper control of every stage is required to assure the fidelity of RNAPII 
transcription. The passage from one stage to the other is controlled by complex signalling 
checkpoints that are also coupled to the processing of nascent pre-mRNA (Cramer et al., 
2001; Phatnani and Greenleaf, 2006; Cho EJ, 2007; Egloff and Murphy, 2008; Margaritis 
and Holstege, 2008; Buratowski S, 2009; Cowling VH, 2010). Because Rct1 has a negative 
effect on Cdk9 kinase activity on Ser2 CTD substrate (Skrahina T, 2009), it might be 
required to regulate one or more RNAPII transcription checkpoints.  
The genome wide ChIP analysis revealed that RNAPII distribution is different along the 
introns and exons. In mammals RNAPII signal is higher along the exonic than intronic 
sequences  (Brodsky et al., 2005; Schwartz et al., 2009), wheras in S. pombe the RNAPII 
signal accumulates mainly along the intronic sequences of low expressed genes (Wilhelm 
et al., 2009). This suggests that the RNAPII processivity is reduced on introns in fission 
yeasts (further referred as an intron-dependent stalling of RNAPII), possibly as a 
consequence of a splicing quality control checkpoint. In accordance, my ChIP 
exepriments also show that the RNAPII signal is increased along the intronic sequences 
of low expressed dis2 and osm1 genes (see Fig. 3.14.A. and B.), but not along the highly 
transcribed rho1 gene.  
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Rct1 is known to interact with CTD domain of RNAPII (Gullerova et al., 2007) and the 
distribution of Rct1 signal in Rct1-ChIP experiments along the dis2, osm1 and rho1 genes 
closely resemble that of RNAPII, suggesting that RNAPII and Rct1 ‘’travel’’ along the 
genes together (compare Fig. 3.14 and 3.15.). Supported by an intriguing finding that the 
deletion of Rct1 RS domain changes the activity of GAL4-BD-Rct1 protein in the yeast two 
hybrid assay (Fig. 3.1.C.), I suggest that the RS domain of Rct1 might modulate the 
activity of full length Rct1 protein while associated with the RNAPII complex in vivo. 
Interestingly, the deletion of Rct1 RS domain also resulted in increased RNAPII signal on 
dis2 transcriptional unit at the position D5, e.i. at the position where the signal is 
reduced compared to the intronic sequence in the full length protein background (Fig. 
3.14.A.). Importantly, the deletion of Rct1 RS domain did not result in reduced or 
increased Rct1 protein levels along the dis2, osm1 and rho1 transcriptional units when 
compared to the full length Rct1 protein (Fig. 3.15.), although the total expression of 
Rct1 ΔRS protein was increased compared to the full length protein (see Fig. 3.12.D.). 
Therefore I propose that the Rct1 RS domain might be needed to release RNAPII from 
the intron-dependent stalling.  
The inability of truncated Rct1 ΔRS protein to release the RNAPII from the intron 
depended RNAPII stalling on dis2 gene can reflect (i) an impaired recruitment of splicing 
factors to transcribing RNAPII or (ii) an impaired spliceosome assembly or (iii) simply an 
impaired signalling between the spliceosome and RNAPII. I was able to show that Rct1 RS 
domain deletion does not affect the splicing efficiency of dis2, osm1 and rho1 mRNAs 
(Fig. 3.16 and 3.17.), arguing that the Rct1 RS domain deletion effect on the co-
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transcriptional splicing is rather rate-limiting then qualitative trait. Furthermore, I 
showed that Srp2 protein, but not Srp1, associates with the dis2, osm1 and rho1 
transcriptional units in ChIP experiments with similar distribution pattern as the RNAPII 
and Rct1. Consistent with the results of in vitro pull down experiments (Fig. 3.7.), this 
suggests that not only the Rct1, but also the Srp2 associates with RNAPII during the 
transcription. Furthermore, the deletion of Rct1 RS domain had no significant effect on 
Srp2 distribution along dis2 transcriptional unit, showing that the recruitment of this 
splicing factor is not impaired.  
It is not easy to reconstruct events that are needed to release RNAPII from the intron-
dependent RNAPII stalling. The increased RNAPII signal on introns in fission yeasts was 
correlated with reduced H3K36me3 methylation signal (Wilhelm et al., 2009). It is 
therefore possible that the epigenetic marking contributes to the RNAPII release from 
intron-dependent stalling, as has already been suggested for some other organisms 
(Andersson et al., 2009; Schwartz et al., 2009; Hon et al., 2009; Kolasinska-Zwierz et al., 
2009). My ChIP experiments suggest that yeasts require Rct1 for the RNAPII release from 
intron-dependent RNAPII stalling at dis2 gene.  Furthermore, my and some other ChIP 
data (Guiguen et al., 2007; Viladevall et al., 2009; Skrahina T, 2009) suggest that Cdk9, 
Rct1 and Srp2 are all associated with Ser5 and Ser2 phosphorylated RNAPII during the 
whole elongation phase of transcription. There is no similar experimental evidence 
showing that Prp2 is associated with RNAPII CTD during the whole elongation phase of 
transcription. But based on experiments with its mammalian homologue U2AF65 it seems 
plausible that it also associates with RNAPII, at least transiently (Robert et al., 2002; 
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Ujvari et al., 2004). Also my pull down experiments show that Prp2 is able to interact 
with the RNAPII in vitro (Fig. 3.7.A.).  I consider it plausible that Cdk9, Rct1, Prp2 and Srp2 
proteins interact transiently with each other on the RNAPII CTD platform and that the 
nature of these interactions changes in accordance with the progression of the splicing 
process. Therefore, I propose a following model for Prp2/Srp2-dependent Rct1-mediated 
RNAPII release from the intron dependent-stalling on dis2 intron (Fig. 4.1.). 
 
Figure 4.1. A proposed working model of Prp2 and/or Srp2-dependent Cdk9 inhibition by Rct1 
on intron region.  
During the productive elongation phase of transcription the Ser2 of RNAPII CTD is 
phosphorylated by Cdk9 kinase. The splicing factors (here U1 snRNP, Prp2 and Srp2) are pre-
associated with the transcribing RNAPII, so that they are ready to recognize the signal sequences 
that appear on the nascent pre-mRNA (A). On the intron region Rct1 likely inhibits the activity of 
Cdk9 kinase that leads to reduced RNAPII processivity( B).  At this stage the Prp2 and Srp2 are 
free to interact with the pre-mRNA. When the 5’ and 3’ splice site appear on the nascent pre-
mRNA they are recognized by U1 snRNP and Prp2 and the spliceosomal E complex is created on 
RNAPII CTD platform (C). When an enhancer sequence appears on the nascent pre-mRNA it is 
recognized by Srp2 protein to stabilize the interactions between the U1 and U2 snRNPs of the 
spliceosomal A complex. Around this stage Rct1 likely dissociates from the inhibitory Cdk9 
complex resulting in increased RNAPII processivity and in the RNAPII release form the intron-
dependent stalling (D).   
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For simplicity, in my model Rct1 can interact either with Cdk9 or one of the splicing 
factors (Prp2 or Srp2) while on the RNAPII CTD platfom. It is plausible that Rct1 does not 
inhibit Cdk9 activity during the productive elongation on exon (Fig. 4.1.A.), because it 
would likely have a negative effect on RNAPII processivity (Gullerova et al., 2007; 
Skrahina T, 2009). It is possible that at this stage Rct1 also interacts with some other 
RNAPII associated factors, for example Srp2 and/or Prp2, or with the CTD itself. When 
RNAPII starts transcription of the intron, the Rct1 might create an inhibitory complex 
with Cdk9 that results in reduced RNAPII processivity (Fig. 4.1.B. and C.). But the reasons 
for reduced RNAPII activity might be of a complex character. For example, the overall 
chromatin architecture of intronic DNA might contribute to the reduced RNAPII 
processivity (Schwartz et al., 2009). However, there exists also experimental evidence 
suggesting that the spliceosomal assembly is coupled to the regulation of RNAPII 
processivity (Fong and Zhou, 2001; Kameoka et al., 2004; Bres etal., 2005; Barboric et al., 
2009; see also part 1.4.1. for details). It is therefore possible that RNAPII elongation 
factors somehow sense the stage of spliceosomal assembly and adopt the RNAPII 
processivity and chromain architecture accordingly (Zhong et al., 2009). I have shown 
that Rct1 RS domain is required for RNAPII release from intron-dependent staling at dis2 
gene. I therefore consider it plausible that the Rct1 associated with Cdk9 somehow 
senses the progress of spliceosomal assembly, possibly by its RS domain and modulates 
the activity of Cdk9 accordingly. Other possible model scenario is that Rct1 is released 
from the interaction with Cdk9 and associates with Prp2 and/or Srp2 during a specific  
4. Discussion 
 
159 
step of spliceosomal assembly, e.g. spliceosomal A complex, resulting in enhanced 
RNAPII processivity (Fig. 4.1.D).  
 
Figure 4.2. A proposed role for Rct1 in coupling spliceosomal assembly to RNAPII transcription 
in S. pombe. 
In the pre-spliceosomal E complex the 5’ splice site (GU) is recognized by U1 snRNP, the 3’ splice 
site (AG) by U2AFSM, the polypirimidine tract (Py) by Prp2 (U2AFLG) and the branch point 
sequence (BP) by Bpb1 (SF1/BBP). The interaction between the U2AFSM and 3’ splice site can be 
further stabilized by ESE-bound SR protein Srp2. At this stage Rct1 likely inhibits the activity of 
Cdk9 towards Ser2 of RNAPII CTD (A). In the pre-spliceosomal A complex the Bpb1 is replaced by 
U2 snRNP that interacts with U1 snRNP and Prp2. At this stage Prp2 might interact with Uap2 
(TAT/SF1) that can positively stimulate the activity of CDK9 on Ser2 CTD substrate. At the same 
time Rct1 likely dissociates off the inhibitory Cdk9 complex and might modulate the activity and 
substrate specificity of Prp2 and/or Srp2 and therefore contribute to the spliceosomal 
rearrangements (B). 
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It is also possible that Rct1 changes the activity of Prp2 and/or Srp2 in a way that results 
in enhanced RNAPII transcription (Fig. 4.2.B.). For example, Prp2 is known to interact 
with Uap2, a fission yeast homologue of TAT-SF1 transcription factor (McKinney et al., 
1997) and TAT-SF1 in turn interacts with CDK9/cyclin T1 complex (Fong and Zhou, 2001). 
The TAT-SF1 is a component of the mammalian spliceosomal A complex (Behzadnia et 
al., 2007) and is required for recruitment of snRNP complexes to RNAPII CTD (Fong and 
Zhou, 2001). There is no direct experimental evidence that TAT-SF1 stimulates the 
activity of CDK9 kinase; however, it seems plausible, because the snRNP recruitment is 
CTD phosphorylation-dependent (Fong and Zhou, 2001). It is therefore tempting to 
speculate that Rct1 might enhance the Cdk9 activity and RNAPII processivity in Prp2 and 
Uap2-dependent manner during the release from the intron dependent stalling (Fig. 
4.2.B.).  
It is also possible that different models are employed under different physiological 
conditions or on different genes. Indeed, the effect of Rct1 on RNAPII transcription and 
pre-mRNA splicing is likely gene-specific. Gullerova et al. (2007) showed that reduced 
Rct1 protein levels in diploid cells during the meiotic differentiation result in increased 
transcription and splicing of a subset of genes, which are specifically spliced upon the 
meiotic induction (Averbeck et al., 2005; Moldon et al., 2008). By contrast, the 
constitutively spliced genes are not influenced by Rct1 protein levels. Transcription-
dependent splicing of one of these genes, rem1, is known to be regulated by the 
promotor sequence of the gene in cooperation with forkhead transcription factors Fkh1 
and Mei4 in transcription-dependent manner (Malapeira et al., 2005; Moldon et al., 
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2008; see also part 1.4.3. for details). Importantly, Moldon et al. (2008) showed that 
Mei4 is also required to load active spliceosome on transcribing RNAPII. Gullerova et al. 
(2007) showed that in the time course of meiosis Rct1 becomes enriched along the 
transcription units of Rct1-dependent genes. In combination with our current data, we 
can speculate that Rct1 might act to enhance Mei4-dependent spliceosomal recruitment 
along these genes, possibly via interactions with Prp2 and/or Srp2 and/or Srp1.  
The gene specific effect of Rct1 on transcription and splicing likely occurs also in mitotic 
cells. For example the loss of Rct1 protein in cycling cells results in chromosome 
segregation and cytokinesis defects (Gullerova et al., 2007), suggesting that Rct1 effect 
on transcription is not general, but rather gene specific. Interestingly, similar phenotypes 
were assigned to mutations in Prp2, Cdk9 and Lsk1 proteins that are known to interact 
with Rct1 (Takahashi et al., 1994; Karagiannis et al., 2005; Webb et al., 2005a; 
Karagiannis and Balasubramanian, 2007; Viladevall et al., 2009). It is therefore tempting 
to speculate that Rct1 might regulate the expression and/or splicing of some genes 
required for chromosome segregation and cytokinesis.   
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4.2. INTERACTIONS OF Rct1 WITH TRANSLIN 
The PPIases usually recognize and modify high number of protein targets. This is well 
documented in the case of Pin1/Ess1 PPIase that modulates the activity of many protein 
targets involved in diverse cellular processes (Lu and Zhou, 2007b). To extend our 
knowledge of Rct1 protein targets I performed yeast two hybrid screen with Rct1 as bait. 
By screening the S. pombe pTN-TH7 library of pooled mitotic and meiotic cDNAs I have 
identified several putative targets of Rct1 (Tab. 3.1.). Surprisingly, I did not identify any of 
the known Rct1 targets in the screen. This was particularly surprising, because the 
interactions between the AtCyp59 and plant SR proteins were detected employing 
similar yeast two hybrid assay (Gullerova et al., 2006). On the contrary, Rct1 interactions 
with CTD, Cdk9 and Lsk1 were studied solely in vitro, as any attempts to assay for the 
interactions in the yeast two hybrid assays were not successful (Skrahina T, 2009). One of 
the isolated cDNAs encoded a conserved protein translin (Tsn1). Based on our knowledge 
of Rct1 and available information about Tsn1 I decided to analyze Tsn1 interaction with 
Rct1 further.  
Tsn1 is reported to be, like Rct1, a nuclear protein (ORFeome data in Matsuyama et al., 
2006). Several reports suggests that Tsn1 is involved in RNA and/or DNA metabolism 
(Sengupta and Rao, 2002; Yang et al., 2003; Cho et al., 2005; Chiaruttini et al., 2009; Liu 
et al., 2009) and tsn1 mRNA expression is up-regulated during meiotic differentiation in a 
similar manner to rct1 mRNA (Mata et al., 2002). Furthermore, Tsn1 is highly conserved 
in higher eukaryotes, but like Rct1 does not have any homologue in S. cerevisiae.  
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Translin has been extensively studied in humans, mouse, fruit flies and also in fission 
yeasts and was implicated in diverse biological processes (reviewed in Li et al., 2008; 
Jaendling and McFarlane, 2010). These include mRNA trafficking and translational 
repression in mammalian neuronal cells (Gu et al., 1998; Muramatsu et al., 1998;  
Finkenstadt et al., 2000; Chiaruttini et al., 2009) and spermatocytes (Gu et al., 1998; Wu 
and Hecht, 2000; Yang et al., 2003; Cho et al., 2005), RISC-dependent mRNA degradation 
in Drosophila (Wang et al., 2004; Liu et al., 2009), regulation of steroidogenic factor-1 
(SF-1)-stimulated transcription in mammals (Mellon et al., 2007), genome stability 
regulation and DNA recombination (Aoki et al., 1995; Kasai et al., 1997; Taira et al.,1998; 
Hosaka et al., 2000;  Sengupta and Rao, 2002), cell growth regulation (Ishida et al., 2002; 
Yang and Hecht, 2004) and microRNA stability (Yu and Hecht, 2008). Translin assembles 
into octamers (or decamers in Drosophila) in vitro (VanLoock et al., 2001; Sugiura et al., 
2004; Gupta et al., 2008) and binds single stranded DNA and RNA sequences (Yang et al., 
2003; Jacob et al., 2004; Cho et al., 2005). It also creates heteromeric complex with TRAX 
protein that is likewise implicated in nucleic acid binding (Vargheese et al., 2001; 
Finkenstadt et al., 2002; Li and Baraban, 2004, Gupta et al., 2005). Translin and TRAX are 
paralogous proteins, suggesting that they functionally co-evolved. Indeed, TRAX 
expression is under the tight control of translin and this trait is evolutionary conserved 
from yeast to humans (Chennathukuzhi et al., 2003; Laufman et al., 2005; Claussen et al., 
2006). Furthermore, it seems likely that TRAX regulates translin affinity for either RNA or 
DNA (Chennathukuzhi et al. 2001; Lluis et al., 2010). Fission yeast translin and TRAX 
proteins share the main biochemical characteristics with translin/TRAX complexes of 
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higher eukaryotes (Laufman et al., 2005). Yet, the biological function of Tsn1/TRAX 
complex in yeasts is unknown, but the experimental evidence of Jaendling et al., (2008) 
suggests that it is not involved in DNA recombination.    
Translin is reported to be predominantly cytoplasmic protein, however, it is known to 
localize to nucleus in hematopoetic cell lines and in HeLa cells in a response to DNA-
damaging drugs (Aoki et al., 1995; Kasai et al., 1997). It was also found to be specifically 
associated with centrosomes, bipolar mitotic splindles and midbodies in mice and 
centrosomes in Xenopus oocytes (Castro et al., 2000; Ishida et al., 2002). In large scale 
protein localization study with fission yeasts it was found mainly in the nucleus, but also 
in cytoplasm (Matsuyama et al., 2006). My experiments did not validate the data form 
this study. First, I could not detect the GFP-tagged Tsn1 protein in cells where the tsn1 
gene was tagged with GFP on chromosome, suggesting that GFP tag interferes with Tsn1 
expression or Tsn1 protein stability. Second, I observed the Tsn1-HA signal mainly in the 
cytoplasm of formaldehyde fixed wt + pMGT and Δtsn1 + pMGT cells (Fig. 3.25. and 
3.26.). Nevertheless, it is still possible that a small portion of Tsn1 localizes to the cell 
nucleus. In fact, the Tsn1-ChIP data suggest that at least a part of Tsn1 is associated with 
nuclear chromatin in a way similar to Rct1 (Fig. 3.27.).  
My pull down experiments revealed that Rct1 interacts with the recombinant Tsn1 
protein in vitro, and that both PPIase and RRM domains are involved in the interaction 
(Fig. 3.3. and 3.5.). The Rct1 RS domain is also required for the interaction. The main role 
of RS domain in the interaction seems to be stabilization of PPIase and RRM domain 
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structure, but we also cannot exclude the direct participation of RS domain in the 
interaction. Similar to SR proteins, I could not reproduce the pull down interaction of 
translin with Rct1 employing the co-immunoprecipitation assay. Again, one possible 
explanation is that the in vivo interactions are only transient or phosphorylation-
dependent and therefore under the detection limit of the co-immunoprecipitation assay. 
Another possibility is that Rct1 interacts only with Tsn1 monomers or homomers that are 
likely not abundant in the cell. Yet, this kind of interaction might be important for the 
assembly of functional Tsn1/TRAX heteromeric complexes. Indeed, one of the putative 
Rct1 target sites lies within the loop region and the proper structure of this loop was 
reported to play an essential function in the translin oligomerization in Drosophila (Gupta 
et al., 2008). I also tested Tsn1 for the interactions with fission yeast SR proteins and 
splicing related kinases. Surprisingly, the pull down experiments revealed that Tsn1 
interacts with splicing factor Prp2 (Potashkin et al., 1989; Webb et al., 2005; Sridharan 
and Singh, 2007) and splicing related Prp4 kinase (Alahari et al., 1993; Gross et al., 1997), 
suggesting that Tsn1 might be, like Rct1, involved in the pre-mRNA processing.  
Neither deletion nor overexpression of tsn1 gene has any reproducible effect on the 
viability or cell morphology of the fission yeasts (see Fig. 3.20. and Laufman et al., 2005; 
Jaendling et al., 2008).  Interestingly, the expression levels of Tsn1 and Rct1 mRNAs are 
increased during the meiotic differentiation, being highest during the first and second 
meiotic division (Mata et al., 2002), suggesting that the two proteins might be required 
for a meiosis-specific process. Accordingly, I could show that Tsn1 protein level increases 
during the meiosis I and II (Fig. 3.23.). Furthermore, my experiments revealed that both 
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overexpression and deletion of tsn1 in diploid cells result in significantly decreased 
sporulation efficiency in otherwise wild type cells (Fig 3.21.). This suggests that a precise 
amount of Tsn1 is required for proper meiotic differentiation.  By introducing the pat1-
114/pat1-114 mutation into the Δtsn1/Δtsn1 strain the decreased sporulation efficiency 
of Δtsn1/Δtsn1 strain was fully restored (Fig. 3.24.). It is therefore possible that Tsn1 is 
needed, directly or indirectly, to deactivate the negative regulator of meiosis Pat1 that 
acts at an early stage of meiosis. It was previously reported that Rct1 negatively 
regulates sporulation efficiency in a dosage-dependent manner (Gullerova et al., 2007), 
whereas I showed here that the rct1 gene deletion is epistatic over the tsn1 
overexpression (Fig. 3.12.). It is therefore possible that Rct1 regulates the activity of Tsn1 
during the meiotic differentiation. Although the precise function of Tsn1 in meiosis is 
unclear, the interaction of Tsn1 with Prp4 and Prp2 and the fact that Rct1 influences 
splicing of meiotic genes (Gullerova et al., 2007) suggest that both genes might act 
together to regulate meiosis-specific transcription and/or splicing.  
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• Dates (from – to)  13. 1. - 15. 1. 2009 
• Name and type of 
organisation providing 
education and training 
 European Molecular Biology Organisation, EMBO 
• Principal 
subjects/occupational skills 
covered 
 EMBO workshop on "Regulatory RNAs in Pro- & Eukaryotes" 
 
LABORATORY EXPERIENCES 
• Dates (from – to)  2007 - 2010 
• position  PhD student 
• lab head  Dr. Lorkovic Zdravko   
•institute/department/  
place/country  
 Max F. Perutz Laboratories, Department of Molecular Biology 
and Biochemistry, Dr. Bohr-Gasse 9, 1030 Wien, Austria 
•name of project  The role of Schizosaccharomyces pombe cyclophilin Rct1 in coupling 
splicing to RNA polymerase II transcription 
• Dates (from – to)  2004 – 2007  
• position  Diploma student  
• lab head  Prof. Tomaska Lubomir   
•institute/department/ 
place/country  
 Comenius University - Faculty of Natural Sciences, Department 
of Genetics, Mlynska dolina B-1, 842 15 Bratislava, SLOVAKIA 
•name of project   Vacuolar and mitochondrial communication induced by 
nigericin in the yeasts Saccharomyces cerevisiae 
 
